Omega Protein (OME) 10-K 10 Mar 14 2013 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Mar. 03, 2014	Jun. 30, 2013
Document and Entity Information [Abstract]	'	'	'
Entity Registrant Name	'Omega Protein Corp	'	'
Document Type	'10-K	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Common Stock, Shares Outstanding	'	20,896,734	'
Entity Public Float	'	'	$180,439,387
Amendment Flag	'false	'	'
Entity Central Index Key	'0001053650	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Filer Category	'Accelerated Filer	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Document Period End Date	31-Dec-13	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$34,059	$55,998
Receivables, net	21,140	17,267
Inventories	94,339	66,659
Deferred tax asset, net	1,062	1,165
Prepaid expenses and other current assets	3,915	3,430
Total current assets	154,515	144,519
Other assets, net	5,234	10,789
Property, plant and equipment, net	144,113	127,640
Goodwill	19,600	7,986
Other intangible assets, net	7,932	4,362
Total assets	331,394	295,296
Current liabilities:	'	'
Current maturities of long-term debt	3,112	3,058
Current portion of capital lease obligation	'	268
Accounts payable	5,380	3,000
Accrued liabilities	29,145	31,741
Total current liabilities	37,637	38,067
Long-term debt, net of current maturities	21,130	24,242
Deferred tax liability, net	19,351	15,794
Pension liabilities, net	4,117	9,826
Other long-term liabilities	1,929	1,764
Total liabilities	84,164	89,693
Commitments and contingencies	'	'
Stockholders’ equity:	'	'
Preferred stock, $0.01 par value; 10,000,000 authorized shares; none issued	0	0
Common Stock, $0.01 par value; 80,000,000 authorized shares; 20,804,189 and 19,883,940 shares issued and outstanding at December 31, 2013 and 2012, respectively	203	195
Capital in excess of par value	136,428	129,040
Retained earnings	116,807	86,292
Accumulated other comprehensive loss	-6,208	-9,924
Total stockholders’ equity	247,230	205,603
Total liabilities and stockholders’ equity	$331,394	$295,296

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parentheticals) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Preferred stock par value (in Dollars per share)	$0.01	$0.01
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Common Stock, par value (in Dollars per share)	$0.01	$0.01
Common Stock, shares authorized	80,000,000	80,000,000
Common Stock, shares issued	20,804,189	19,883,940
Common Stock, shares outstanding	20,804,189	19,883,940

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (USD $)	12 Months Ended
Share data in Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Revenues	$244,293,000	[1]	$235,639,000	[2]	$251,743,000	[3]
Cost of sales	161,543,000		193,583,000		197,069,000
Gross profit	82,750,000		42,056,000		54,674,000
Selling, general, and administrative expense	25,293,000		21,737,000		23,050,000
Research and development expense	2,407,000		2,209,000		1,588,000
Operating income	48,013,000		12,626,000		54,359,000
Interest income	18,000		32,000		43,000
Interest expense	-1,658,000		-1,335,000		-2,109,000
Other expense, net	-394,000		-365,000		-408,000
Income before income taxes	45,979,000		10,958,000		51,885,000
Provision for income taxes	15,464,000		6,895,000		17,728,000
Net income	30,515,000		4,063,000		34,157,000
Other comprehensive income (loss):	'		'		'
Energy swap adjustment, net of tax expense (benefit) of $81, $241, and ($486), respectively	151,000		448,000		-925,000
Pension benefits adjustment, net of tax expense (benefit) of $1,920, $165 and ($1,306), respectively	3,565,000		307,000		-2,071,000
Comprehensive income	34,231,000		4,818,000		31,161,000
Basic earnings per share (See Note 13) (in Dollars per share)	$1.50		$0.21		$1.77
Weighted average common shares outstanding (in Shares)	19,913		19,420		19,238
Diluted earnings per share (See Note 13) (in Dollars per share)	$1.45		$0.20		$1.71
Weighted average common shares and potentialcommon share equivalents outstanding (in Shares)	20,634		19,874		19,923
Charges related to U.S. Attorney investigation	'		7,990,000		545,000
Impairment of intangible assets	266,000		129,000		'
Plant Closure [Member]	'		'		'
Loss (gain) on disposition of assets	6,597,000		'		'
Disposal of Assets [Member]	'		'		'
Loss (gain) on disposition of assets	174,000		-2,635,000		2,096,000
Oil Spill [Member]	'		'		'
Other comprehensive income (loss):	'		'		'
Proceeds from Catastrophe	'		'		-26,177,000
Storm 2005 [Member]	'		'		'
Other comprehensive income (loss):	'		'		'
Proceeds from Catastrophe	'		'		($787,000)
[1]	Excludes revenue from internal customers of $1.3 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.
[2]	Excludes revenue from internal customers of $1.6 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.
[3]	Excludes revenue from internal customers of $0.4 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.

Consolidated_Statements_of_Com1

Consolidated Statements of Comprehensive Income (Parentheticals) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Energy swap adjustment, tax expense (benefit)	$81	$241	($486)
Pension benefits adjustment, tax expense (benefit)	$1,920	$165	($1,306)

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:	'	'	'
Net income	$30,515	$4,063	$34,157
Adjustments to reconcile net income (loss) to net cash provided by operating activities:	'	'	'
Depreciation and amortization	21,056	17,999	16,430
Impairment of intangible assets	266	129	'
Provisions for losses on receivables	103	48	48
Share based compensation	1,982	3,721	3,295
Deferred income taxes	3,579	2,272	4,255
Changes in assets and liabilities:	'	'	'
Receivables	-2,630	-494	-4,751
Inventories	-26,855	-1,766	10,181
Prepaid expenses and other current assets	-191	-616	126
Other assets	4,092	-6,379	-3,850
Accounts payable	1,644	-779	761
Accrued liabilities	-5,250	11,855	-95
Pension liability, net	-2,144	-735	-748
Other long-term liabilities	165	52	816
Net cash provided by operating activities	32,020	26,735	62,721
Cash flows from investing activities:	'	'	'
Proceeds from disposition of assets	470	6,152	2,339
Land and building purchased in capital lease extinguishment	-5,005	'	'
Capital expenditures	-24,796	-25,064	-23,352
Net cash used in investing activities	-56,007	-18,731	-32,211
Cash flows from financing activities:	'	'	'
Principal payments of long-term debt	-3,058	-2,994	-3,007
Principal payments of capital lease obligation	-309	-517	-474
Debt issuance costs	'	-389	'
Proceeds from stock options exercised	4,009	469	2,879
Excess tax benefit of stock options exercised	1,406	34	1,699
Net cash provided by (used in) financing activities	2,048	-3,397	1,097
Net (decrease) increase in cash and cash equivalents	-21,939	4,607	31,607
Cash and cash equivalents at beginning of year	55,998	51,391	19,784
Cash and cash equivalents at end of year	34,059	55,998	51,391
Cash paid during the year for:	'	'	'
Interest	1,865	1,991	2,205
Income taxes	8,107	3,836	12,257
Disposal of Assets and Plant Closure [Member]	'	'	'
Adjustments to reconcile net income (loss) to net cash provided by operating activities:	'	'	'
Loss (gain) on disposition of assets	5,514	'	'
Disposal of Assets [Member]	'	'	'
Adjustments to reconcile net income (loss) to net cash provided by operating activities:	'	'	'
Loss (gain) on disposition of assets	174	-2,635	2,096
InCon [Member]	'	'	'
Cash flows from investing activities:	'	'	'
Acquisitions	'	181	-9,028
Wisconsin Specialty Protein [Member]	'	'	'
Cash flows from investing activities:	'	'	'
Acquisitions	-26,676	'	'
Cyvex [Member]	'	'	'
Cash flows from investing activities:	'	'	'
Acquisitions	'	'	($2,170)

Consolidated_Statements_of_Sto

Consolidated Statements of Stockholders' Equity (USD $)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Total
In Thousands, unless otherwise specified
Balance at Dec. 31, 2010	$188	$116,950	$48,072	($7,683)	$157,527
Balance (in Shares) at Dec. 31, 2010	18,827	'	'	'	'
Issuance of common stock	6	7,793	'	'	7,799
Issuance of common stock (in Shares)	536	'	'	'	'
Restricted stock activity	'	74	'	'	74
Restricted stock activity (in Shares)	206	'	'	'	'
Net Income	'	'	34,157	'	34,157
Other comprehensive income (loss):	'	'	'	'	'
Energy swap adjustment, net of tax	'	'	'	-925	-925
Pension benefits adjustment, net of tax	'	'	'	-2,071	-2,071
Balance at Dec. 31, 2011	194	124,817	82,229	-10,679	196,561
Balance (in Shares) at Dec. 31, 2011	19,569	'	'	'	'
Issuance of common stock	1	3,603	'	'	3,604
Issuance of common stock (in Shares)	100	'	'	'	'
Restricted stock activity	'	620	'	'	620
Restricted stock activity (in Shares)	215	'	'	'	'
Net Income	'	'	4,063	'	4,063
Other comprehensive income (loss):	'	'	'	'	'
Energy swap adjustment, net of tax	'	'	'	448	448
Pension benefits adjustment, net of tax	'	'	'	307	307
Balance at Dec. 31, 2012	195	129,040	86,292	-9,924	205,603
Balance (in Shares) at Dec. 31, 2012	19,884	'	'	'	'
Issuance of common stock	8	6,019	'	'	6,027
Issuance of common stock (in Shares)	862	'	'	'	'
Restricted stock activity	'	1,369	'	'	1,369
Restricted stock activity (in Shares)	58	'	'	'	'
Net Income	'	'	30,515	'	30,515
Other comprehensive income (loss):	'	'	'	'	'
Energy swap adjustment, net of tax	'	'	'	151	151
Pension benefits adjustment, net of tax	'	'	'	3,565	3,565
Balance at Dec. 31, 2013	$203	$136,428	$116,807	($6,208)	$247,230
Balance (in Shares) at Dec. 31, 2013	20,804	'	'	'	'

Consolidated_Statements_of_Sto1

Consolidated Statements of Stockholders' Equity (Parentheticals) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Energy swap adjustment, tax expense (benefit)	$81	$241	($486)
Pension benefits adjustment, tax expense (benefit)	$1,920	$165	($1,306)

Note_1_Significant_Accounting_

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation

12 Months Ended

Dec. 31, 2013

Accounting Policies [Abstract]

'

Significant Accounting Policies [Text Block]

'

NOTE 1.    SIGNIFICANT ACCOUNTING POLICIES

SUMMARY OF OPERATIONS AND BASIS OF PRESENTATION

Business Description

Omega Protein Corporation is a nutritional company that develops, produces and delivers healthy products throughout the world to improve the nutritional integrity of functional foods, dietary supplements and animal feeds. The Company operates through two industry segments: animal nutrition and human nutrition.

The animal nutrition segment is comprised primarily of two subsidiaries: Omega Protein, Inc. (“Omega Protein”) and Omega Shipyard, Inc. (“Omega Shipyard”). Omega Protein, the Company’s principal operating subsidiary, is the successor to a business conducted since 1913. Omega Protein produces and markets a variety of products produced from menhaden (a herring-like species of fish found in commercial quantities in the U.S. coastal waters of the Atlantic Ocean and Gulf of Mexico), including regular grade and value-added specialty fish meals, crude and refined fish oils and fish solubles. Omega Protein’s fish meal products are primarily used as a protein ingredient in animal feed for swine, aquaculture and household pets. Fish oil is utilized primarily for animal and aquaculture feeds, as well as additives to human food products and dietary supplements. Omega Protein’s fish solubles are sold primarily to livestock feed manufacturers, aquaculture feed manufacturers and for use as an organic fertilizer. Omega Protein’s business is seasonal in nature and generally has higher revenues during the third quarter of each fiscal year. A portion of Omega Protein’s production is transferred to the human nutrition segment where it is further processed and sold. Omega Shipyard owns and operates a drydock facility in Moss Point, Mississippi that is used to provide shoreside maintenance for Omega Protein’s fishing fleet and, subject to outside demand and excess capacity, occasionally for third-party vessels.

The human nutrition segment, which operates under the name Nutegrity, has three primary product lines: protein products, Omega-3 fish oil ingredients and other nutraceutical ingredients. Nutegrity is comprised primarily of three subsidiaries: Cyvex Nutrition, Inc. (“Cyvex”), InCon Processing, L.L.C. (“InCon”) and Wisconsin Specialty Protein, L.L.C. (“WSP”). Cyvex, acquired by the Company in December 2010, is located in Irvine, California and participates in the nutraceutical industry as an ingredient provider. InCon, acquired by the Company in September 2011, is located in Batavia, Illinois and is a specialty processor that utilizes molecular distillation technology to concentrate Omega-3 fish oils and, subject to outside demand and excess capacity, a variety of other compound products for third-party tolling customers. WSP, acquired by the Company on February 27, 2013, is a manufacturer and marketer of specialty dairy and other protein products headquartered in Madison, Wisconsin and operates a production facility in Reedsburg, Wisconsin. See Note 2 – Acquisition of Wisconsin Specialty Protein, L.L.C. for additional information related to the Company’s acquisition of WSP.

Consolidation

The consolidated financial statements include the accounts of Omega Protein Corporation and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

Financial Statement Preparation

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Company’s financial statements and the accompanying notes and the reported amounts of revenues and expenses during the reporting period. Actual amounts, when available, could differ from those estimates and those differences could have a material effect on the financial statements.

Certain amounts applicable to the prior periods have been reclassified to conform to the classifications currently followed. For the years ended December 31, 2012 and 2011, the Company reclassified $0.2 million and $0.5 million, respectively, of cash flows from investing activities to cash flows from operating activities related to accrued capital expenditures.  This revision was not considered to be material, individually or in the aggregate, to previously issued financial statements. The revisions had no effect on the results of operations (net or comprehensive income) or financial condition (stockholders’ equity).

Gulf of Mexico Oil Spill

In 2010, the Company accounted for $18.7 million in emergency payments received from the Gulf Coast Claims Facility (“GCCF”) during September and October related to damages incurred from the Gulf of Mexico oil spill in its inventory and cost of sales. The payments partially reduced cost of sales by 4.4%, or $8.2 million for the year ended December 31, 2011.

In April 2011, the Company agreed to a final settlement of all of its claims for costs and damages incurred as a result of the oil spill caused by the Deepwater Horizon explosion and received a final payment of $26.2 million, net of fees and expenses, from the GCCF. The amount was recognized as “Proceeds/gains resulting from Gulf of Mexico oil spill” in the Company’s consolidated statement of comprehensive income for the year ended December 31, 2011.

In total, the Company received payments of $44.8 million, net of fees and expenses, from the GCCF in 2010 and 2011. As a part of the final settlement, the Company released and waived all current and future claims against BP and all other potentially responsible parties with regard to the oil spill.

For additional information, see Note 4 – Gulf of Mexico Oil Spill.

Revenue Recognition

The Company derives revenue principally from the sales of a variety of protein and oil products derived from menhaden. In addition and as a result of its recent acquisitions of Cyvex, InCon and WSP, the Company’s revenues also include sales of dietary supplement ingredients to the nutraceutical industry and whey protein products to the food and nutritional supplement industries. The Company recognizes revenue for the sale of its products when price is established, collectability is reasonably assured, and title and rewards of ownership of its products are transferred to the customer.

Shipping and Handling

Amounts billed to customers associated with shipping and handling are included in revenues and the related costs are included in cost of sales. For 2013, 2012 and 2011, $9.4 million, $14.4 million and $16.5 million of shipping and handling costs are included in cost of sales, respectively.

Cash and Cash Equivalents

The Company considers cash in banks and short-term investments with original maturities of three months or less as cash and cash equivalents.

Allowances for Doubtful Accounts

The Company’s receivables are recorded at net realizable value. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of the Company’s customers to make required payments. The Company considers the following factors when determining if collection is reasonably assured: customer credit worthiness, past transaction history with the customer, and changes in customer payment terms. If the Company has no previous experience with the customer, the Company typically obtains reports from credit organizations to ensure that the customer has a history of paying its creditors. The Company may also request financial information, including financial statements or other documents (e.g., bank statements), or may obtain a letter of credit from the customer to ensure that the customer has the means of making payment. If the financial condition of the Company’s customers were to deteriorate, adversely affecting their ability to make payments, additional allowances would be required.

Inventories

Omega Protein’s fishing season runs from mid-April to the first of November in the Gulf of Mexico and from the beginning of May into December in the Atlantic. Government regulations generally preclude Omega Protein from fishing during the off-seasons.

Omega Protein’s inventory cost system considers all costs associated with an annual fish catch and its processing, both variable and fixed, including both costs incurred during the off-season and during the fishing season. Omega Protein’s costing system allocates cost to inventory quantities on a per unit basis as calculated by a formula that considers total estimated inventoriable costs for a fishing season (including off-season costs) to total estimated units of production and the relative fair market value of the individual products produced. Omega Protein adjusts the cost of sales, off-season costs and inventory balances at the end of each quarter based on revised estimates of total inventoriable costs and units of production. Omega Protein’s lower-of-cost-or-market-value analyses at year-end and at interim periods compare the total estimated per unit production cost of Omega Protein’s expected production to the projected per unit market prices of the products. The impairment analyses involve estimates of, among other things, future fish catches and related costs, and expected commodity prices for the fish products as well as projected purchase commitments from customers. These estimates, which management believes are reasonable and supportable, involve estimates of future activities and events which are inherently imprecise and from which actual results may differ materially.

During the off-seasons, in connection with the upcoming fishing seasons, Omega Protein incurs costs (e.g., plant and vessel related labor, utilities, rent, repairs, and depreciation) that are directly related to Omega Protein’s infrastructure. These costs accumulate in inventory and are applied as elements of the cost of production of Omega Protein’s products throughout the fishing season ratably based on Omega Protein’s monthly units of production and the expected total units of production for the season.

Any costs incurred during abnormal downtime related to activity at Omega Protein’s plants are charged to expense as incurred. Such costs were incurred and offset by proceeds received from the Gulf Coast Claims Facility (“GCCF”) during 2011 as a consequence of the Deepwater Horizon explosion and the resulting oil spill in the Gulf of Mexico in April 2010. For additional information, see Note 4 – Gulf of Mexico Oil Spill.

The human nutrition segment generally uses standard costing for inventory it manufactures and FIFO for nutraceutical inventory. The Company’s inventory is stated at the lower of cost or market.

Business Interruption Insurance Proceeds

During 2012, the Company received approximately $0.3 million in proceeds, net of deductible, from its business interruption insurance coverage provider related to an incident causing downtime at one of its Gulf of Mexico production facilities in September 2011. The proceeds were calculated based on lost inventory production as well as a small amount of excess costs incurred by the Company as a result of the incident. Given that the Company experienced a slight decrease in production as a result of the incident, the proceeds related to lost inventory production were recognized as an increase in revenues and the proceeds related to excess costs were recognized as a reduction in cost of goods sold.

Insurance

Omega Protein carries insurance for certain losses relating to its vessels and Jones Act liabilities for employees aboard its vessels. Omega Protein records gross insurance reserves by using an estimation process that considers Company-specific and industry information as well as management’s experience, assumptions and consultation with counsel. These reserves include estimated settlement costs. In addition, insurance receivables are recorded for those portions of the claims in excess of Company insurance policy annual aggregate deductibles and stop losses. Management’s current estimated range of liabilities related to such cases is based on claims for which management can estimate the amount and range of loss. For those claims where there may be a range of loss, Omega Protein has recorded an estimated liability inside that range, based on management’s experience, assumptions and consultation with counsel. The process of estimating and establishing reserves for these claims is inherently uncertain and the actual ultimate net cost of a claim may vary materially from the estimated amount reserved. There is some degree of inherent variability in assessing the ultimate amount of losses associated with these claims due to the extended period of time that transpires between when a claim occurs and the full settlement of the claim. This variability is generally greater for Jones Act claims by vessel employees. Omega Protein evaluates loss estimates associated with claims and losses as additional information becomes available and revises its estimates. Although management believes estimated reserves related to these claims are adequately recorded, it is possible that actual results could significantly differ from the recorded reserves, which could materially impact Omega Protein’s business, financial condition or results of operations.

The Company is primarily self-insured for health insurance. The Company purchases individual stop loss coverage with a large deductible. As a result, the Company is primarily self-insured for claims and associated costs up to the amount of the deductible, with claims in excess of the deductible amount being covered by insurance. Expected claims estimates are based on health care trend rates and historical claims data; actual claims may differ from those estimates. The Company evaluates its claims experience related to this coverage with information obtained from its risk management consultants.

Assumptions used in preparing these insurance estimates are based on factors such as claims settlement patterns, claim development trends, claim frequency and severity patterns, inflationary trends and data reasonableness. Together these factors will generally affect the analysis and determination of the “best estimate” of the projected ultimate claim losses. The results of these evaluations are used to both analyze and adjust the Company’s insurance loss reserves.

In addition to the above insurance policies, the Company maintains insurance coverage for property, inventory, workers compensation, general liability, product liability and other items. The nature and extent of the insurance coverage varies by line of policy.

Advertising Costs

The costs of advertising are expensed as incurred.

Research and Development

Costs incurred in research and development activities, primarily related to the Omega Protein Technology and Innovation Center, are expensed as incurred.

Energy Swap Agreements

The Company does not enter into financial instruments for trading or speculative purposes. During 2013, 2012 and 2011, Omega Protein entered into energy swap agreements to manage portions of its cash flow exposure related to the volatility of natural gas, diesel and fuel oil energy prices for its fish meal and fish oil production operations. The swaps effectively fix pricing for the quantities listed below during the consumption periods.

Energy Swap

Consumption Period

Quantity

Price Per Unit

Energy Swap Asset/(Liability) as of

Deferred Tax Asset/(Liability) as of

December 31,

December 31,

2013

2013

Diesel - NYMEX Heating Oil Swap

Oct.

-

Nov., 2013

998,700 Gallons

$

2.88

$

131,400

$

(46,000

)

Natural Gas - NYMEX Natural Gas Swap

Apr.

-

Oct., 2014

307,374 MMBTUs

$

3.67

143,200

(50,100

)

$

274,600

$

(96,100

)

Energy Swap

Consumption Period

Quantity

Price Per Unit

Energy Swap Asset/(Liability) as of

Deferred Tax Asset/(Liability) as of

December 31,

December 31,

2012

2012

Diesel - NYMEX Heating Oil Swap

May

-

November, 2013

1,359,782 Gallons

$

2.82

$

244,800

$

(53,800

)

Natural Gas - NYMEX Natural Gas Swap

April

-

October, 2013

381,150 MMBTUs

$

3.94

(149,600

)

52,300

Fuel Oil – No.6 1.0% NY-Platts Swap

May

-

November, 2013

676,200 Gallons

$

2.26

39,000

(13,600

)

$

134,200

$

(15,100

)

As of December 31, 2013 and 2012, Omega Protein has recorded a current asset in prepaid expenses of $0.3 million and $0.1 million, respectively, to recognize the fair value of energy swap derivatives, and has also recorded a deferred tax liability of $0.1 million and $15,100, respectively, associated therewith. The effective portion of the change in fair value from inception to December 31, 2013 is recorded in “accumulated other comprehensive loss” in the Company’s consolidated financial statements. The following table illustrates the changes recorded, net of tax, in accumulated other comprehensive loss resulting from the energy swap agreements.

(in thousands)

2013

2012

Balance at January 1,

$

28

$

(420

)

Amounts, net of tax, reclassified to unallocated inventory cost pool,

(127

)

328

Net change associated with current period swap transactions, net of tax,

278

120

Balance at December 31,

$

179

$

28

The $0.2 million reported in accumulated other comprehensive loss as of December 31, 2013 will be reclassified to the unallocated inventory cost pool in the period when the energy consumption takes place. The amount to be reclassified, net of taxes, during the next 12 months is expected to be $0.2 million.

The aggregate fair value of derivative instruments in gross asset positions as of December 31, 2013 and December 31, 2012 was $0.3 million and $0.3 million, respectively. These amounts represent the maximum exposure to loss at the reporting date as a result of all of the counterparties failing to perform as contracted. This exposure could be reduced by up to $0 and $0.2 million, respectively, of liabilities included in master netting arrangements with those same counterparties.

As of December 31, 2013 (in thousands)

Gross

Gross

Net Amounts

Amounts of

Amounts of

of Assets

Recognized

Assets

(Liabilities)

Assets

(Liabilities)

Presented in

(Liabilities)

Offset

the Balance Sheet

Energy swap derivatives – asset position

$

275

$

-

$

275

As of December 31, 2012 (in thousands)

Gross

Gross

Net Amounts

Amounts of

Amounts of

of Assets

Recognized

Assets

(Liabilities)

Assets

(Liabilities)

Presented in

(Liabilities)

Offset

the Balance Sheet

Energy swap derivatives – asset position

$

295

$

(161

)

$

134

If, at any time, the swaps are determined to be ineffective, in whole or in part, due to changes in the Company’s energy usage or underlying hedge agreements or assumptions, the fair value of the portion of the energy swaps determined to be ineffective will be recognized as a gain or loss in cost of sales for the applicable period. For 2013 and 2012, the Company recognized a charge of $0.1 million and a reduction $0.1 million, respectively, to cost of sales resulting from transactions associated with the ineffectiveness of diesel energy swaps. See Note 21 – Fair Value Disclosures for additional information.

Subsequent to December 31, 2013, Omega Protein entered into the following energy swap agreements:

Energy Swap

Consumption Period

Quantity

Price Per Unit

Diesel - NYMEX Heating Oil Swap

May

-

November, 2014

333,366 Gallons

$

2.95

Propane – NGL-Mont Belvieu Propane

June

-

November, 2014

683,000 Gallons

$

1.09

Income Taxes

The Company utilizes the asset and liability method to account for income taxes. This method requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of existing temporary differences between the financial reporting and tax reporting basis of assets and liabilities, and operating loss and tax credits carryforwards for tax purposes. The Company records a valuation allowance to reduce the deferred tax assets to the amount that is more likely than not to be realized. The Company believes that the deferred tax assets recorded as of December 31, 2013, net of the valuation allowance, are realizable through future reversals of existing taxable temporary differences and future taxable income. If the Company were to subsequently determine that it would be able to realize deferred tax assets in the future in excess of the net recorded amount, the adjustment would increase earnings for the period in which such determination was made. The Company will continue to assess the adequacy of the valuation allowance on a quarterly basis. Any changes to the estimated valuation allowance could be material to the consolidated financial condition and results of operations.

Accounting for the Impairment of Long-Lived Assets

The Company evaluates at each balance sheet date the continued appropriateness of the carrying value of its long-lived assets, including its long-term receivables and property, plant and equipment. The Company reviews long-lived assets for impairment when events or changes in circumstances indicate that the carrying amount of any such assets or grouping of assets may not be recoverable. The Company has grouped certain assets together (primarily marine vessels) for impairment testing on a fleet basis. If indicators of impairment are present, management evaluates the undiscounted cash flows estimated to be generated by those assets or grouping of assets compared to the carrying amount of those items. The net carrying value of assets or grouping of assets not recoverable is reduced to fair value. The Company considers continued operating losses, or significant and long-term changes in business conditions, to be its primary indicators of a potential impairment.

Plant Closure

Property, plant and equipment impairments related to the Cameron, Louisiana plant are made in accordance with the impairment of long-lived assets policy. Employee severance related charges have been recognized to the extent that the amount is probable, measurable and no-future service is expected or for those still employed, recognized pro-rata over the remaining service period. Ongoing clean-up and dismantlement costs will be recognized as incurred unless obligated and measureable by a contractual commitment. See Note 5 – Plant Closure for additional information related to the charges incurred.

Property, Equipment and Depreciation

Property and equipment additions are recorded at cost. Depreciation of property and equipment is computed by the straight-line method at rates expected to amortize the cost of property and equipment, net of salvage value, over their estimated useful lives. Estimated useful lives, determined at the date of acquisition, of new assets acquired are based primarily on the review of existing property and equipment as well as other factors. Estimated useful lives are as follows:

Useful Lives

(years)

Stainless steel equipment

25

Fishing vessels and fish processing plants

15

-

20

Machinery, equipment, furniture and fixtures and other

3

-

10

Replacements and major improvements are capitalized and amortized over a period of 5 to 15 years. Upon sale or retirement, the costs and related accumulated depreciation are eliminated from the accounts. Any resulting gains or losses are included in the statement of comprehensive income.

Acquisitions, Goodwill and Other Intangible Assets

Goodwill is measured as the excess of the cost of an acquisition over the sum of the amounts assigned to the fair value of tangible and intangible assets acquired less liabilities assumed. The determination of the fair value of the intangible assets acquired involves certain judgments and estimates. These judgments can include, but are not limited to, the cash flows that an asset is expected to generate in the future and the appropriate weighted average cost of capital.

The Company does not amortize goodwill or indefinite-lived intangible assets but performs tests for impairment annually, or when indications of potential impairment exist, utilizing a fair value approach at the reporting unit level. The Company determines fair value using widely accepted valuation techniques, including the income approach which estimates the fair value of its reporting units based on the future discounted cash flows, and the market approach which estimates the fair value of its reporting units based on comparable market prices. In testing for a potential impairment of goodwill, the Company estimates the fair value of its reporting units to which goodwill relates and compares it to the carrying value (book value) of the assets and liabilities related to those businesses.

All of the Company’s goodwill and other intangible assets are the result of acquisitions in the human nutrition segment. This segment is comprised of two reporting units, 1) InCon and Cyvex and 2) WSP.

The Company amortizes other intangible assets with determinable lives over their estimated useful lives. The Company records an impairment charge on these assets when it determines that their carrying value may not be recoverable. The carrying value is not recoverable if it exceeds the undiscounted future cash flows resulting from the use of the asset and its eventual disposition. When there is existence of one or more indicators of impairment, the Company measures any impairment of intangible assets based on a projected discounted cash flow method using a discount rate determined by the Company’s management to be commensurate with the risk inherent in its business model. The Company’s estimates of future cash flows attributable to its other intangible assets require significant judgment based on the Company’s historical and anticipated results and are subject to many factors. See Note 11 - Goodwill and Other Intangible Assets for more information about goodwill and other intangible assets.

Pension Plans

The Company records the overfunded or underfunded status of defined benefit pension and postretirement plans as an asset or liability in its statement of financial position and changes in that funded status in the year in which the changes occur through other comprehensive income. The Company also measures the funded status of a plan as of the date of its year-end statement of financial position. The Company’s policy is to fund its pension plan at amounts not less than the minimum requirements of the Employee Retirement Income Security Act of 1974.

In 2002, the Board of Directors authorized a plan to freeze the Company’s pension plan in accordance with ERISA rules and regulations so that new employees, hired after July 31, 2002, are not eligible to participate in the pension plan and further benefits no longer accrue for existing participants. The freezing of the pension plan had the effect of vesting all existing participants in their pension benefits in the plan. See Note 16 – Benefit Plans for additional information related to the Company’s pension plans.

Comprehensive Income (Loss)

Comprehensive income (loss) is defined as change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources, including foreign currency translation adjustments, interest and energy swap transactions, and pension benefits adjustments, including recognition of actuarial losses. The Company presents comprehensive income (loss) in its consolidated statements of comprehensive income and consolidated statements of stockholders’ equity.

Accumulated Comprehensive Loss

The components of accumulated other comprehensive loss included in stockholders’ equity are as follows:

Changes in Accumulated Other Comprehensive Loss by Component

For the Year Ended December 31, 2013 (in thousands)

Gains and Losses

Defined Benefit

Total

On Cash Flow

Pension Items

Hedges

Beginning balance December 31, 2012

$

28

$

(9,952

)

$

(9,924

)

Other comprehensive income before reclassifications

278

2,560

2,838

Amounts reclassified from accumulated other comprehensive loss

(127

)

(a)

1,005

(b)

878

Net current-period other comprehensive income

151

3,565

3,716

Ending balance December 31, 2013

$

179

$

(6,387

)

$

(6,208

)

(a)

This accumulated other comprehensive income component is reclassified to the unallocated inventory cost pool in the period when the energy consumption takes place.

(b)

This accumulated other comprehensive income component is included in the computation of net periodic pension costs as amortization of actuarial loss which are explained in more detail in Note 16.

Changes in Accumulated Other Comprehensive Loss by Component

For the Year Ended December 31, 2012 (in thousands)

Gains and Losses

Defined Benefit

Total

On Cash Flow

Pension Items

Hedges

Beginning balance December 31, 2011

$

(420

)

$

(10,259

)

$

(10,679

)

Other comprehensive income (loss) before reclassifications

120

(679

)

(559

)

Amounts reclassified from accumulated other comprehensive loss

328

(a)

986

(b)

1,314

Net current-period other comprehensive income

448

307

755

Ending balance December 31, 2012

$

28

$

(9,952

)

$

(9,924

)

(a)

This accumulated other comprehensive loss component is reclassified to the unallocated inventory cost pool in the period when the energy consumption takes place.

(b)

This accumulated other comprehensive income component is included in the computation of net periodic pension costs as amortization of actuarial loss which are explained in more detail in Note 16.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and trade accounts receivable. The Company’s customer base generally remains consistent from year to year. The Company performs ongoing credit evaluations of its customers and generally does not require material collateral. The Company maintains reserves for potential credit losses and such losses have historically been within management’s expectations.

At December 31, 2013, the Company had cash deposits concentrated primarily in one major bank and two money market funds. The Company believes that credit risk in such investments is minimal.

Earnings per Share

Basic earnings per share is calculated by dividing net income allocated to common shares outstanding by the weighted average number of shares of common stock outstanding. Diluted earnings per share assumes the exercise of stock options provided the effect is not anti-dilutive.

The Company grants certain incentive compensation awards, including restricted stock, to employees and non-employee directors that are considered to be participating securities. Due to the presence of participating securities, we have calculated our earnings per share using the two-class method. See Note 13 – Reconciliation of Basic and Diluted per Share Data.

Stock-Based Compensation

The Company has a stock-based compensation plan, which is described in more detail in Note 16.

Shares Issued to Directors

In 2013 and 2012, approximately 3,200 and 7,600 shares of the Company’s stock were issued to directors in non-cash transactions as payment in lieu of Board retainer and per diem fees. Expenses were recognized on these non-cash transactions of approximately $25,200 and $56,100. In 2011, no shares of the Company’s common stock were issued to directors in non-cash transactions as payment in lieu of Board retainer and per diem fees.

Shareholder Rights Plan

In June 2010, the Company’s Board of Directors adopted a Shareholder Rights Plan. The Plan is designed to protect the Company from unfair or coercive takeover tactics and to prevent an acquirer from gaining control of the Company without offering a fair price to all shareholders. See Note 22 – Shareholders Rights Plan for additional information.

Recently Issued Accounting Standards

In July 2013, the FASB issued ASU No. 2013-11 which amended the Income Taxes Topic of the Accounting Standards Codification to eliminate a diversity in practice for the presentation of unrecognized tax benefits when net operating loss carryforwards, similar tax losses or tax credit carryforwards exist. The amendment requires that the unrecognized tax benefit be presented as a reduction of the deferred tax assets associated with the carryforwards except in certain circumstances when it would be reflected as a liability. This guidance is effective for annual periods and interim periods within those annual periods beginning after December 15, 2013. The Company is currently evaluating the impact the adoption of this guidance will have on its consolidated financial statements.

In February 2013, the FASB issued ASU No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income. The standard requires companies to present, either in a single note or parenthetically on the face of the financial statements, the effect of significant amounts reclassified from each component of accumulated other comprehensive income based on its source and the income statement line items affected by the reclassification. The standard is effective prospectively for public entities for fiscal years, and interim periods within those years, beginning after December 12, 2012, which corresponds to the Company’s first fiscal quarter beginning January 1, 2013. The Company’s adoption of FASB ASU No. 2013-02, effective January 1, 2013, did not have an impact on the Company’s consolidated results of operations or financial position.

In January 2013, the FASB issued ASU No. 2013-01, Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities. The standard limits the scope of balance sheet offsetting disclosures, contained in the new guidance issue in December 2011 discussed below, to recognized derivative instruments, repurchase agreements and securities borrowing and lending transactions. Effective for annual and interim periods beginning on or after January 1, 2013, the Company’s adoption of FASB ASU No. 2013-01 effective January 1, 2013 did not have an impact on the Company’s consolidated results of operations, financial position and related disclosures.

In July 2012, the FASB issued ASU No. 2012-02 regarding subsequent measurement guidance for long-lived intangibles. This guidance is meant to reduce the cost and complexity of performing an impairment test for indefinite-lived intangible assets by simplifying how an entity tests those assets for impairment and to improve consistency in impairment testing guidance among long-lived asset categories. This guidance is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012, which corresponds to the Company’s first fiscal quarter beginning January 1, 2013. The Company’s adoption of FASB ASU No. 2012-02 effective January 1, 2013 did not have an impact on the Company’s consolidated results of operations, financial position and related disclosures.

In December 2011, the FASB issued ASU No. 2011-11, Disclosures about Offsetting Assets and Liabilities. The standard requires an entity to disclose information about offsetting and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position. The amendments in this update will enhance disclosures required by U.S. GAAP by requiring improved information about financial instruments and derivative instruments to help reconcile differences in the offsetting requirements under U.S. GAAP and International Financial Reporting Standards (IFRS). The amendments are effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. The Company’s adoption of FASB ASU No. 2011-11 effective January 1, 2013 did not have an impact on the Company’s consolidated results of operations or financial position.

Note_2_Acquisition_of_Wisconsi

Note 2 - Acquisition of Wisconsin Specialty Protein, L.L.C.	12 Months Ended
	Dec. 31, 2013
Wisconsin Specialty Protein [Member]	'
Note 2 - Acquisition of Wisconsin Specialty Protein, L.L.C. [Line Items]	'
Mergers, Acquisitions and Dispositions Disclosures [Text Block]	'
	NOTE 2. ACQUISITION OF WISCONSIN SPECIALTY PROTEIN, L.L.C.
	A. Description of the Transaction
	On February 27, 2013, the Company acquired 100% of the outstanding equity interest of WSP, a Wisconsin limited liability company, in a cash transaction pursuant to the terms of an agreement and plan of merger. WSP is now a wholly owned subsidiary of the Company and operates as part of Nutegrity. The legacy WSP business produces and markets a variety of value-added whey protein ingredients for the food and nutritional supplement industries, including organic and other specialty protein products, using processes applicable to a variety of nutritional dairy ingredients. The Company believes the acquisition of WSP enhances its presence in the specialty proteins markets and advances its goal of providing sustainable, value-added nutrition ingredients. WSP is included as part of the Company’s human nutrition segment.
	B. Recording of Assets Acquired and Liabilities Assumed
	The Company paid an aggregate cash purchase price for the equity of WSP of $26.5 million plus $0.6 million representing WSP’s excess working capital on the closing date and reimbursable capital expenditures, utilizing cash on hand.
	The Company incurred approximately $0.8 million in pretax transaction costs directly related to the acquisition that were expensed and included in selling, general and administrative expenses in the consolidated statement of comprehensive income for the year ended December 31, 2013. The acquisition costs consisted primarily of legal, advisory, valuation, and other consulting fees. The transaction has been accounted for using the acquisition method of accounting which requires, among other things, that all assets acquired and liabilities assumed from acquisitions be recognized at their fair values as of the acquisition date. Any excess of the purchase price over the fair values of the net assets acquired are recorded as goodwill.
			(in thousands)
	Cash		$	403
	Other current assets, net including receivables, prepaid and inventory			2,515
	Property, plant, and equipment, net			14,095
	Identifiable intangible assets (a)			4,448
	Liabilities assumed			(5,996	)
	Total identifiable net assets			15,465
	Goodwill			11,614
	Total consideration		$	27,079
		(a)	See Note 11 – Goodwill and Other Intangible Assets for weighted average lives.
	Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Specifically, the goodwill recorded as part of the acquisition of WSP includes the following:
	● the expected synergies and other benefits that the Company believes will result from combining the operations of WSP with the operations of Nutegrity, the Company’s human nutrition segment,
	● any intangible assets that do not qualify for separate recognition, and
	● the value of the going-concern element of WSP’s existing business (the higher rate of return on the assembled collection of net assets versus if the Company had acquired all of the net assets separately).
	The Company does not amortize goodwill or indefinite-lived intangible assets but performs tests for impairment annually, or when indications of potential impairment exist, utilizing a fair value approach at the reporting unit level. See Note 11 - Goodwill and Other Intangible Assets, for more information about goodwill and other intangible assets.
	C. Unaudited Pro Forma Financial Information
	The unaudited financial information in the table below summarizes the combined results of operations of the Company and WSP on a pro forma basis, as though the companies had been combined as of January 1, 2012. The pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had actually taken place on January 1, 2012 and is not intended to be a projection of future results or trends.
			Revenue			Net income (loss)
			(in thousands)
	WSP from February 27, 2013 – December 31, 2013		$	9,810		$	(195	)
	2013 supplemental pro forma from January 1, 2013 – December 31, 2013		$	246,361		$	30,518
	2012 supplemental pro forma from January 1, 2012 – December 31, 2012		$	247,109		$	4,997
InCon [Member]	'
Note 2 - Acquisition of Wisconsin Specialty Protein, L.L.C. [Line Items]	'
Mergers, Acquisitions and Dispositions Disclosures [Text Block]	'
	NOTE 3. ACQUISITION OF INCON PROCESSING, L.L.C.
	A. Description of the Transaction
	In September 2011, the Company acquired all of the outstanding equity of InCon, a Delaware limited liability company, in a cash transaction pursuant to the terms of an equity purchase agreement. The equity of InCon was indirectly held by four individuals (the “Sellers”), three of whom continue to be employed by InCon and share in the management of InCon’s business. InCon is now a wholly owned subsidiary of the Company and operates as part of Nutegrity. InCon is a specialty toll processor that designs, pilots, synthesizes and purifies specialty chemical compounds, utilizing molecular distillation technology to concentrate a variety of compound products, including Omega-3 fish oils.
	B. Recording of Assets Acquired and Liabilities Assumed
	At closing, the Company paid an aggregate cash purchase price for the equity of InCon of $8.7 million, utilizing cash on hand, and also paid $0.6 million representing InCon’s estimated working capital on the closing date. The working capital portion of the purchase price was subject to a post-closing adjustment to account for differences between estimated working capital and actual working capital of InCon as of the closing date. During 2012, the Company received a payment from the Sellers of $0.2 million to account for the final working capital adjustment.
	The Sellers may also earn additional amounts based on the annual earnings before interest, taxes, depreciation, and amortization (“EBITDA”) of InCon’s toll processing and specialty product business during calendar years 2012 through 2016. The Company and the Sellers amended the earn-out terms on April 25, 2013 by lowering the earn-out by 35% of the original formula in 2013 and all future years. The annual earn-out provisions (as amended) are determined based on a percentage of InCon’s EBITDA, adjusted for certain product sales and costs, which percentage ranges from 3.25% of the first $3.0 million of EBITDA to 19.5% of EBITDA in excess of $12.0 million.
	The annual earn-out payments, if any, will be estimated on a quarterly basis and paid subsequent to year end. The Company will record the estimated contractual obligation as compensation expense during each year as it is deemed probable that such amount will be payable. In addition, the earn-out payments are subject to certain reductions associated with future InCon capital expenditures and forfeitures based on termination of employment. There were no earn-out payments recorded during 2012 and 2013.
	The Company incurred approximately $0.1 million in pretax transaction costs directly related to the acquisition that were expensed and included in selling, general and administrative expenses in the Consolidated Statements of Comprehensive Income for the year ended December 31, 2011. The acquisition costs consisted primarily of legal, advisory, valuation, and other consulting fees. The transaction has been accounted for using the acquisition method of accounting which requires, among other things, that most assets acquired and liabilities assumed from acquisitions be recognized at their fair values as of the acquisition date. Any excess of the purchase price over the fair values of the net assets acquired are recorded as goodwill. The following table summarizes the fair values of the InCon assets and acquired liabilities assumed based on the total consideration at acquisition of $9.3 million.
			Amounts recognized as of acquisition date
			(in thousands)
	Working capital (a)		$	593
	Property, plant, and equipment, net			6,400
	Identifiable intangible assets (b)			1,341
	Total identifiable net assets			8,334
	Goodwill			936
	Total consideration, net of final working capital adjustment		$	9,270
		(a)	Includes cash and cash equivalents, accounts receivable, spare parts inventory and accounts payable.
		(b)	See Note 11 – Goodwill and other intangible assets for weighted average lives.
	Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Specifically, the goodwill recorded as part of the acquisition of InCon includes the following:
	● the expected synergies and other benefits that the Company believes will result from combining the operations of InCon with the operations of Nutegrity, the Company’s human nutrition segment,
	● any intangible assets that do not qualify for separate recognition, and
	● the value of the going-concern element of InCon’s existing business (the higher rate of return on the assembled collection of net assets versus if Omega had acquired all of the net assets separately).
	The Company does not amortize goodwill or indefinite-lived intangible assets but performs tests for impairment annually, or when indications of potential impairment exist, utilizing a fair value approach at the reporting unit level. See Note 11 - Goodwill and Other Intangible Assets, for more information about goodwill and other intangible assets.

Note_4_Gulf_Of_Mexico_Oil_Spil

Note 4 - Gulf Of Mexico Oil Spill Disaster	12 Months Ended
	Dec. 31, 2013
Extraordinary and Unusual Items [Abstract]	'
Extraordinary Items Disclosure [Text Block]	'
	NOTE 4. GULF OF MEXICO OIL SPILL
	As a result of the oil spill caused by the Deepwater Horizon oil rig explosion in the Gulf of Mexico in April 2010 and the subsequent temporary and intermittent closures of certain commercial and recreational fishing grounds by the Louisiana Department of Fisheries and Wildlife, the Mississippi Department of Marine Resources and the National Oceanic and Atmospheric Administration (“NOAA”), Omega Protein’s total fish catch for 2010 was materially impacted. In addition, Omega Protein incurred costs associated with the temporary re-deployment of many of its Gulf of Mexico fishing vessels, costs to purchase fish meal from third party vendors to offset lost production, and increased costs per unit of production resulting from intermittent plant closures.
	During 2010, Omega Protein filed a claim for damages with BP and also met with BP’s third party claims adjuster.  In August 2010, the claims process for BP was moved to the GCCF, a claims facility tasked with claims administration and payment distribution for those businesses and individuals that suffered damages and incurred other costs related to the oil spill.
	In September and October 2010, Omega Protein received its first and second emergency payments from the GCCF of $7.3 million and $11.4 million, respectively.  The majority of the first and second emergency payments were credited to the 2010 unallocated inventory cost pool (including off-season costs). Because both of these payments were included in the cost per unit of production calculation for the 2010 fishing season, cost of sales was partially reduced by 4.4%, or $8.2 million, and 8.9%, or $10.5 million, for the years ended December 31, 2011 and 2010, respectively.
	In April 2011, the Company agreed to a final settlement of all of its claims for costs and damages incurred as a result of the oil spill caused by the Deepwater Horizon explosion and received a final payment of $26.2 million, net of fees and expenses, from the GCCF. The amount was recognized as “Proceeds/gains resulting from Gulf of Mexico oil spill” in the Company’s Consolidated Statements of Comprehensive Income for the year ended December 31, 2011.
	In total, the Company received payments of $44.8 million, net of fees and expenses, from the GCCF in 2010 and 2011. As a part of the final settlement, the Company released and waived all current and future claims against BP and all other potentially responsible parties with regard to the oil spill.

Note_5_Plant_Closure

Note 5 - Plant Closure	12 Months Ended
	Dec. 31, 2013
Disposal Groups Plant Closure Disclsoure [Abstract]	'
Disposal Groups Plant Closure Disclsoure [Text Block]	'
	NOTE 5. PLANT CLOSURE
	In December 2013, the Company effectively closed its menhaden fish processing plant located in Cameron, Louisiana and is re-deploying certain vessels from that facility to the Company’s other Gulf Coast facilities located in Abbeville, Louisiana and Moss Point, Mississippi. In conjunction with the closure, the following charges were incurred in the Company’s consolidated statements of comprehensive income during 2013:
		2013
		(in thousands)
	Impairment of property, plant and equipment	$	4,796
	Write-off material and supplies inventory		97
	Employee severance accruals		345
	Estimated decommissioning costs		250
	Other ongoing closure costs not attributable to future production		1,109
	Total loss related to plant closure	$	6,597
	In addition to the above recognized losses, the Company expects that it may have additional losses related to additional impairment of property, plant and equipment, ongoing employee severance expenses and ongoing cost not attributable to future production such as clean-up and disassembly.

Note_6_Receivables_Net

Note 6 - Receivables, Net	12 Months Ended
	Dec. 31, 2013
Receivables [Abstract]	'
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	'
	NOTE 6. RECEIVABLES, NET
	Receivables as of December 31, 2013 and 2012 are summarized as follows:
		2013			2012
		(in thousands)
	Trade	$	18,689		$	11,513
	Insurance		1,806			4,980
	Income tax		714			871
	Other		310			236
	Total accounts receivable		21,519			17,600
	Less allowance for doubtful accounts		(379	)		(333	)
	Receivables, net	$	21,140		$	17,267
	As of December 31, 2012, the insurance receivable included approximately $3.4 million related to the salvage costs and other related claims incurred by the Company associated with the sinking of the F/V Sandy Point in May 2011. Of that amount, approximately $3.1 million was received in June 2013 in final settlement of the receivable.

Note_7_Inventory

Note 7 - Inventory	12 Months Ended
	Dec. 31, 2013
Inventory Disclosure [Abstract]	'
Inventory Disclosure [Text Block]	'
	NOTE 7. INVENTORY
	The major classes of inventory as of December 31, 2013 and 2012 are summarized as follows:
		2013		2012
		(in thousands)
	Fish meal	$	30,119	$	26,511
	Fish oil		41,081		17,352
	Fish solubles		2,599		1,391
	Nutraceutical products		3,650		4,181
	Dairy protein products		1,355		—
	Unallocated inventory cost pool (including off-season costs)		6,655		7,403
	Other materials and supplies		8,880		9,821
	Total inventory	$	94,339	$	66,659
	Inventory at December 31, 2013 and 2012 is stated at the lower of cost or market. The elements of December 31, 2013 unallocated inventory cost pool include Omega Protein’s plant and vessel related labor, utilities, rent, repairs and depreciation, to be allocated to inventories produced through the 2014 fishing season.

Note_8_Prepaid_Expenses_and_Ot

Note 8 - Prepaid Expenses and Other Current Assets	12 Months Ended
	Dec. 31, 2013
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]	'
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]	'
	NOTE 8. PREPAID EXPENSES AND OTHER CURRENT ASSETS
	Prepaid expenses and other current assets as of December 31, 2013 and 2012 are summarized below:
		2013		2012
		(in thousands)
	Prepaid insurance	$	2,422	$	2,554
	Selling expenses		869		436
	Fair market value of energy swaps, current portion		275		134
	Whey process filters		38		—
	Leases		53		118
	Other prepaids and expenses		258		188
	Total prepaid expenses and other current assets	$	3,915	$	3,430
	Amounts included in prepaid expenses and other current assets consist primarily of prepaid operating expenses including insurance, rents, and selling expenses. Energy swap assets are valued at each reporting date at their fair value (see Note 21 – Fair Value Disclosures for additional information). Prepaid selling expenses are expensed in those periods in which the related revenue is recognized.

Note_9_Other_Assets

Note 9 - Other Assets	12 Months Ended
	Dec. 31, 2013
Disclosure Text Block Supplement [Abstract]	'
Other Assets Disclosure [Text Block]	'
	NOTE 9. OTHER ASSETS
	Other assets as of December 31, 2013 and 2012 are summarized as follows:
		2013		2012
		(in thousands)
	Fish nets, net of accumulated amortization of $2,610 and $1,243	$	1,517	$	1,432
	Insurance receivable, net of allowance for doubtful accounts		3,048		8,572
	Title XI debt issuance costs		272		302
	Other debt issuance costs		299		391
	Deposits and other		98		92
	Total other assets, net	$	5,234	$	10,789
	Amortization expense for fishing nets amounted to approximately $1.4 million, $1.3 million, and $1.2 million for the years ended December 31, 2013, 2012 and 2011, respectively.
	As of December 31, 2013 and December 31, 2012, the insurance receivable of $3.0 million and $8.6 million, respectively, primarily relates to Jones Act claims for employees aboard its vessels. This estimated amount is recorded gross of estimated claims which may be due to claimants and is included in accrued insurance liabilities.
	The Company carries insurance for certain losses relating to its fishing unit’s vessels and Jones Act liability for employees aboard its vessels (collectively, “Vessel Claims Insurance”). The typical Vessel Claims Insurance policy contains an annual aggregate deductible (“AAD”) for which Omega Protein remains responsible, while the insurance carrier is responsible for all applicable amounts which exceed the AAD. It is Omega Protein’s policy to accrue current amounts due and record amounts paid out on each claim. Once payments exceed the AAD, Omega Protein records an insurance receivable for a given policy year, net of allowance for doubtful accounts. As of December 31, 2013 and 2012, there was no allowance for doubtful insurance receivable accounts.

Note_10_Property_Plant_and_Equ

Note 10 - Property, Plant, and Equipment	12 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment Disclosure [Text Block]	'
	NOTE 10. PROPERTY, PLANT AND EQUIPMENT
	Property, plant and equipment as of December 31, 2013 and 2012 are summarized as follows:
		2013			2012
		(in thousands)
	Land	$	7,457		$	7,229
	Plant assets		159,337			148,451
	Fishing vessels		101,745			103,754
	Furniture and fixtures		7,091			7,225
	Construction in progress		16,846			11,214
	Total property and equipment		292,476			277,873
	Less accumulated depreciation and impairment		(148,363	)		(150,233	)
	Property, plant and equipment, net	$	144,113		$	127,640
	Depreciation expense for 2013, 2012 and 2011 was $18.9 million, $16.3 million, and $14.7 million, respectively.
	The Company capitalizes interest as part of the acquisition cost of a qualifying asset. Interest is capitalized only during the period of time required to complete and prepare the asset for its intended use. For 2013, 2012 and 2011, the Company capitalized interest of approximately $312,300, $765,300, and $245,300, respectively.
	In December 2013, the Company closed its Cameron, Louisiana menhaden processing plant and is re-deploying some of its harvesting and processing assets to the three remaining menhaden processing plants. As a result of the closure, the Company recognized a $4.8 million impairment of its fixed assets that it does not plan to use in future operations. For more information see Note 5 – Plant Closure.
	On June 1, 2012, the Company completed the sale of its Morgan City, Louisiana facility. The property last operated as a processing facility in 1999 but had recently been used primarily as a storage and training facility. Net cash proceeds from the sale after preparation costs, fees and expenses were approximately $5.2 million. For 2012, the Company recognized a gain on the sale of approximately $4.0 million which is included in gain on disposal of assets in the Company’s statement of comprehensive income.

Note_11_Goodwill_and_Other_Int

Note 11 - Goodwill and Other Intangible Assets	12 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill and Intangible Assets Disclosure [Text Block]	'
	NOTE 11. GOODWILL AND OTHER INTANGIBLE ASSETS
	During 2013, the Company decided to discontinue use of the Cyvex and InCon brand names over time and replace them with a single brand, Nutegrity, and concluded that the carrying value of those trade names exceeded the fair value.  Subsequently, annual testing of the indefinite life intangible assets of InCon, Cyvex and WSP was performed, and it was concluded that the carrying value of Cyvex’s other trade names exceeded the fair value.  As a result, a cumulative $0.3 million impairment expense was recognized during the year ended December 31, 2013.
	The Company also completed its annual impairment testing of goodwill for 1) InCon and Cyvex, as a single reporting unit, and 2) WSP, and concluded that the fair value exceeded the carrying value.  As of December 31, 2013, the calculated fair value of InCon’s trade secrets exceeds its $1.0 million carrying value by 5%; key assumptions in the fair value calculation include future fish oil sales, the portion of sales attributable to trade secrets and the discount rate.  The calculated fair value of goodwill and other indefinite life intangible assets exceed their carrying values by 20% or more.    It should be noted that the calculated fair values on which the assessments of goodwill and indefinitely lived intangible assets are based are highly subjective given the early stage and transitional nature of the businesses.
	During 2012, the Company completed its annual impairment testing of goodwill and indefinite life intangible assets for InCon.  The Company concluded that the carrying value of its trade names exceeded the fair value by approximately $0.1 million.  As a result, impairment expense was $0.1 million for the year ended December 31, 2012.
	All of the Company’s goodwill and other intangible assets are the result of acquisitions in the human nutrition segment. The following table summarizes the changes in the carrying amount of goodwill resulting from the Company’s acquisitions (in thousands):
		WSP				Cyvex and			Total
						Incon
	1-Jan-13	$	—				7,986		$	7,986
	Acquisitions (1)		11,614				—			11,614
	31-Dec-13	$	11,614				7,986		$	19,600
	(1) On February 27, 2013, the Company acquired WSP, and the allocation of the purchase price over the fair value of the tangible and intangible assets acquired resulted in $11.6 million of goodwill.
	The following table summarizes the Company’s intangible assets (dollars in thousands):
		December 31,			December 31,			Weighted
		2013			2012			Average
								Life (years)
	Carrying value of intangible assets subject to amortization:
	Customer relationships and non-competes	$	5,930		$	2,934
	Less accumulated amortization		(613	)		(325	)		10
	Total intangible assets subject to amortization, net	$	5,317		$	2,609
	Indefinite life intangible assets – trade names/secrets and other		2,615			1,753
	Total intangible assets	$	7,932		$	4,362
	Amortization expense of the Company’s intangible assets for the year ended December 31, 2013 and 2012 was approximately $0.6 million and $0.3 million, respectively. Estimated future amortization expense related to intangible assets is as follows (in thousands):
	2014		663
	2015		655
	2016		654
	2017		654
	Thereafter		2,691
	Total estimated future amortization expense	$	5,317

Note_12_Notes_Payable_and_Long

Note 12 - Notes Payable and Long-Term Debt	12 Months Ended
	Dec. 31, 2013
Disclosure Text Block [Abstract]	'
Long-term Debt [Text Block]	'
	NOTE 12. NOTES PAYABLE AND LONG-TERM DEBT
	At December 31, 2013 and 2012, the Company's long-term debt consisted of the following:
			December 31,			December 31,
			2013			2012
			(in thousands)
	U.S. government guaranteed obligations (Title XI loans) collateralized by a first lien on certain vessels and certain plant assets:
	Amounts due in installments through 2025, interest from 5.7% to 7.6%		$	24,211		$	27,228
	Amounts due in installments through 2014, interest at Eurodollar rates plus 0.5% (0.7% and 0.8% at December 31, 2013 and December 31, 2012, respectively)			31			72
	Total debt			24,242			27,300
	Less current maturities			(3,112	)		(3,058	)
	Long-term debt		$	21,130		$	24,242
	The Title XI loans are secured by certain liens on the Company’s fishing vessels and mortgages on the Company’s Reedville, Virginia and Abbeville, Louisiana plants.
	In June 2011, pursuant to the Title XI program, the United States Department of Commerce Fisheries Finance Program (the “FFP”) approved a financing application made by the Company in the amount of $10.0 million (the “Approval Letter”) which expires on June 20, 2016. To date, the Company has not borrowed any amounts under the Approval Letter and its ability to do so may be adversely affected by an EPA notice that the Company’s Omega Protein subsidiary is ineligible, as a result of its previous convictions under the Clean Water Act, for receipt of government contracts or benefits in certain cases. See “Risk Factors” for further detail on this EPA notice. As of December 31, 2013, the Company had approximately $24.2 million of borrowings outstanding under Title XI and was in compliance with all of the covenants contained therein.
	In March 2012, the Company entered into an Amended and Restated Loan Agreement (the “Loan Agreement”) with Wells Fargo Bank, National Association, as administrative agent (the “Agent”) for the lenders (currently Wells Fargo Bank, National Association and JP Morgan Chase Bank, N.A.) (collectively, the “Lenders”) pursuant to which the Lenders agreed to extend credit to the Company in the form of loans (each a “Loan” and collectively, the “Loans”) on a revolving basis of up to $60.0 million (the “Commitment”).
	At the election of the Company, any Loans will bear interest at the lesser of (a) the Base Rate (defined as a fluctuating rate equal to the highest of: (x) the rate of interest most recently announced by Agent as its “prime rate,” (y) a rate determined by Agent to be 1.50% above daily one month LIBOR (except during certain periods of time), and (z) the Federal Funds Rate plus 1.00%) plus the Applicable Margin (as defined in the Loan Agreement), (b) a rate per annum determined by Agent to be equal to LIBOR in effect for the applicable interest period plus the Applicable Margin, or (c) the Maximum Rate (as defined in the Loan Agreement).
	All obligations of the Company under the Loan Agreement are secured by a first and superior lien (subject to Permitted Liens, as defined in the Loan Agreement) against any and all assets of the Company (other than certain excluded property, including property pledged to secure Title XI loans).
	The Loan Agreement requires the Company to comply with various affirmative and negative covenants affecting the Company’s businesses and operations. In addition, the Loan Agreement requires the Company to comply with the following financial covenants:
		●	The Company is required to maintain on a consolidated basis Tangible Net Worth equal to at least the sum of the following: (a) $150,000,000, plus (b) 50% of net income (if positive, with no deduction for losses) earned in each quarterly accounting period commencing after June 30, 2011, plus (c) 100% of the net proceeds from any Equity Interests (as defined in the Loan Agreement) issued after the date of the Loan Agreement, plus (d) 100% of any increase in stockholders’ equity resulting from the conversion of debt securities to Equity Interests after the Closing Date.
		●	The Company is required to maintain on a consolidated basis an Asset Coverage Ratio (as defined in the Loan Agreement) of at least 2.50 to 1.00.
		●	The Company is required to maintain a positive Adjusted Profitability (as defined in the Loan Agreement), measured on a trailing four quarters basis.
	All Loans and all other obligations outstanding under the Loan Agreement are payable in full on March 21, 2017. As of December 31, 2013 and December 31, 2012, the Company had no amounts outstanding under the $60 million Loan Agreement and approximately $3.5 million and $3.1 million, respectively, in letters of credit. As of December 31, 2013, the Company was in compliance with all financial covenants under the Loan Agreement. The Company has no off-balance sheet arrangements other than normal operating leases and standby letters of credit.
	Annual Maturities
	The annual maturities of long-term debt for the five years ending December 31, 2018 and thereafter are as follows (in thousands):
	2014			2015			2016		2017	2018	Thereafter
	$3,113			$2,643			$2,800		$2,788	$2,969	$9,929

Note_13_Reconciliation_of_Basi

Note 13 - Reconciliation of Basic and Diluted Per Share Data	12 Months Ended
	Dec. 31, 2013
Earnings Per Share [Abstract]	'
Earnings Per Share [Text Block]	'
	NOTE 13. RECONCILIATION OF BASIC AND DILUTED PER SHARE DATA (in thousands except per share data)
	For the Years Ended December 31:	2013				2012				2011
	Allocation of earnings:
	Net income	$	30,515			$	4,063			$	34,157
	Income allocated to participating securities		(687	)			(49	)			(30	)
	Income allocated to common shares outstanding	$	29,828			$	4,014			$	34,127
	Weighted average common shares outstanding		19,913				19,420				19,238
	Basic earnings per share				1.5				0.21				1.77
	Stock options assumed exercised		721				454				685
	Weighted average diluted common shares and potential common share equivalents outstanding		20,634				19,874				19,923
	Diluted earnings per share				1.45				0.2				1.71
	Options to purchase the following number of shares of common stock (in thousands) were outstanding during the year ended December 31, but were excluded from the computation of diluted earnings per share because the adjusted exercise prices of the options based upon the assumed proceeds were greater than the average market price of the shares during that year.
	2013	2012		2011
	130	811		135

Note_14_Income_Taxes

Note 14 - Income Taxes	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	NOTE 14. INCOME TAXES
	The Company’s provision for income taxes consisted of the following:
			Years Ended December 31,
		2013			2012			2011
					(in thousands)
	Current:
	State	$	1,265		$	453		$	276
	U.S.		11,031			4,288			10,924
	Deferred:
	State		227			294			920
	U.S.		2,941			1,860			5,608
	Provision (benefit) for income taxes	$	15,464		$	6,895		$	17,728
	For federal income tax purposes, the Company’s previous net operating losses and alternative minimum tax credit carryforward were fully utilized as of December 31, 2011.
	As of December 31, 2013, for state income tax purposes, the Company had $10.3 million in net operating losses expiring in 2015 through 2029.
	Our income tax return for the 2011 tax year is currently under examination by the IRS. We do not expect that the results of this examination will have a material effect on our financial condition or results of operations.
	The following table reconciles the income tax provisions computed using the U.S. statutory rate of 35% for 2013, 2012 and 2011 to the provisions reflected in the financial statements.
			Years Ended December 31,
			2013			2012			2011
					(in thousands)
	Taxes at statutory rate	$	16,097		$	3,835		$	18,159
	Other non-deductible expenses		145			163			189
	Qualified production activities deduction		(1,334	)		(193	)		(1,305	)
	Charges related to U.S. Attorney investigation		—			2,625			—
	State taxes, net of federal benefit		969			485			778
	Excess executive compensation		—			—			128
	Impact of federal tax credits (1)		(85	)		—			490
	Change in deferred tax asset valuation allowance (2)		(77	)		(55	)		(1,120	)
	Impact of federal tax rate adjustment to 35%		—			—			491
	Other		(251	)		35			(82	)
	Provision (benefit) for income taxes	$	15,464		$	6,895		$	17,728
	(1) As a result of recognizing certain tax credits in 2011, the Company realized a $490,000 income tax expense.
	(2) During the fourth quarter of 2011, the Company reversed a deferred tax valuation allowance of $1,025,000 related to wage credits and $95,000 related to state net operating losses.
	The American Jobs Creation Act of 2004 (the “Act”) provides a deduction for income from qualified domestic production activities, which was phased in from 2005 through 2010. In return, the Act also provides for a two-year phase-out of the existing extra-territorial income exclusion (ETI) for foreign sales that was viewed to be inconsistent with international trade protocols by the European Union.
	Under the guidance in FASB ASC 740-10-55 to the Tax Deduction on Qualified Production Activities Provided by the American Jobs Creation Act of 2004, the deduction is treated as a “special deduction”. As such, the special deduction has no effect on deferred tax assets and liabilities existing at the enactment date. Rather, the impact of this deduction is reported in the period in which the deduction is claimed on the Company’s tax return.
	Temporary differences and tax credit carryforwards that gave rise to significant portions of deferred tax assets and liabilities as of December 31, 2013 and 2012 are as follows:
		2013			2012
		(in thousands)
	Deferred tax assets:
	Assets and accruals not yet deductible	$	4,369		$	3,639
	Equity based compensation		3,429			3,243
	Equity in loss of unconsolidated affiliates		125			125
	Tax credit carryforward		225			225
	Pension liability		3,716			5,636
	State income tax		492			404
	Valuation allowance		(584	)		(661	)
	Total deferred tax assets		11,772			12,611
	Deferred tax liabilities:
	Property and equipment		(21,844	)		(20,814	)
	Intangible assets		(590	)		(187	)
	Pension and other retirement benefits		(1,350	)		(1,272	)
	Assets currently deductible		(6,277	)		(4,967	)
	Total deferred tax liabilities		(30,061	)		(27,240	)
	Net deferred tax liability	$	(18,289	)	$	(14,629	)
	Deferred income tax asset (liability) current	$	1,062		$	1,165
	Deferred income tax asset (liability) non-current		(19,351	)		(15,794	)
	Net deferred tax liability	$	(18,289	)	$	(14,629	)
	The Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction and various states. With a few exceptions, the Company is no longer subject to U.S. federal, state and local or non-U.S. income tax examinations by tax authorities for years before 2001.
	A reconciliation of the beginning and ending amount of unrecognized tax benefits, as presented in “Other long-term liabilities” on the balance sheet, is as follows:
		2013			2012			2011
		(in thousands)
	Balance at January 1,	$	1,514		$	1,513		$	896
	Additions for tax positions of prior years		58			37			451
	Reductions for tax positions of prior years		—			(36	)		—
Additions based on tax positions related to the current year		—			—			166
Balance at December 31,	$	1,572		$	1,514		$	1,513
Included in the balances at December 31, 2013, 2012 and 2011 are $1.6 million, $1.5 million, and $1.5 million, respectively, of tax positions for which the ultimate deductibility is uncertain. The final settlement of these uncertain positions could positively or negatively impact the effective tax rate in the period settled. Because of the impact of deferred tax accounting, other than interest and penalties, the disallowance of the shorter deductibility period would not materially affect the annual effective tax rate but would accelerate the payment of cash to the taxing authority to an earlier period.
The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. The Company recorded an accrual for payment of $81,000 in interest and $26,000 in penalties at December 31, 2013. The Company recorded an accrual for payment of $53,000 in interest and a reversal of $2,000 in penalties at December 31, 2012. The Company recorded an accrual for payment of $33,000 in interest and $166,000 in penalties at December 31, 2011.

Note_15_Accrued_Liabilities

Note 15 - Accrued Liabilities	12 Months Ended
	Dec. 31, 2013
Disclosure Text Block Supplement [Abstract]	'
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]	'
	NOTE 15. ACCRUED LIABILITIES
	Accrued liabilities as of December 31, 2013 and December 31, 2012 are summarized as follows:
		December 31,		December 31,
		2013		2012
		(in thousands)
	Insurance	$	7,222	$	12,307
	Reserve for plant closure costs		595		—
	Reserve for U.S. Attorney investigation		—		7,655
	Salary and benefits		9,423		4,989
	Trade creditors		5,100		3,914
	Taxes, other than income tax		64		42
	Income tax		4,132		—
	Deferred revenue		2,362		2,060
	Contractual obligations		—		470
	Accrued interest		200		225
	Other		47		79
	Total accrued liabilities	$	29,145	$	31,741
	As of December 31, 2013 and 2012, deferred revenue was $2.4 million and $2.1 million, respectively, representing payments primarily received from international customers related to revenues which were not recognized until the subsequent period due to revenue recognition criteria.
	See Note 18. Commitments and Contingencies – Regulatory Matters for information on the U.S. Attorney’s Office investigation.

Note_16_Benefit_Plans

Note 16 - Benefit Plans	12 Months Ended
	Dec. 31, 2013
Disclosure Text Block Supplement [Abstract]	'
Compensation and Employee Benefit Plans [Text Block]	'
	NOTE 16. BENEFIT PLANS
	Defined Contribution Plan
	All qualified employees of the Company are covered under the Omega Protein 401(k) Savings and Retirement Plan (the “Plan”) as of December 31, 2013. WSP’s 401(k) plan was incorporated into the Plan as of May 1, 2013. The Company’s matching contributions to the Plan were approximately $1.2 million, $1.1 million, and $1.0 million during 2013, 2012, and 2011, respectively.
	Pension Plan
	Plan benefits are generally based on an employee’s years of service and compensation level. The plan has adopted an excess benefit formula integrated with covered compensation.
	In 2002, the Board of Directors froze the Company’s pension plan in accordance with ERISA rules and regulations so that new employees, after July 31, 2002, are not eligible to participate in the pension plan and further benefits no longer accrue for existing participants. The freezing of the pension plan had the effect of vesting all existing participants in their pension benefits in the plan.
	Amounts listed as pension benefits adjustment under the caption “Comprehensive Income (loss)” on the Consolidated Statements of Stockholders’ Equity of $3.6 million, $0.3 million, and ($2.1) million for 2013, 2012, and 2011, respectively, represent the change, net of tax, in the portion of the additional pension liability recorded under “Accumulated Other Comprehensive Loss” on the Consolidated Balance Sheet. During 2014, the Company expects total net periodic benefit cost to be approximately $0.8 million. The amounts in accumulated other comprehensive loss that are expected to be recognized as a component of net periodic benefit cost during the 2014 year are as follows (in thousands):
	Net Actuarial Loss (Gain)		$	915
	Prior Service Cost		$	0
	The Company’s funding policy is to make contributions as required by applicable regulations. The Company uses a December 31 measurement date for its pension plan. The following tables set forth the benefit obligations, fair value of plan assets, and the funded status of the Company’s pension plan, amounts recognized in the Company’s financial statements, and the principal weighted average assumptions used:
			Years Ended December 31,
			2013				2012
			(in thousands)
	Accumulated Benefit Obligations		$	25,945			$	29,202
	Change in Benefit Obligation
	Benefit Obligation at beginning of year		$	29,202			$	28,527
	Service Cost			—				—
	Interest Cost			991				1,095
	Plan Amendments			—				—
	Actuarial (Gain) Loss			(2,288	)			1,269
	Benefits Paid			(1,960	)			(1,689	)
	Benefit Obligation at end of year		$	25,945			$	29,202
	Change in Plan Assets
	Plan Assets at Fair Value at beginning of year		$	19,376			$	17,659
	Actual Return on Plan Assets			2,663				1,527
	Company Contributions			1,749				1,879
	Benefits Paid			(1,960	)			(1,689	)
	Plan Assets at Fair Value at end of year		$	21,828			$	19,376
	Funded Status of the Plan		$	(4,117	)		$	(9,826	)
	Additional Amounts Recognized in the Statement of Financial Position:
	Long-term Liabilities		$	(4,117	)		$	(9,826	)
	Amounts Recognized in Accumulated Other Comprehensive Loss:
	Net Actuarial (Loss) Gain, net of tax		$	(6,387	)		$	(9,952	)
	Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Loss:
	Net Actuarial (Loss) Gain, net of tax		$	2,560			$	(679	)
	Reversal of Amortization Item:
	Amortization of Net Loss, net of tax			1,005				986
	Total Recognized in Other Comprehensive Loss, net of tax		$	3,565			$	307
	The Company, in consultations with its actuarial firm, employs a building block approach in determining the assumed long-term rate of return for plan assets. The Company reviews historical market data and long-term historical relationships between equities and fixed income in accordance with the widely-accepted capital market principle that assets with higher volatility generally generate greater returns over the long run. The Company also evaluates current market factors such as inflation and interest rates before it determines long-term capital market assumptions. After taking into account diversification of asset classes and the need to periodically re-balance asset classes, the Company establishes the assumed long-term portfolio rate of return by a building block approach. The Company also reviews peer data and historical returns to check its long-term rate of return for reasonability and appropriateness.
	A change in the assumed discount rate creates a deferred actuarial gain or loss. Generally, when the assumed discount rate decreases compared to the prior measurement date, a deferred actuarial loss is created. When the assumed discount rate increases compared to the prior measurement date, a deferred actuarial gain is created. Actuarial gains and losses also are created when actual results differ from assumptions. The net of the deferred gains and losses are amortized to pension expense over the average service life of the remaining plan participants, when it exceeds certain thresholds defined in FASB ASC 715-30-35. This approach to amortization of gains and losses has the effect of reducing the volatility of pension expense attributable to investment returns and liability experience. Over time, it is not expected to reduce or increase the pension expense relative to an approach that immediately recognizes losses and gains.
	As a result of the annual review of assumptions, the Company’s 2014 expected return on plan assets is 7.25%, consistent with 2013, and the discount rate increased from 3.47% to 4.36%. The discount rate selected by the Company is consistent with general movements in interest rates. Additionally, the Company performed a yield curve analysis which concluded that when the Citigroup Yield Curve is applied to the Plan, it produces a discount rate of 4.36% and the selected discount rate is equal to the yield curve analysis.
			Years Ended December 31,
			2013				2012
	Assumptions
	Weighted average assumptions used to determine benefit obligations at end of year
	Discount Rate			4.36	%			3.47	%
	Long-Term Rate of Return			7.25	%			7.25	%
	Salary Scale up to age 50		N/A				N/A
	Salary Scale over age 50		N/A				N/A
			Years Ended December 31,
			2013				2012				2011
	Weighted average assumptions used to determine net periodic benefit cost at beginning of year
	Discount Rate			3.47	%			4.01	%			5.08	%
	Long-Term Rate of Return			7.25	%			7.25	%			7.25	%
	Salary Scale up to age 50		N/A				N/A				N/A
	Salary Scale over age 50		N/A				N/A				N/A
				Years Ended December 31,
			2013				2012				2011
							(in thousands)
	Components of net periodic benefit cost:
	Service cost		$	—			$	—			$	—
	Interest cost			990				1,095				1,276
	Expected return on plan assets			(1,027	)			(1,303	)			(1,274	)
Amortization of net loss			1,561				1,517				1,189
Net periodic benefit cost		$	1,524			$	1,309			$	1,191
Plan Assets
The Company’s pension plan weighted-average asset allocations at December 31, 2013 and 2012, by asset category are as follows:
		Plan Assets
		at
		December 31,
Asset Category		2013								2012
		Actual				Target				Actual			Target
Equity			64.5	%			60	%			59.9	%		60	%
Debt securities			35.5				40				40.1			40
Other			—				—				—			—
Total			100	%			100	%			100	%		100	%
The fair values of the Company’s pension plan assets by major category are presented below. The fair value of the Company’s plan assets are estimated based on quoted prices for similar instruments in active markets and therefore are categorized, except as noted, as Level 2 of the fair value hierarchy. See Note 21 - Fair Value Disclosures for additional information related to fair value measurements and disclosures.
		Fair Value of Plan Assets at
		December 31,
		(in thousands)
		Fair Value Measurements Using Level 2
		(except as noted)
Asset Category		2013				2012
Equity Securities
Large-Cap Growth		$	4,833			$	3,946
Large Company Value			2,031				1,772
Mid-Cap Growth			897				753
Mid-Cap Value			915				768
Small Company Growth			873				774
Small Company Value			912				785
International			2,604	*			1,852	*
REIT			1,016				955
Fixed Income Securities
U.S. Treasuries			2,525				2,409
U.S. Govt. Agencies			2,003				2,333
Corporate bonds			2,077				2,093
International fixed income			220				332
Asset-backed securities			608				255
Mortgage-backed securities			314				349
Total		$	21,828			$	19,376
*Categorized as Level 1 of the fair value hierarchy.
Plan assets are well diversified and managed by independent investment advisors, who are in turn overseen and monitored by an investment advisor engaged by the Investment Committee. The Plan’s investment objective is long-term capital appreciation with a prudent level of risk. The Plan’s Investment Committee periodically completes asset performance studies with the goal of maintaining an optimal asset allocation in order to meet future Plan benefit obligations. The investment objectives of the Plan assets have a long-term focus and the Plan is invested in accordance with prudent investment practices that emphasize long-term investment fundamentals which avoid any significant concentrations of risks.
Equity securities do not include any of the Company’s common stock at December 31, 2013 and 2012, respectively.
Projected Benefit Payments for the years ending December 31, 2014 – 2022
				(in thousands)
2014		2015		2016		2017		2018		2019-2023
$1,769		$1,767		$1,789		$1,787		$1,797		$8,907
Expected Contributions during 2014
The Company expects to make contributions of $2.0 million to the pension plan in 2014.
Stock Incentive Plans
On January 26, 1998, the 1998 Long-Term Incentive Plan of the Company (the “1998 Incentive Plan”) was approved by the Company’s Board. The 1998 Incentive Plan provided for the grant of any or all of the following types of awards: stock options, stock appreciation rights, stock awards and cash awards. These options generally vest ratably over three years from the date of grant and expire ten years from the date of grant. Non-vested options are generally forfeited upon termination of employment.
On January 26, 1998, the Non-Management Director Stock Option Plan (the “Directors Plan”) was approved by the Board. The Directors Plan provided that the initial Chairman of the Board be granted options to purchase 568,200 shares of the Common Stock and each other initial non-employee director of the Company will be granted options to purchase 14,200 shares of Common Stock at a price determined by the Board.
On June 27, 2000, the 1998 Incentive Plan and the Director Plan were amended and restated in their entirety and renamed the 2000 Long-Term Incentive Plan (“2000 Incentive Plan”), and the 2000 Incentive Plan was approved by the Company’s stockholders. Under the 2000 Incentive Plan, the Company is authorized to issue shares of Common Stock pursuant to “Awards” granted in various forms, including incentive stock options (intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended), non-qualified stock options, and other similar stock-based Awards. The substantive changes from the 1998 Incentive Plan and the Directors Plan in the amendment and restatement of the 2000 Incentive Plan were (a) the 2000 Incentive Plan allows annual option grant awards of 10,000 shares to each non-employee Director and (b) the 2000 Incentive Plan allows for the aggregate number of option shares available for issuance under the plan to equal 25% of the number of shares of common stock outstanding at any time with an absolute maximum of no more than 15 million shares available for awards at any time. Reference is made to the Company’s 2000 proxy statement for a complete summary of all the differences among the three plans.
On April 13, 2006, the Board of Directors approved the establishment of the Omega Protein Corporation 2006 Incentive Plan (“2006 Incentive Plan”) which was subsequently approved by the Company’s stockholders and became effective on June 7, 2006. Reference is made to the Company’s 2006 proxy statement for a complete summary of the 2006 Incentive Plan.
The Company has granted stock options under the 2006 Incentive Plan in the form of non-qualified stock options. See “Stock-Based Compensation” regarding the method the Company utilizes to record compensation expense for employee stock options. The Company establishes the exercise price based on the fair market value of the Company’s stock (as defined in the relevant plan) at the date of grant. Each quarter, the Company reports the potential dilutive impact of stock options in its diluted earnings per common share using the treasury-stock method. Out-of-the-money stock options (i.e., the average stock price during the period is below the strike price of the stock option) are not included in diluted earnings per common share.
The Company has also issued shares of restricted stock under the 2006 Incentive Plan. Holders of shares of restricted stock are entitled to all rights of a stockholder of the Company, including the right to vote the shares and receive any dividends or other distributions. The shares are considered issued and outstanding on the date granted and are included in the basic earnings per share calculation.
Stock-Based Compensation
Stock Options
Net income for the years ended December 31, 2013, 2012, and 2011 includes $0.6 million, $3.1 million and $3.2 million ($0.4 million, $2.0 million and $2.1 million after-tax), respectively, of stock-based compensation costs related to stock options which are primarily included in selling, general and administrative expenses in the consolidated statement of comprehensive income. As of December 31, 2013, there was $0 of unrecognized compensation costs related to non-vested stock options.
There were 859,000 stock option exercises during 2013. A summary of option activity under the plans for years 2013, 2012 and 2011 is as follows (options in thousands):
		2013								2012						2011
		Number of				Weighted				Number of			Weighted			Number of			Weighted
		Shares				Average				Shares			Average			Shares			Average
		Underlying				Exercise				Underlying			Exercise			Underlying			Exercise
		Options				Prices				Options			Prices			Options			Prices
Outstanding at beginning of year			2,652			$	6.19				2,776		$	6.12			3,271		$	5.86
Granted			—				—				98		$	6.8			60		$	13.41
Exercised			(859	)		$	4.67				(92	)	$	4.46			(536	)	$	5.37
Expired			—				—				—			—			—			—
Forfeited			(7	)		$	12.81				(130	)	$	6.42			(19	)	$	5.33
Outstanding at end of year			1,786			$	6.89				2,652		$	6.19			2,776		$	6.12
Exercisable at end of year			1,786			$	6.89				2,206		$	6.31			1,228		$	6.51
Weighted-average fair value of options granted							—						$	3.76					$	7.48
		Aggregate Intrinsic Value
		2013				2012				2011
						(in thousands)
Options outstanding as of December 31		$	9,814			$	2,045			$	3,770
Options exercisable as of December 31		$	9,814			$	1,660			$	1,716
Options exercised during the year		$	5,430			$	224			$	4,365
The following table further describes the Company’s stock options outstanding as of December 31, 2013.
				Options Outstanding and Exercisable
Range of				Number			Weighted Average		Weighted Average
Exercise Prices				Outstanding			Remaining		Exercise Prices
				at 12/31/2013			Contractual Life (years)
$2.22	to	$4.70			420,097		5.9		$	4.5
$4.71	to	$6.00			34,000		4.6		$	5.13
$6.01	to	$7.55			1,157,502		6.8		$	6.99
$7.56	to	$10.58			44,200		3.6		$	8.65
$10.59	to	$15.88			130,000		5.8		$	13.59
					1,785,799
		Year Ended				Weighted Average
		31-Dec-13				Grant-Date
						Fair Value
Nonvested options as of January 1, 2013			446,671			$	3.21
Granted			—				—
Vested			(466,671	)		$	3.21
Forfeited			—				—
Nonvested options as of December 31, 2013			—				—
The fair value of the Company’s stock options is the estimated present value at grant date using the Black-Scholes option pricing model with the following weighted average assumptions for the years ended December 31, 2012 and 2011: expected dividend yield of 0%, and 0%; weighted-average volatility of 65.7%, and 64.1%; risk-free interest rate of 0.86%, and 1.64%; and an expected term of 5 to 6 years. The expected dividend yield is based on the Company’s annual dividend payout at grant date. Expected volatility is based on the historical volatility of the Company’s stock for a period approximating the expected life. The risk-free interest rate is based on the U.S. treasury yield in effect at the time of grant and has a term equal to the expected life. The expected term of the options represents the period of time the options are expected to be outstanding.
Restricted Stock
The Company has issued shares of restricted stock under the 2006 Incentive Plan. Shares of restricted stock have generally vested on the third anniversary of the grant date except for shares of restricted stock granted to non-employee directors which vest six months after the grant date. Non-vested shares are generally forfeited upon the termination of employment or service as a director. Holders of shares of restricted stock are entitled to all rights of a stockholder of the Company, including the right to vote the shares and receive any dividends or other distributions. The non-vested shares are considered participating securities and the Company has calculated earnings per share using the two-class method. See Note 13 – Reconciliation of Basic and Diluted Per Share Data.
Net income for the years ended December 31, 2013, 2012, and 2011 includes $1.4 million, $0.6 million and $0.1 million ($0.9 million, $0.4 million and $0.1 million after-tax), respectively, of stock-based compensation costs related to restricted stock which are primarily included in selling, general and administrative expenses in the consolidated statement of comprehensive income. As of December 31, 2013, there was approximately $1.5 million ($0.9 million after tax) of unrecognized compensation cost related to non-vested restricted shares that is expected to be recognized over a weighted-average period of 1.3 years. Based on restricted stock issued as of December 31, 2013, share-based compensation expense for fiscal year 2014 is expected to be approximately $1.0 million ($0.7 million after tax).
The following table shows restricted stock issued and outstanding under the 2006 Long-Term Incentive Plan to the Company’s employees and non-employee directors for the year ended December 31, 2013:
Date of Restricted		Grant Date				Restricted Stock Issued			Date of
Stock Award		Fair Value				and Outstanding			Vesting
						as of December 31, 2013
28-Feb-13		$	7.97				25,000		28-Feb-16
1-Jul-13		$	9.08				33,036		1-Jan-14
							58,036
A summary of the Company’s non-vested restricted stock activity is presented below.
		2013				Wgt. Avg.
		(in shares)				Grant Date
						Fair Value
Outstanding at beginning of year			420,698			$	7.19
Granted			58,036			$	8.6
Vested			—				—
Expired			—				—
Forfeited			—				—
Outstanding at end of year			478,734			$	7.36
The aggregate intrinsic value of the Company’s outstanding restricted stock at December 31, 2013 and 2012 was $6.0 million and $2.6 million, respectively. 238,734 shares of the Company’s restricted shares outstanding at December 31, 2013 are expected to vest during the year 2014.

Note_17_Hurricane_Losses_Insur

Note 17 - Hurricane Losses, Insurance Recoveries and Other Proceeds	12 Months Ended
	Dec. 31, 2013
Extraordinary and Unusual Items [Abstract]	'
Unusual or Infrequent Items Disclosure [Text Block]	'
	NOTE 17. HURRICANE LOSSES, INSURANCE RECOVERIES AND OTHER PROCEEDS
	2005 Hurricanes
	In August 2005, Omega Protein’s Moss Point, Mississippi fish processing facility and adjacent shipyard were severely damaged by Hurricane Katrina. In September 2005, Omega Protein’s Cameron, Louisiana and the Abbeville, Louisiana fish processing facilities were also severely damaged by Hurricane Rita.
	In August 2007, the Company filed a lawsuit in the District Court of Harris, Texas 295th Judicial District, against its prior insurance broker, Aon, who procured the Company’s property insurance policies for the 2005/2006 policy year, which were the subject of prior litigation as a result of claims relating to Hurricanes Rita and Katrina. In June 2011, all outstanding claims related to the lawsuit were settled and the Company recorded $0.8 million, net of fees and expenses, as “Other proceeds/gains resulting from natural disaster, net – 2005 storms” in the consolidated statement of comprehensive income for the year ended December 31, 2011. As a part of the final settlement, the Company released and waived all claims against Aon for all matters addressed in the litigation.

Note_18_Commitments_And_Contin

Note 18 - Commitments And Contingencies	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	NOTE 18. COMMITMENTS AND CONTINGENCIES
	Operating Lease Payable
	The Company has noncancellable operating leases, primarily for land and building, that expire over one to seven years.
	Future minimum payments under non-cancelable operating lease obligations for the five years ending December 31, 2017 and thereafter are as follows (in thousands):
	2014	2015	2016	2017	2018	Thereafter
	$2,861	$2,502	$1,728	$1,613	$1,559	$1,472
	Rental expense for long-term operating leases was $2.7 million, $2.4 million and $2.3 million in 2013, 2012 and 2011, respectively.
	InCon Contingency
	In September 2011, the Company acquired all of the outstanding equity of InCon in a cash transaction pursuant to the terms of an equity purchase agreement. The equity of InCon was indirectly held by four individuals (the “Sellers”), two of whom continue to be employed by InCon and share in the management of InCon’s business. InCon is now a wholly owned subsidiary of the Company.
	In addition to the acquisition date cash purchase price, the Sellers may also earn additional amounts based on the annual EBITDA of InCon’s toll processing and specialty product business during calendar years 2012 through 2016. The Company and the Sellers amended the earn-out terms on April 25, 2013 by lowering the earn-out by 35% of the original formula in 2013 and all future years. The annual earn-out provisions (as amended) are determined based on a percentage of InCon’s EBITDA, adjusted for certain product sales and costs, which percentage ranges from 3.25% of the first $3.0 million of EBITDA to 19.5% of EBITDA in excess of $12.0 million.
	The annual earn-out payments, if any, will be estimated on a quarterly basis and paid subsequent to year end. The Company will record the estimated contractual obligation as compensation expense during each year as it is deemed probable that such amount will be payable. In addition, the earn-out payments are subject to certain reductions associated with future InCon capital expenditures and forfeitures based on termination of employment of a Seller. For the years ended December 31, 2013 and 2012, the Company has not recorded an annual earn-out estimate.
	Legal Contingencies
	On May 18, 2011, the Company’s fishing vessel, F/V Sandy Point, was involved in a collision with a commercial cargo vessel. As a result of the collision, the Company’s vessel sank and three Company crew members died. Representatives of the three deceased crewmembers, as well as certain other crewmembers, filed lawsuits against the Company. All claims in the matter have been settled. All claims arising from the incident have been covered by the Company’s insurance policies, subject to customary deductibles.
	In conjunction with the sinking of the vessel, the Company recorded a net insurance receivable of approximately $5.9 million related primarily to costs expended salvaging the sunken vessel from the Mississippi ship channel and other claims and a net receivable of $1.8 million related to the insurance value of the vessel. The $1.8 million receivable related to the vessel value was received in 2011. An additional $5.7 million related to the salvage of the vessel was received from the Company’s primary insurance carrier when in June 2013, the Company completed the settlement of the vessel and salvage receivables with its insurance carrier.
	The Company has been named in a lawsuit filed in federal court in the Southern District of Mississippi in connection with the death of an employee at the Company’s Moss Point, Mississippi plant in April 2012. The lawsuit alleges that the Company intentionally caused the employee’s death, a claim that the Company emphatically denies. The Company believes that the claim is covered by the state’s workers compensation statute which provides that worker compensation benefits are the exclusive remedy for a work-related injury or death under these circumstances. The Company intends to contest the claim vigorously.
	Insurance
	The Company believes its insurance coverage to be in such form, against such risks, for such amounts and subject to such deductibles and self-retentions as are generally prudent for its operations but the securing of such coverage by necessity requires judgment in the balancing of retained risk and the cost effectiveness of such insurance programs. In recent years, for example, the Company has elected to increase its deductibles and self-retentions in order to manage rising insurance premium costs. These higher deductibles and self-retentions will expose the Company to greater risk of loss if future claims occur.
	Insurance coverage may not be available in the future at current costs or on what the Company considers to be commercially reasonable terms. Furthermore, any insurance proceeds received for any loss of, or damage to, any of the Company’s facilities may not be sufficient to restore the loss or damage without negative impact on our results of our business, financial condition or results of operations. In addition, should a Company insurer become insolvent, the Company would be responsible for payment of all outstanding claims associated with that insurer’s policies.
	Regulatory Matters
	The Company is subject to various possible claims and lawsuits regarding environmental matters. Except as noted below, management believes that costs, if any, related to these matters will not have a material adverse effect on the results of operations, cash flows or financial position of the Company.
	In April 2010, the Company received a request for information from the EPA concerning its bail wastewater practices used in its fishing operations at its Reedville, Virgina facility. In February 2011, the U.S. Coast Guard conducted inspections at the Company’s Reedville facility regarding the Reedville vessels’ bilge water discharge practices. Based on these inquiries, both agencies commenced investigations of the Company’s bail waste water and bilge water practices at its Reedville facility. The U.S. Attorney’s Office for the Eastern District of Virginia subsequently reviewed both the results of the Coast Guard inspection and the EPA request for information.
	In June 2013, the Company’s subsidiary, Omega Protein, resolved both the U.S. Coast Guard and EPA investigations by entering into a plea agreement with the United States Attorney’s Office for the Eastern District of Virginia. Pursuant to terms of the plea agreement, the Company’s subsidiary pled guilty to two Clean Water Act violations. The plea agreement required the subsidiary to pay a $5.5 million fine, be placed on a three year term of probation, and implement an environmental compliance program. In addition to the $5.5 million fine, the subsidiary was required to make a $2.0 million contribution to the National Fish and Wildlife Foundation to fund projects in Virginia related to the protection of the environmental health of the Chesapeake Bay. The plea agreement was approved by the U.S. District Court for the Eastern District of Virginia in June 2013 and the subsidiary paid both the $5.5 million fine and the $2.0 million contribution in July 2013. Omega Protein will be on probation until June 2016, unless the probation period is terminated earlier by the court. The Company recorded charges related to the investigation of $8.0 million and $0.5 million for the years ended 2012 and 2011, respectively.
	In 2013, Omega Protein requested an equivalency determination from the U.S. Coast Guard for its Gulf of Mexico fleet regarding the use of certain vessel equipment required for “ocean-going vessels” (as defined by Coast Guard regulations) that operate beyond the 12 nautical mile limit. In April 2013 the Coast Guard granted Omega Protein a partial waiver for its 2013 fishing season that allowed Omega Protein to travel, but not fish, outside 12 nautical miles of shore. In January 2014, the Coast Guard granted Omega Protein’s request to utilize alternate and enhanced management procedures to satisfy the Coast Guard’s required vessel equipment, subject to certain restrictions. The Coast Guard also granted Omega Protein a 12 month waiver from the equipment requirements to allow the Company sufficient time to implement these alternate measures and also allowed fishing beyond the 12 nautical mile limit for a 12 month period, subject to certain restrictions. The Company intends to implement these measures by the beginning of the 2015 fishing season.
	In May 2012, the North Carolina Division of Marine Fisheries in the Department of Environment and Natural Resources issued a proclamation that banned the commercial fishing of menhaden using purse seine netting in North Carolina state waters. The restrictions in the proclamation were subsequently enacted into law by the North Carolina General Assembly, effectively prohibiting the Company’s fishing operations in these state waters. Federal waters outside the North Carolina three-nautical mile state water limit remain unaffected. In 2011, the Company caught approximately 1.6% of its total 2011 fish catch in North Carolina state waters.
	Indemnification
	The Company’s Articles of Incorporation and By-Laws limit the liability of the Company’s officers and directors to the fullest extent permitted by Nevada law. Nevada provides that directors of Nevada corporations may be relieved of monetary liabilities for breach of their fiduciary duties as directors, except under certain circumstances, including (i) acts or omissions which involve intentional misconduct, fraud or a knowing violation of law or (ii) the willful or grossly negligent payment of unlawful distributions.
	The Company’s Articles of Incorporation and By-Laws generally require the Company to indemnify its directors and officers to the fullest extent permitted by Nevada law. The Company’s Articles of Incorporation and By-Laws also require the Company to advance expenses to its directors and its officers to the fullest extent permitted by Nevada law upon receipt of an undertaking by or on behalf of such director or officer to repay such amount if it should be ultimately determined that they are not entitled to indemnification by the Company. The Company also has entered into indemnification agreements with all of its directors and certain of its officers which provides for the indemnification and advancement of expenses by the Company. The Company also maintains director and officer liability insurance with respect to liabilities arising out of certain matters, including matters arising under the securities laws. This insurance is subject to limitations, conditions and deductibles set forth in the respective insurance policy.

Note_19_Related_Party_Transact

Note 19 - Related Party Transactions	12 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
Related Party Transactions Disclosure [Text Block]	'
	NOTE 19. RELATED PARTY TRANSACTIONS
	In September 2011, the Company acquired all of the outstanding equity of InCon in a cash transaction pursuant to the terms of an equity purchase agreement. The equity of InCon was indirectly held by four individuals (the “Sellers”), two of whom continue to be employed by InCon and share in the management of InCon’s business. During the year ended December 31, 2012, the Company received a payment from the Sellers of $0.2 million to account for a final working capital adjustment in conjunction with the acquisition.
	The Sellers own and operate privately held businesses with which InCon continues to provide toll distillation services and pilot plant runs, primarily InCon Process Systems and InCon Industries. From the acquisition date on September 9, 2011 through December 31, 2011, InCon recorded revenue of $0.2 million from these related parties. During the years ended December 31, 2013 and 2012, InCon recorded revenue from these related parties of approximately $0.5 million and $0.3 million, respectively. Purchases from these same related parties were approximately $82,500 and $2,500 for the years ending December 31, 2013 and 2012.

Note_20_Industry_Segment_and_G

Note 20 - Industry Segment and Geographic Information	12 Months Ended
	Dec. 31, 2013
Segment Reporting [Abstract]	'
Segment Reporting Disclosure [Text Block]	'
	NOTE 20. INDUSTRY SEGMENT AND GEOGRAPHIC INFORMATION
	Segment Information
	The Company reports in two segments, animal nutrition and human nutrition. These segments are managed separately and information on each segment is provided to the chief operating decision makers as they make decisions about the Company’s overall resource allocation and assess performance.
	The animal nutrition segment is primarily comprised of the Company’s fishing related assets. These assets produce fish meal, oil and solubles that are sold primarily to animal nutrition customers. A portion of the Company’s fish oil is also partially refined and transferred at cost to the human nutrition segment where it is further refined and concentrated for sale to the human nutrition market. The human nutrition segment is comprised of assets used to produce, procure, market and sell product to human nutrition markets.
	The tables below present information about reported segments for 2013, 2012 and 2011 (in thousands).
	2013		Animal Nutrition			Human Nutrition(1)			Unallocated			Total
	Revenue (2)		$	213,236		$	31,057		$	—		$	244,293
	Cost of sales			136,146			25,397			—			161,543
	Gross profit			77,090			5,660			—			82,750
	Selling, general and administrative expenses including research and development)			2,744			6,959			17,997			27,700
	Loss related to plant closure			6,597			—			—			6,597
	Other (gains) and losses			140			305			(5	)		440
	Operating income		$	67,609		$	(1,604	)	$	(17,992	)	$	48,013
	Depreciation and amortization		$	17,946		$	2,369		$	741		$	21,056
	Identifiable assets		$	277,063		$	53,093		$	1,238		$	331,394
	Capital expenditures		$	19,080		$	5,350		$	366		$	24,796
		-1	Includes revenues and related expenses for WSP from February 27, 2013 through December 31, 2013.
		-2	Excludes revenue from internal customers of $1.3 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.
	2012		Animal Nutrition			Human Nutrition			Unallocated			Total
	Revenue (3)		$	213,624		$	22,015		$	—		$	235,639
	Cost of sales			176,588			16,995			—			193,583
	Gross profit			37,036			5,020			—			42,056
	Selling, general and administrative expenses (including research and development)			2,564			3,795			17,587			23,946
	Charges related to U.S. Attorney investigation			7,990			—			—			7,990
	Other (gains) and losses			(2,635	)		129			—			(2,506	)
	Operating income		$	29,117		$	1,096		$	(17,587	)	$	12,626
	Depreciation and amortization		$	15,859		$	1,315		$	825		$	17,999
	Identifiable assets		$	266,307		$	27,109		$	1,880		$	295,296
	Capital expenditures		$	22,810		$	1,759		$	495		$	25,064
		-3	Excludes revenue from internal customers of $1.6 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.
	2011		Animal Nutrition			Human Nutrition			Unallocated			Total
	Revenue (4)		$	236,489		$	15,254		$	—		$	251,743
	Cost of sales			187,092			9,977			—			197,069
	Gross profit			49,397			5,277			—			54,674
	Selling, general and administrative expenses (including research and development)			2,804			3,286			18,548			24,638
	Charges related to U.S. Attorney investigation			545			—			—			545
	Other (gains) and losses			(24,869	)		1			—			(24,868	)
	Operating income		$	70,917		$	1,990		$	(18,548	)	$	54,359
	Depreciation and amortization		$	15,098		$	648		$	684		$	16,430
	Identifiable assets		$	248,672		$	27,048		$	2,110		$	277,830
	Capital expenditures		$	22,542		$	566		$	244		$	23,352
		-4	Excludes revenue from internal customers of $0.4 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.
	A reconciliation of total segment operating income to total earnings from operations before income taxes for the years ended December 31, 2013, 2012, and 2011 is as follows (in thousands):
			Year ended December 31,
			2013			2012			2011
	Operating income for reportable segments		$	48,013		$	12,626		$	54,359
	Interest income			18			32			43
	Interest expense			(1,658	)		(1,335	)		(2,109	)
	Other expense, net			(394	)		(365	)		(408	)
	Income before income taxes		$	45,979		$	10,958		$	51,885
	Geographical and Other Information
	The Company’s export sales were approximately $120 million, $142 million, and $165 million in 2013, 2012, and 2011, respectively. Such sales were made primarily to Asian, European and Canadian markets. In 2013, 2012 and 2011, sales to the Company’s top customer were approximately $22.7 million, $43.5 million and $38.6 million, respectively. The top customer was Nestle Purina Pet Care for 2013, Hong Kong Ruiboer for 2012 and Pacific Tide Limited for 2011. In addition, in 2011 a second customer, Hong Kong Ruiboer, also accounted for approximately $36.8 million of revenue.
	The following table shows the geographical distribution of revenues (in millions) based on location of customers:
			Years Ended December 31,
			2013						2012						2011
			Revenues			Percent			Revenues			Percent			Revenues		Percent
	U.S.		$	123.9			50.7	%	$	93.8			39.8	%	$	86.6		34.4	%
	Mexico			1.3			0.5			0.9			0.4			0.9		0.3
	Europe			31.5			12.9			18.6			7.9			30.3		12.1
	Canada			11.6			4.8			13.2			5.6			15.4		6.1
	Asia (1)			70.9			29			104.2			44.2			114.3		45.4
	South & Central America			4.8			2			4.7			2			4		1.6
	Other			0.3			0.1			0.2			0.1			0.2		0.1
Total		$	244.3			100	%	$	235.6			100	%	$	251.7		100	%
(1) Of this balance, China comprised approximately $47.4 million, $89.5 million and $102.6 million for the years ended December 31, 2013, 2012 and 2011, respectively.
The following table sets forth the Company’s revenues by product (in millions) and the approximate percentage of total revenues represented thereby, for the indicated periods:
		Years Ended December 31,
		2013						2012						2011
		Revenues			Percent			Revenues			Percent			Revenues		Percent
Fish Meal		$	142.5			58.3	%	$	160.7			68.2	%	$	175.5		69.8	%
Fish Oil			43.8			18			27.6			11.7			39.6		15.7
Refined Fish Oil			22.7			9.3			17.8			7.6			15.6		6.2
Fish Solubles and Other			4.2			1.7			7.5			3.2			5.8		2.3
Dietary Supplement and Food Ingredients and Products			31.1			12.7			22			9.3			15.2		6
Total		$	244.3			100	%	$	235.6			100	%	$	251.7		100	%

Note_21_Fair_Value_Disclosures

Note 21 - Fair Value Disclosures	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Fair Value Disclosures [Text Block]	'
	NOTE 21. FAIR VALUE DISCLOSURES
	The following disclosures of the estimated fair value of financial instruments are made in accordance with the requirements of FASB ASC 825-10-50, Disclosure About Fair Value of Financial Instruments. The estimated fair value amounts have been determined by the Company using available market information and appropriate valuation methodologies and are described in the following paragraphs.
	Fair value estimates are subject to certain inherent limitations. Estimates of fair value are made at a specific point in time, based on relevant market information and information about the financial instrument. The estimated fair values of financial instruments presented below are not necessarily indicative of amounts the Company might realize in actual market transactions. Estimates of fair value are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.
	The carrying amounts of cash and cash equivalents, accounts receivables, accounts payable, and accrued expenses approximate fair value because of the short maturity of these items. For non-financial assets, such as goodwill, carrying values are compared to fair value on an annual basis as required by impairment standards and the carrying value is reduced when determined necessary as a result of impairment testing. At December 31, 2013, the Company had no borrowings under its bank credit facility except for $3.5 million in letters of credit support obligations.
	FASB ASC 820-10 defines fair value, provides a consistent framework for measuring fair value under accounting principles generally accepted in the United States and expands fair value financial statement disclosure requirements. The FASB’s prescribed valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect our market assumptions. The standard classifies these inputs into the following hierarchy:
	Level 1 Inputs– Quoted prices for identical instruments in active markets.
	Level 2 Inputs– Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.
	Level 3 Inputs– Instruments with primarily unobservable value drivers.
	The carrying values and respective fair values of the Company’s long-term debt are presented below (in thousands). The fair value of the Company’s long-term debt is estimated based on the quoted market prices available to the Company for issuance of similar debt with similar terms at year end 2013.
		Years Ended December 31,
		2013		2012
	Long-term Debt (Level 2):
	Carrying Value	$	24,242	$	27,300
	Estimated Fair Value	$	25,285	$	29,940
	The following tables set forth by level within the fair value hierarchy the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis as of December 31, 2013 and December 31, 2012. As required by FASB ASC 820-10, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company's assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.
		31-Dec-13
		Fair Value Measurements Using								Assets
		Level 1		Level 2			Level 3			(Liabilities) at
										Fair Value
	Assets (Liabilities) (in thousands)
	Energy swap	$	—	$	275		$	—	$	275
	Total Assets (Liabilities)	$	—	$	275		$	—	$	275
		31-Dec-12
		Fair Value Measurements Using								Assets
		Level 1		Level 2			Level 3			(Liabilities) at
										Fair Value
	Assets (Liabilities) (in thousands)
	Energy swap	$	—	$	134		$	—	$	134
	Total Assets (Liabilities)	$	—	$	134		$	—	$	134
	The determination of the fair values above incorporates various factors required under FASB ASC 820-10. These factors include not only the credit standing of the counterparties involved and the impact of credit enhancements (such as cash deposits, letters of credit and priority interests), but also the impact of the Company’s nonperformance risk on its liabilities.
	The fair value of the diesel, Bunker C fuel oil and natural gas energy swaps is derived from the underlying market price of similar instruments at a specific valuation date. The underlying market price for the diesel and natural gas swaps is based upon the NYMEX Futures Curve. The underlying market price for the Bunker C fuel oil swaps is based upon the Platts Forward Curve HP 1.0%. These methods rely upon quoted prices for similar instruments in active markets. When such inputs have a significant impact on the measurement of fair value, the instrument is categorized in Level 2.
	The following table provides a reconciliation of all assets and (liabilities) measured at fair value on a recurring basis which use Level 3 or significant unobservable inputs or significant value drivers for the years ended December 31, 2013 and 2012 (in thousands). There have been no transfers between the hierarchy levels for the periods presented. The interest rate swap agreements matured at the end of March 2012 and are no longer outstanding.
		Fair Value Measurements Using Significant
		Unobservable Inputs (Level 3 Inputs)
		Year Ended
		December 31,
		2013		2012
	Beginning Balance	$	—	$	(103	)
	Net Loss reclassified into interest expense related to interest rate swap transactions unrealized		—		—
	Net change associated with current period interest rate swap transactions realized		—		103
	Ending Balance	$	—	$	—

Note_22_Shareholder_Rights_Pla

Note 22 - Shareholder Rights Plan	12 Months Ended
	Dec. 31, 2013
Stockholders' Equity Note [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	NOTE 22. SHAREHOLDER RIGHTS PLAN
	In June 2010, the Company’s Board of Directors adopted a Shareholder Rights Plan. The Plan is designed to protect the Company from unfair or coercive takeover tactics and to prevent an acquirer from gaining control of the Company without offering a fair price to all shareholders. Pursuant to the Plan, the Board declared a dividend of one Right for each outstanding share of the Company’s Common Stock. Each Right will entitle the holder (except for the 15% acquirer described below) to buy a share of Company Common Stock (or an equivalent) at a 50% discount.
	The Rights will trade with the Company’s Common Stock until exercisable. The Rights will not be exercisable until ten days following a public announcement that a person or group has acquired 15% of the Company’s Common Stock or until ten business days after a person or group begins a tender offer that would result in ownership of 15% of the Company’s Common Stock, subject to certain extensions by the Board. In the event that an acquirer becomes a 15% beneficial owner of Common Stock, the Rights “flip in” and become Rights to buy the Company’s Common Stock at a 50% discount, and Rights owned by that acquirer become void.
	In the event that the Company is merged and its Common Stock is exchanged or converted, or if 50% or more of the Company’s assets or earnings power is sold or transferred, the Rights “flip over” and entitle the holders to buy shares of the acquirer’s common stock at a 50% discount. A tender or exchange offer for all outstanding shares of the Company’s Common Stock at a price and on terms determined to be fair and otherwise in the best interests of the Company and its shareholders by a majority of the Company’s independent directors will not trigger either the “flip-in” or “flip-over” provisions.
	The Rights may be redeemed by the Company for $0.01 per right at any time until ten days following the first public announcement that an acquirer has acquired the level of ownership that triggers the Rights Plan. The Rights extend for 10 years and will expire on June 30, 2020 unless otherwise amended or terminated by the Board.

Note_23_Quarterly_Financial_Da

Note 23 - Quarterly Financial Data (Unaudited)	12 Months Ended
	Dec. 31, 2013
Quarterly Financial Information Disclosure [Abstract]	'
Quarterly Financial Information [Text Block]	'
	NOTE 23. QUARTERLY FINANCIAL DATA (UNAUDITED)
	Seasonal and Quarterly Results
	The following table presents certain unaudited operating results for each of the Company’s preceding eight quarters. The Company believes that the following information includes all adjustments (consisting only of normal recurring adjustments) that the Company considers necessary for a fair presentation, in accordance with generally accepted accounting principles. The operating results for any interim period are not necessarily indicative of results for any other period.
			Quarters Ended 2013
			March 31,			June 30,		September 30,		December 31,
			2013			2013		2013		2013
					(in thousands, except per share amounts)
	Revenues (1)		$	48,923		$	41,777	$	87,620	$	65,973
	Gross profit (1) (4)			12,097			13,283		29,420		27,950
	Operating income (1)(5)			4,723			6,690		21,921		14,679
	Net income (1)			2,845			3,990		13,962		9,718
	Earnings per share (2):
	Basic			0.14			0.2		0.68		0.47
	Diluted			0.14			0.19		0.66		0.45
			Quarters Ended 2012
			March 31,			June 30,		September 30,		December 31,
			2012			2012		2012		2012
					(in thousands, except per share amounts)
	Revenues (1)		$	41,088		$	47,448	$	83,970	$	63,133
	Gross profit (1)			8,892			6,847		13,398		12,919
	Operating income (1) (3)			3,170			4,201		2,904		2,351
	Net income (loss) (1) (3)			1,830			2,510		231		(508	)
	Earnings (loss) per share (2):
	Basic			0.09			0.13		0.01		(0.03	)
	Diluted			0.09			0.13		0.01		(0.03	)
		-1	Revenues, gross profit, operating income, and net income (loss) are rounded to thousands each quarter. Therefore, the sum of the quarterly amounts may not equal the annual amounts reported.
		-2	Earnings per share are computed independently for each quarter and the full year based upon respective average shares outstanding. Therefore, the sum of the quarterly earnings per share amounts may not equal the annual amounts reported.
		-3	Included in the quarter ended September 30, 2012 expense is a $4.1 million charge related to the U.S. Attorney investigation. A similar additional charge of $3.6 million was recognized for the quarter ended December 31, 2012. These charges were non-deductible for federal tax purposes.
		-4	Gross profit as a percentage of revenues for the quarter ended December 31, 2013 increased substantially as compared to the previous three quarters of 2013. This increase was due to greater than anticipated inventory production after September 30, 2013. As a result, standard cost for 2013 inventory, for which sales commenced largely in the third quarter of 2013, was decreased and cumulatively adjusted all previous sales of 2013 inventory production during the quarter ended December 31, 2013. The impact of the change in standard cost to the quarter ended December 31, 2013 is estimated to be approximately $4 million.
		-5	Included in the quarter ended December 31, 2013 expense is a $6.6 million charge related to the loss on the plant closure.
	The Company’s menhaden harvesting and processing business is seasonal in nature. Omega Protein generally has higher sales during the menhaden harvesting season (which includes the second and third quarter of each fiscal year) due to increased product availability and customer demand. Additionally, due to differences in gross profit margins for Omega Protein’s various products, any variation in the mix of product sales between quarters may result in significant variations of total gross profit margins. As a result, the Company’s quarterly operating results have fluctuated in the past and may fluctuate in the future. In addition, from time to time Omega Protein defers sales of inventory based on prices for its products, which may affect comparable period comparisons.

Schedule_of_Valuation_and_Qual

Schedule of Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2013
Valuation and Qualifying Accounts [Abstract]	'
Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]	'
	SCHEDULE OF VALUATION AND QUALIFYING ACCOUNTS
	Description		Balance at		Charged to			Deductions			Balance at
			Beginning		Costs and						End of
			of Period		Expenses						Period
	December 31, 2011:
	Allowance for doubtful accounts (A)		$	371,340	$	81,000	(B)	$	159,279	(C)	$	293,061
	December 31, 2012:
	Allowance for doubtful accounts (A)		$	293,061	$	48,000		$	—		$	341,061
	December 31, 2013:
	Allowance for doubtful accounts (A)		$	341,061	$	103,322	(D)	$	57,602		$	386,781
		(A)	Includes allowance for doubtful accounts receivable and insurance receivable.
		(B)	During 2011, the acquisition of InCon added an additional $33,000 to the allowance for doubtful accounts.
		(C)	During 2011, a fully reserved insurance receivable of $0.2 million was written off.
		(D)	During 2013, the acquisition of WSP added an additional $47,822 to the allowance for doubtful accounts.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)

12 Months Ended

Dec. 31, 2013

Accounting Policies [Abstract]

'

Consolidation, Policy [Policy Text Block]

'

Consolidation

The consolidated financial statements include the accounts of Omega Protein Corporation and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

Basis of Accounting, Policy [Policy Text Block]

'

Financial Statement Preparation

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Company’s financial statements and the accompanying notes and the reported amounts of revenues and expenses during the reporting period. Actual amounts, when available, could differ from those estimates and those differences could have a material effect on the financial statements.

Certain amounts applicable to the prior periods have been reclassified to conform to the classifications currently followed. For the years ended December 31, 2012 and 2011, the Company reclassified $0.2 million and $0.5 million, respectively, of cash flows from investing activities to cash flows from operating activities related to accrued capital expenditures.  This revision was not considered to be material, individually or in the aggregate, to previously issued financial statements. The revisions had no effect on the results of operations (net or comprehensive income) or financial condition (stockholders’ equity).

Legal Costs, Policy [Policy Text Block]

'

Gulf of Mexico Oil Spill

In 2010, the Company accounted for $18.7 million in emergency payments received from the Gulf Coast Claims Facility (“GCCF”) during September and October related to damages incurred from the Gulf of Mexico oil spill in its inventory and cost of sales. The payments partially reduced cost of sales by 4.4%, or $8.2 million for the year ended December 31, 2011.

In April 2011, the Company agreed to a final settlement of all of its claims for costs and damages incurred as a result of the oil spill caused by the Deepwater Horizon explosion and received a final payment of $26.2 million, net of fees and expenses, from the GCCF. The amount was recognized as “Proceeds/gains resulting from Gulf of Mexico oil spill” in the Company’s consolidated statement of comprehensive income for the year ended December 31, 2011.

In total, the Company received payments of $44.8 million, net of fees and expenses, from the GCCF in 2010 and 2011. As a part of the final settlement, the Company released and waived all current and future claims against BP and all other potentially responsible parties with regard to the oil spill.

For additional information, see Note 4 – Gulf of Mexico Oil Spill.

Revenue Recognition, Policy [Policy Text Block]

'

Revenue Recognition

The Company derives revenue principally from the sales of a variety of protein and oil products derived from menhaden. In addition and as a result of its recent acquisitions of Cyvex, InCon and WSP, the Company’s revenues also include sales of dietary supplement ingredients to the nutraceutical industry and whey protein products to the food and nutritional supplement industries. The Company recognizes revenue for the sale of its products when price is established, collectability is reasonably assured, and title and rewards of ownership of its products are transferred to the customer.

Shipping and Handling Cost, Policy [Policy Text Block]

'

Shipping and Handling

Amounts billed to customers associated with shipping and handling are included in revenues and the related costs are included in cost of sales. For 2013, 2012 and 2011, $9.4 million, $14.4 million and $16.5 million of shipping and handling costs are included in cost of sales, respectively.

Cash and Cash Equivalents, Policy [Policy Text Block]

'

Cash and Cash Equivalents

The Company considers cash in banks and short-term investments with original maturities of three months or less as cash and cash equivalents.

Receivables, Policy [Policy Text Block]

'

Allowances for Doubtful Accounts

The Company’s receivables are recorded at net realizable value. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of the Company’s customers to make required payments. The Company considers the following factors when determining if collection is reasonably assured: customer credit worthiness, past transaction history with the customer, and changes in customer payment terms. If the Company has no previous experience with the customer, the Company typically obtains reports from credit organizations to ensure that the customer has a history of paying its creditors. The Company may also request financial information, including financial statements or other documents (e.g., bank statements), or may obtain a letter of credit from the customer to ensure that the customer has the means of making payment. If the financial condition of the Company’s customers were to deteriorate, adversely affecting their ability to make payments, additional allowances would be required.

Inventory, Policy [Policy Text Block]

'

Inventories

Omega Protein’s fishing season runs from mid-April to the first of November in the Gulf of Mexico and from the beginning of May into December in the Atlantic. Government regulations generally preclude Omega Protein from fishing during the off-seasons.

Omega Protein’s inventory cost system considers all costs associated with an annual fish catch and its processing, both variable and fixed, including both costs incurred during the off-season and during the fishing season. Omega Protein’s costing system allocates cost to inventory quantities on a per unit basis as calculated by a formula that considers total estimated inventoriable costs for a fishing season (including off-season costs) to total estimated units of production and the relative fair market value of the individual products produced. Omega Protein adjusts the cost of sales, off-season costs and inventory balances at the end of each quarter based on revised estimates of total inventoriable costs and units of production. Omega Protein’s lower-of-cost-or-market-value analyses at year-end and at interim periods compare the total estimated per unit production cost of Omega Protein’s expected production to the projected per unit market prices of the products. The impairment analyses involve estimates of, among other things, future fish catches and related costs, and expected commodity prices for the fish products as well as projected purchase commitments from customers. These estimates, which management believes are reasonable and supportable, involve estimates of future activities and events which are inherently imprecise and from which actual results may differ materially.

During the off-seasons, in connection with the upcoming fishing seasons, Omega Protein incurs costs (e.g., plant and vessel related labor, utilities, rent, repairs, and depreciation) that are directly related to Omega Protein’s infrastructure. These costs accumulate in inventory and are applied as elements of the cost of production of Omega Protein’s products throughout the fishing season ratably based on Omega Protein’s monthly units of production and the expected total units of production for the season.

Any costs incurred during abnormal downtime related to activity at Omega Protein’s plants are charged to expense as incurred. Such costs were incurred and offset by proceeds received from the Gulf Coast Claims Facility (“GCCF”) during 2011 as a consequence of the Deepwater Horizon explosion and the resulting oil spill in the Gulf of Mexico in April 2010. For additional information, see Note 4 – Gulf of Mexico Oil Spill.

The human nutrition segment generally uses standard costing for inventory it manufactures and FIFO for nutraceutical inventory. The Company’s inventory is stated at the lower of cost or market.

Insurance Premiums Revenue Recognition, Policy [Policy Text Block]

'

Business Interruption Insurance Proceeds

During 2012, the Company received approximately $0.3 million in proceeds, net of deductible, from its business interruption insurance coverage provider related to an incident causing downtime at one of its Gulf of Mexico production facilities in September 2011. The proceeds were calculated based on lost inventory production as well as a small amount of excess costs incurred by the Company as a result of the incident. Given that the Company experienced a slight decrease in production as a result of the incident, the proceeds related to lost inventory production were recognized as an increase in revenues and the proceeds related to excess costs were recognized as a reduction in cost of goods sold.

Liability Reserve Estimate, Policy [Policy Text Block]

'

Insurance

Omega Protein carries insurance for certain losses relating to its vessels and Jones Act liabilities for employees aboard its vessels. Omega Protein records gross insurance reserves by using an estimation process that considers Company-specific and industry information as well as management’s experience, assumptions and consultation with counsel. These reserves include estimated settlement costs. In addition, insurance receivables are recorded for those portions of the claims in excess of Company insurance policy annual aggregate deductibles and stop losses. Management’s current estimated range of liabilities related to such cases is based on claims for which management can estimate the amount and range of loss. For those claims where there may be a range of loss, Omega Protein has recorded an estimated liability inside that range, based on management’s experience, assumptions and consultation with counsel. The process of estimating and establishing reserves for these claims is inherently uncertain and the actual ultimate net cost of a claim may vary materially from the estimated amount reserved. There is some degree of inherent variability in assessing the ultimate amount of losses associated with these claims due to the extended period of time that transpires between when a claim occurs and the full settlement of the claim. This variability is generally greater for Jones Act claims by vessel employees. Omega Protein evaluates loss estimates associated with claims and losses as additional information becomes available and revises its estimates. Although management believes estimated reserves related to these claims are adequately recorded, it is possible that actual results could significantly differ from the recorded reserves, which could materially impact Omega Protein’s business, financial condition or results of operations.

The Company is primarily self-insured for health insurance. The Company purchases individual stop loss coverage with a large deductible. As a result, the Company is primarily self-insured for claims and associated costs up to the amount of the deductible, with claims in excess of the deductible amount being covered by insurance. Expected claims estimates are based on health care trend rates and historical claims data; actual claims may differ from those estimates. The Company evaluates its claims experience related to this coverage with information obtained from its risk management consultants.

Assumptions used in preparing these insurance estimates are based on factors such as claims settlement patterns, claim development trends, claim frequency and severity patterns, inflationary trends and data reasonableness. Together these factors will generally affect the analysis and determination of the “best estimate” of the projected ultimate claim losses. The results of these evaluations are used to both analyze and adjust the Company’s insurance loss reserves.

In addition to the above insurance policies, the Company maintains insurance coverage for property, inventory, workers compensation, general liability, product liability and other items. The nature and extent of the insurance coverage varies by line of policy.

Advertising Costs, Policy [Policy Text Block]

'

Advertising Costs

The costs of advertising are expensed as incurred.

Research and Development Expense, Policy [Policy Text Block]

'

Research and Development

Costs incurred in research and development activities, primarily related to the Omega Protein Technology and Innovation Center, are expensed as incurred.

Derivatives, Policy [Policy Text Block]

'

Energy Swap Agreements

The Company does not enter into financial instruments for trading or speculative purposes. During 2013, 2012 and 2011, Omega Protein entered into energy swap agreements to manage portions of its cash flow exposure related to the volatility of natural gas, diesel and fuel oil energy prices for its fish meal and fish oil production operations. The swaps effectively fix pricing for the quantities listed below during the consumption periods.

Energy Swap

Consumption Period

Quantity

Price Per Unit

Energy Swap Asset/(Liability) as of

Deferred Tax Asset/(Liability) as of

December 31,

December 31,

2013

2013

Diesel - NYMEX Heating Oil Swap

Oct.

-

Nov., 2013

998,700 Gallons

$

2.88

$

131,400

$

(46,000

)

Natural Gas - NYMEX Natural Gas Swap

Apr.

-

Oct., 2014

307,374 MMBTUs

$

3.67

143,200

(50,100

)

$

274,600

$

(96,100

)

Energy Swap

Consumption Period

Quantity

Price Per Unit

Energy Swap Asset/(Liability) as of

Deferred Tax Asset/(Liability) as of

December 31,

December 31,

2012

2012

Diesel - NYMEX Heating Oil Swap

May

-

November, 2013

1,359,782 Gallons

$

2.82

$

244,800

$

(53,800

)

Natural Gas - NYMEX Natural Gas Swap

April

-

October, 2013

381,150 MMBTUs

$

3.94

(149,600

)

52,300

Fuel Oil – No.6 1.0% NY-Platts Swap

May

-

November, 2013

676,200 Gallons

$

2.26

39,000

(13,600

)

$

134,200

$

(15,100

)

As of December 31, 2013 and 2012, Omega Protein has recorded a current asset in prepaid expenses of $0.3 million and $0.1 million, respectively, to recognize the fair value of energy swap derivatives, and has also recorded a deferred tax liability of $0.1 million and $15,100, respectively, associated therewith. The effective portion of the change in fair value from inception to December 31, 2013 is recorded in “accumulated other comprehensive loss” in the Company’s consolidated financial statements. The following table illustrates the changes recorded, net of tax, in accumulated other comprehensive loss resulting from the energy swap agreements.

(in thousands)

2013

2012

Balance at January 1,

$

28

$

(420

)

Amounts, net of tax, reclassified to unallocated inventory cost pool,

(127

)

328

Net change associated with current period swap transactions, net of tax,

278

120

Balance at December 31,

$

179

$

28

The $0.2 million reported in accumulated other comprehensive loss as of December 31, 2013 will be reclassified to the unallocated inventory cost pool in the period when the energy consumption takes place. The amount to be reclassified, net of taxes, during the next 12 months is expected to be $0.2 million.

The aggregate fair value of derivative instruments in gross asset positions as of December 31, 2013 and December 31, 2012 was $0.3 million and $0.3 million, respectively. These amounts represent the maximum exposure to loss at the reporting date as a result of all of the counterparties failing to perform as contracted. This exposure could be reduced by up to $0 and $0.2 million, respectively, of liabilities included in master netting arrangements with those same counterparties.

As of December 31, 2013 (in thousands)

Gross

Gross

Net Amounts

Amounts of

Amounts of

of Assets

Recognized

Assets

(Liabilities)

Assets

(Liabilities)

Presented in

(Liabilities)

Offset

the Balance Sheet

Energy swap derivatives – asset position

$

275

$

-

$

275

As of December 31, 2012 (in thousands)

Gross

Gross

Net Amounts

Amounts of

Amounts of

of Assets

Recognized

Assets

(Liabilities)

Assets

(Liabilities)

Presented in

(Liabilities)

Offset

the Balance Sheet

Energy swap derivatives – asset position

$

295

$

(161

)

$

134

If, at any time, the swaps are determined to be ineffective, in whole or in part, due to changes in the Company’s energy usage or underlying hedge agreements or assumptions, the fair value of the portion of the energy swaps determined to be ineffective will be recognized as a gain or loss in cost of sales for the applicable period. For 2013 and 2012, the Company recognized a charge of $0.1 million and a reduction $0.1 million, respectively, to cost of sales resulting from transactions associated with the ineffectiveness of diesel energy swaps. See Note 21 – Fair Value Disclosures for additional information.

Subsequent to December 31, 2013, Omega Protein entered into the following energy swap agreements:

Energy Swap

Consumption Period

Quantity

Price Per Unit

Diesel - NYMEX Heating Oil Swap

May

-

November, 2014

333,366 Gallons

$

2.95

Propane – NGL-Mont Belvieu Propane

June

-

November, 2014

683,000 Gallons

$

1.09

Income Tax, Policy [Policy Text Block]

'

Income Taxes

The Company utilizes the asset and liability method to account for income taxes. This method requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of existing temporary differences between the financial reporting and tax reporting basis of assets and liabilities, and operating loss and tax credits carryforwards for tax purposes. The Company records a valuation allowance to reduce the deferred tax assets to the amount that is more likely than not to be realized. The Company believes that the deferred tax assets recorded as of December 31, 2013, net of the valuation allowance, are realizable through future reversals of existing taxable temporary differences and future taxable income. If the Company were to subsequently determine that it would be able to realize deferred tax assets in the future in excess of the net recorded amount, the adjustment would increase earnings for the period in which such determination was made. The Company will continue to assess the adequacy of the valuation allowance on a quarterly basis. Any changes to the estimated valuation allowance could be material to the consolidated financial condition and results of operations.

Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]

'

Accounting for the Impairment of Long-Lived Assets

The Company evaluates at each balance sheet date the continued appropriateness of the carrying value of its long-lived assets, including its long-term receivables and property, plant and equipment. The Company reviews long-lived assets for impairment when events or changes in circumstances indicate that the carrying amount of any such assets or grouping of assets may not be recoverable. The Company has grouped certain assets together (primarily marine vessels) for impairment testing on a fleet basis. If indicators of impairment are present, management evaluates the undiscounted cash flows estimated to be generated by those assets or grouping of assets compared to the carrying amount of those items. The net carrying value of assets or grouping of assets not recoverable is reduced to fair value. The Company considers continued operating losses, or significant and long-term changes in business conditions, to be its primary indicators of a potential impairment.

Costs Associated with Exit or Disposal Activities or Restructurings, Policy

'

Plant Closure

Property, plant and equipment impairments related to the Cameron, Louisiana plant are made in accordance with the impairment of long-lived assets policy. Employee severance related charges have been recognized to the extent that the amount is probable, measurable and no-future service is expected or for those still employed, recognized pro-rata over the remaining service period. Ongoing clean-up and dismantlement costs will be recognized as incurred unless obligated and measureable by a contractual commitment. See Note 5 – Plant Closure for additional information related to the charges incurred.

Property, Plant and Equipment, Policy [Policy Text Block]

'

Property, Equipment and Depreciation

Property and equipment additions are recorded at cost. Depreciation of property and equipment is computed by the straight-line method at rates expected to amortize the cost of property and equipment, net of salvage value, over their estimated useful lives. Estimated useful lives, determined at the date of acquisition, of new assets acquired are based primarily on the review of existing property and equipment as well as other factors. Estimated useful lives are as follows:

Useful Lives

(years)

Stainless steel equipment

25

Fishing vessels and fish processing plants

15

-

20

Machinery, equipment, furniture and fixtures and other

3

-

10

Replacements and major improvements are capitalized and amortized over a period of 5 to 15 years. Upon sale or retirement, the costs and related accumulated depreciation are eliminated from the accounts. Any resulting gains or losses are included in the statement of comprehensive income.

Goodwill and Intangible Assets, Policy [Policy Text Block]

'

Acquisitions, Goodwill and Other Intangible Assets

Goodwill is measured as the excess of the cost of an acquisition over the sum of the amounts assigned to the fair value of tangible and intangible assets acquired less liabilities assumed. The determination of the fair value of the intangible assets acquired involves certain judgments and estimates. These judgments can include, but are not limited to, the cash flows that an asset is expected to generate in the future and the appropriate weighted average cost of capital.

The Company does not amortize goodwill or indefinite-lived intangible assets but performs tests for impairment annually, or when indications of potential impairment exist, utilizing a fair value approach at the reporting unit level. The Company determines fair value using widely accepted valuation techniques, including the income approach which estimates the fair value of its reporting units based on the future discounted cash flows, and the market approach which estimates the fair value of its reporting units based on comparable market prices. In testing for a potential impairment of goodwill, the Company estimates the fair value of its reporting units to which goodwill relates and compares it to the carrying value (book value) of the assets and liabilities related to those businesses.

All of the Company’s goodwill and other intangible assets are the result of acquisitions in the human nutrition segment. This segment is comprised of two reporting units, 1) InCon and Cyvex and 2) WSP.

The Company amortizes other intangible assets with determinable lives over their estimated useful lives. The Company records an impairment charge on these assets when it determines that their carrying value may not be recoverable. The carrying value is not recoverable if it exceeds the undiscounted future cash flows resulting from the use of the asset and its eventual disposition. When there is existence of one or more indicators of impairment, the Company measures any impairment of intangible assets based on a projected discounted cash flow method using a discount rate determined by the Company’s management to be commensurate with the risk inherent in its business model. The Company’s estimates of future cash flows attributable to its other intangible assets require significant judgment based on the Company’s historical and anticipated results and are subject to many factors. See Note 11 - Goodwill and Other Intangible Assets for more information about goodwill and other intangible assets.

Pension and Other Postretirement Plans, Policy [Policy Text Block]

'

Pension Plans

The Company records the overfunded or underfunded status of defined benefit pension and postretirement plans as an asset or liability in its statement of financial position and changes in that funded status in the year in which the changes occur through other comprehensive income. The Company also measures the funded status of a plan as of the date of its year-end statement of financial position. The Company’s policy is to fund its pension plan at amounts not less than the minimum requirements of the Employee Retirement Income Security Act of 1974.

In 2002, the Board of Directors authorized a plan to freeze the Company’s pension plan in accordance with ERISA rules and regulations so that new employees, hired after July 31, 2002, are not eligible to participate in the pension plan and further benefits no longer accrue for existing participants. The freezing of the pension plan had the effect of vesting all existing participants in their pension benefits in the plan. See Note 16 – Benefit Plans for additional information related to the Company’s pension plans.

Comprehensive Income, Policy [Policy Text Block]

'

Comprehensive Income (Loss)

Comprehensive income (loss) is defined as change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources, including foreign currency translation adjustments, interest and energy swap transactions, and pension benefits adjustments, including recognition of actuarial losses. The Company presents comprehensive income (loss) in its consolidated statements of comprehensive income and consolidated statements of stockholders’ equity.

Stockholders' Equity, Policy [Policy Text Block]

'

Accumulated Comprehensive Loss

The components of accumulated other comprehensive loss included in stockholders’ equity are as follows:

Changes in Accumulated Other Comprehensive Loss by Component

For the Year Ended December 31, 2013 (in thousands)

Gains and Losses

Defined Benefit

Total

On Cash Flow

Pension Items

Hedges

Beginning balance December 31, 2012

$

28

$

(9,952

)

$

(9,924

)

Other comprehensive income before reclassifications

278

2,560

2,838

Amounts reclassified from accumulated other comprehensive loss

(127

)

(a)

1,005

(b)

878

Net current-period other comprehensive income

151

3,565

3,716

Ending balance December 31, 2013

$

179

$

(6,387

)

$

(6,208

)

(a)

This accumulated other comprehensive income component is reclassified to the unallocated inventory cost pool in the period when the energy consumption takes place.

(b)

This accumulated other comprehensive income component is included in the computation of net periodic pension costs as amortization of actuarial loss which are explained in more detail in Note 16.

Changes in Accumulated Other Comprehensive Loss by Component

For the Year Ended December 31, 2012 (in thousands)

Gains and Losses

Defined Benefit

Total

On Cash Flow

Pension Items

Hedges

Beginning balance December 31, 2011

$

(420

)

$

(10,259

)

$

(10,679

)

Other comprehensive income (loss) before reclassifications

120

(679

)

(559

)

Amounts reclassified from accumulated other comprehensive loss

328

(a)

986

(b)

1,314

Net current-period other comprehensive income

448

307

755

Ending balance December 31, 2012

$

28

$

(9,952

)

$

(9,924

)

(a)

This accumulated other comprehensive loss component is reclassified to the unallocated inventory cost pool in the period when the energy consumption takes place.

(b)

This accumulated other comprehensive income component is included in the computation of net periodic pension costs as amortization of actuarial loss which are explained in more detail in Note 16.

Concentration Risk, Credit Risk, Policy [Policy Text Block]

'

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and trade accounts receivable. The Company’s customer base generally remains consistent from year to year. The Company performs ongoing credit evaluations of its customers and generally does not require material collateral. The Company maintains reserves for potential credit losses and such losses have historically been within management’s expectations.

At December 31, 2013, the Company had cash deposits concentrated primarily in one major bank and two money market funds. The Company believes that credit risk in such investments is minimal.

Earnings Per Share, Policy [Policy Text Block]

'

Earnings per Share

Basic earnings per share is calculated by dividing net income allocated to common shares outstanding by the weighted average number of shares of common stock outstanding. Diluted earnings per share assumes the exercise of stock options provided the effect is not anti-dilutive.

The Company grants certain incentive compensation awards, including restricted stock, to employees and non-employee directors that are considered to be participating securities. Due to the presence of participating securities, we have calculated our earnings per share using the two-class method. See Note 13 – Reconciliation of Basic and Diluted per Share Data.

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

'

Stock-Based Compensation

The Company has a stock-based compensation plan, which is described in more detail in Note 16.

Shares Issued to Directors

In 2013 and 2012, approximately 3,200 and 7,600 shares of the Company’s stock were issued to directors in non-cash transactions as payment in lieu of Board retainer and per diem fees. Expenses were recognized on these non-cash transactions of approximately $25,200 and $56,100. In 2011, no shares of the Company’s common stock were issued to directors in non-cash transactions as payment in lieu of Board retainer and per diem fees.

Shareholder Rights Plan

In June 2010, the Company’s Board of Directors adopted a Shareholder Rights Plan. The Plan is designed to protect the Company from unfair or coercive takeover tactics and to prevent an acquirer from gaining control of the Company without offering a fair price to all shareholders. See Note 22 – Shareholders Rights Plan for additional information.

New Accounting Pronouncements, Policy [Policy Text Block]

'

Recently Issued Accounting Standards

In July 2013, the FASB issued ASU No. 2013-11 which amended the Income Taxes Topic of the Accounting Standards Codification to eliminate a diversity in practice for the presentation of unrecognized tax benefits when net operating loss carryforwards, similar tax losses or tax credit carryforwards exist. The amendment requires that the unrecognized tax benefit be presented as a reduction of the deferred tax assets associated with the carryforwards except in certain circumstances when it would be reflected as a liability. This guidance is effective for annual periods and interim periods within those annual periods beginning after December 15, 2013. The Company is currently evaluating the impact the adoption of this guidance will have on its consolidated financial statements.

In February 2013, the FASB issued ASU No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income. The standard requires companies to present, either in a single note or parenthetically on the face of the financial statements, the effect of significant amounts reclassified from each component of accumulated other comprehensive income based on its source and the income statement line items affected by the reclassification. The standard is effective prospectively for public entities for fiscal years, and interim periods within those years, beginning after December 12, 2012, which corresponds to the Company’s first fiscal quarter beginning January 1, 2013. The Company’s adoption of FASB ASU No. 2013-02, effective January 1, 2013, did not have an impact on the Company’s consolidated results of operations or financial position.

In January 2013, the FASB issued ASU No. 2013-01, Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities. The standard limits the scope of balance sheet offsetting disclosures, contained in the new guidance issue in December 2011 discussed below, to recognized derivative instruments, repurchase agreements and securities borrowing and lending transactions. Effective for annual and interim periods beginning on or after January 1, 2013, the Company’s adoption of FASB ASU No. 2013-01 effective January 1, 2013 did not have an impact on the Company’s consolidated results of operations, financial position and related disclosures.

In July 2012, the FASB issued ASU No. 2012-02 regarding subsequent measurement guidance for long-lived intangibles. This guidance is meant to reduce the cost and complexity of performing an impairment test for indefinite-lived intangible assets by simplifying how an entity tests those assets for impairment and to improve consistency in impairment testing guidance among long-lived asset categories. This guidance is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012, which corresponds to the Company’s first fiscal quarter beginning January 1, 2013. The Company’s adoption of FASB ASU No. 2012-02 effective January 1, 2013 did not have an impact on the Company’s consolidated results of operations, financial position and related disclosures.

In December 2011, the FASB issued ASU No. 2011-11, Disclosures about Offsetting Assets and Liabilities. The standard requires an entity to disclose information about offsetting and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position. The amendments in this update will enhance disclosures required by U.S. GAAP by requiring improved information about financial instruments and derivative instruments to help reconcile differences in the offsetting requirements under U.S. GAAP and International Financial Reporting Standards (IFRS). The amendments are effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. The Company’s adoption of FASB ASU No. 2011-11 effective January 1, 2013 did not have an impact on the Company’s consolidated results of operations or financial position.

Note_1_Significant_Accounting_1

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Tables)	12 Months Ended
	Dec. 31, 2013
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Tables) [Line Items]	'
Schedule of Changes in Accumulated Other Comprehensive Loss, Net of Tax [Table Text Block]	'
			(in thousands)
			2013				2012
	Balance at January 1,		$	28			$	(420	)
	Amounts, net of tax, reclassified to unallocated inventory cost pool,			(127	)			328
	Net change associated with current period swap transactions, net of tax,			278				120
	Balance at December 31,		$	179			$	28
Offsetting Assets And Liabilities [Table Text Block]	'
	As of December 31, 2013 (in thousands)		Gross				Gross				Net Amounts
			Amounts of				Amounts of				of Assets
			Recognized				Assets				(Liabilities)
			Assets				(Liabilities)				Presented in
			(Liabilities)				Offset				the Balance Sheet
	Energy swap derivatives – asset position		$	275			$	-			$	275
	As of December 31, 2012 (in thousands)		Gross				Gross				Net Amounts
			Amounts of				Amounts of				of Assets
			Recognized				Assets				(Liabilities)
			Assets				(Liabilities)				Presented in
			(Liabilities)				Offset				the Balance Sheet
	Energy swap derivatives – asset position		$	295			$	(161	)		$	134
Property, Plant and Equipment Useful Lives [Table Text Block]	'
		Useful Lives
		(years)
	Stainless steel equipment		25
	Fishing vessels and fish processing plants	15	-	20
	Machinery, equipment, furniture and fixtures and other	3	-	10
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	'
			Gains and Losses				Defined Benefit					Total
			On Cash Flow				Pension Items
			Hedges
	Beginning balance December 31, 2012		$	28			$	(9,952	)		$	(9,924	)
	Other comprehensive income before reclassifications			278				2,560				2,838
	Amounts reclassified from accumulated other comprehensive loss			(127	)	(a)		1,005		(b)		878
	Net current-period other comprehensive income			151				3,565				3,716
	Ending balance December 31, 2013		$	179			$	(6,387	)		$	(6,208	)
			Gains and Losses				Defined Benefit					Total
			On Cash Flow				Pension Items
			Hedges
	Beginning balance December 31, 2011		$	(420	)		$	(10,259	)		$	(10,679	)
	Other comprehensive income (loss) before reclassifications			120				(679	)			(559	)
	Amounts reclassified from accumulated other comprehensive loss			328		(a)		986		(b)		1,314
	Net current-period other comprehensive income			448				307				755
	Ending balance December 31, 2012		$	28			$	(9,952	)		$	(9,924	)
Energy Swap [Member]	'
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Tables) [Line Items]	'
Schedule of Derivative Instruments [Table Text Block]	'
	Energy Swap		Consumption Period			Quantity		Price Per Unit				Energy Swap Asset/(Liability) as of			Deferred Tax Asset/(Liability) as of
												December 31,			December 31,
												2013			2013
	Diesel - NYMEX Heating Oil Swap		Oct.	-	Nov., 2013	998,700 Gallons		$	2.88			$	131,400		$	(46,000	)
	Natural Gas - NYMEX Natural Gas Swap		Apr.	-	Oct., 2014	307,374 MMBTUs		$	3.67				143,200			(50,100	)
												$	274,600		$	(96,100	)
	Energy Swap		Consumption Period			Quantity		Price Per Unit				Energy Swap Asset/(Liability) as of			Deferred Tax Asset/(Liability) as of
												December 31,			December 31,
												2012			2012
	Diesel - NYMEX Heating Oil Swap		May	-	November, 2013	1,359,782 Gallons		$	2.82			$	244,800		$	(53,800	)
	Natural Gas - NYMEX Natural Gas Swap		April	-	October, 2013	381,150 MMBTUs		$	3.94				(149,600	)		52,300
	Fuel Oil – No.6 1.0% NY-Platts Swap		May	-	November, 2013	676,200 Gallons		$	2.26				39,000			(13,600	)
												$	134,200		$	(15,100	)
Diesel and Propane Energy Swap [Member]	'
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Tables) [Line Items]	'
Schedule of Derivative Instruments [Table Text Block]	'
	Energy Swap	Consumption Period			Quantity		Price Per Unit
	Diesel - NYMEX Heating Oil Swap	May	-	November, 2014	333,366 Gallons		$	2.95
	Propane – NGL-Mont Belvieu Propane	June	-	November, 2014	683,000 Gallons		$	1.09

Note_2_Acquisition_of_Wisconsi1

Note 2 - Acquisition of Wisconsin Specialty Protein, L.L.C. (Tables)	12 Months Ended
	Dec. 31, 2013
Wisconsin Specialty Protein [Member]	'
Note 2 - Acquisition of Wisconsin Specialty Protein, L.L.C. (Tables) [Line Items]	'
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	'
		(in thousands)
	Cash	$	403
	Other current assets, net including receivables, prepaid and inventory		2,515
	Property, plant, and equipment, net		14,095
	Identifiable intangible assets (a)		4,448
	Liabilities assumed		(5,996	)
	Total identifiable net assets		15,465
	Goodwill		11,614
	Total consideration	$	27,079
Business Acquisition, Pro Forma Information [Table Text Block]	'
		Revenue			Net income (loss)
		(in thousands)
	WSP from February 27, 2013 – December 31, 2013	$	9,810		$	(195	)
	2013 supplemental pro forma from January 1, 2013 – December 31, 2013	$	246,361		$	30,518
	2012 supplemental pro forma from January 1, 2012 – December 31, 2012	$	247,109		$	4,997
InCon [Member]	'
Note 2 - Acquisition of Wisconsin Specialty Protein, L.L.C. (Tables) [Line Items]	'
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	'
		Amounts recognized as of acquisition date
		(in thousands)
	Working capital (a)	$	593
	Property, plant, and equipment, net		6,400
	Identifiable intangible assets (b)		1,341
	Total identifiable net assets		8,334
	Goodwill		936
	Total consideration, net of final working capital adjustment	$	9,270

Note_5_Plant_Closure_Tables

Note 5 - Plant Closure (Tables)	12 Months Ended
	Dec. 31, 2013
Disposal Groups Plant Closure Disclsoure [Abstract]	'
Schedule of Disposal Group, Plant Closure Disposal [Table Text Block]	'
		2013
		(in thousands)
	Impairment of property, plant and equipment	$	4,796
	Write-off material and supplies inventory		97
	Employee severance accruals		345
	Estimated decommissioning costs		250
	Other ongoing closure costs not attributable to future production		1,109
	Total loss related to plant closure	$	6,597

Note_6_Receivables_Net_Tables

Note 6 - Receivables, Net (Tables)	12 Months Ended
	Dec. 31, 2013
Receivables [Abstract]	'
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	'
		2013			2012
		(in thousands)
	Trade	$	18,689		$	11,513
	Insurance		1,806			4,980
	Income tax		714			871
	Other		310			236
	Total accounts receivable		21,519			17,600
	Less allowance for doubtful accounts		(379	)		(333	)
	Receivables, net	$	21,140		$	17,267

Note_7_Inventory_Tables

Note 7 - Inventory (Tables)	12 Months Ended
	Dec. 31, 2013
Inventory Disclosure [Abstract]	'
Schedule of Inventory, Current [Table Text Block]	'
		2013		2012
		(in thousands)
	Fish meal	$	30,119	$	26,511
	Fish oil		41,081		17,352
	Fish solubles		2,599		1,391
	Nutraceutical products		3,650		4,181
	Dairy protein products		1,355		—
	Unallocated inventory cost pool (including off-season costs)		6,655		7,403
	Other materials and supplies		8,880		9,821
	Total inventory	$	94,339	$	66,659

Note_8_Prepaid_Expenses_and_Ot1

Note 8 - Prepaid Expenses and Other Current Assets (Tables)	12 Months Ended
	Dec. 31, 2013
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]	'
Schedule of Other Current Assets [Table Text Block]	'
		2013		2012
		(in thousands)
	Prepaid insurance	$	2,422	$	2,554
	Selling expenses		869		436
	Fair market value of energy swaps, current portion		275		134
	Whey process filters		38		—
	Leases		53		118
	Other prepaids and expenses		258		188
	Total prepaid expenses and other current assets	$	3,915	$	3,430

Note_9_Other_Assets_Tables

Note 9 - Other Assets (Tables)	12 Months Ended
	Dec. 31, 2013
Disclosure Text Block Supplement [Abstract]	'
Schedule of Other Assets [Table Text Block]	'
		2013		2012
		(in thousands)
	Fish nets, net of accumulated amortization of $2,610 and $1,243	$	1,517	$	1,432
	Insurance receivable, net of allowance for doubtful accounts		3,048		8,572
	Title XI debt issuance costs		272		302
	Other debt issuance costs		299		391
	Deposits and other		98		92
	Total other assets, net	$	5,234	$	10,789

Note_10_Property_Plant_and_Equ1

Note 10 - Property, Plant, and Equipment (Tables)	12 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment [Table Text Block]	'
		2013			2012
		(in thousands)
	Land	$	7,457		$	7,229
	Plant assets		159,337			148,451
	Fishing vessels		101,745			103,754
	Furniture and fixtures		7,091			7,225
	Construction in progress		16,846			11,214
	Total property and equipment		292,476			277,873
	Less accumulated depreciation and impairment		(148,363	)		(150,233	)
	Property, plant and equipment, net	$	144,113		$	127,640

Note_11_Goodwill_and_Other_Int1

Note 11 - Goodwill and Other Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Goodwill [Table Text Block]	'
		WSP				Cyvex and			Total
						Incon
	1-Jan-13	$	—				7,986		$	7,986
	Acquisitions (1)		11,614				—			11,614
	31-Dec-13	$	11,614				7,986		$	19,600
Schedule of Intangible Assets other than Goodwill [Table Text Block]	'
		December 31,			December 31,			Weighted
		2013			2012			Average
								Life (years)
	Carrying value of intangible assets subject to amortization:
	Customer relationships and non-competes	$	5,930		$	2,934
	Less accumulated amortization		(613	)		(325	)		10
	Total intangible assets subject to amortization, net	$	5,317		$	2,609
	Indefinite life intangible assets – trade names/secrets and other		2,615			1,753
	Total intangible assets	$	7,932		$	4,362
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	'
	2014		663
	2015		655
	2016		654
	2017		654
	Thereafter		2,691
	Total estimated future amortization expense	$	5,317

Note_12_Notes_Payable_and_Long1

Note 12 - Notes Payable and Long-Term Debt (Tables)	12 Months Ended
	Dec. 31, 2013
Disclosure Text Block [Abstract]	'
Schedule of Debt [Table Text Block]	'
		December 31,			December 31,
		2013			2012
		(in thousands)
	U.S. government guaranteed obligations (Title XI loans) collateralized by a first lien on certain vessels and certain plant assets:
	Amounts due in installments through 2025, interest from 5.7% to 7.6%	$	24,211		$	27,228
	Amounts due in installments through 2014, interest at Eurodollar rates plus 0.5% (0.7% and 0.8% at December 31, 2013 and December 31, 2012, respectively)		31			72
	Total debt		24,242			27,300
	Less current maturities		(3,112	)		(3,058	)
	Long-term debt	$	21,130		$	24,242
Schedule of Maturities of Long-term Debt [Table Text Block]	'
	2014		2015			2016		2017	2018	Thereafter
	$3,113		$2,643			$2,800		$2,788	$2,969	$9,929

Note_13_Reconciliation_of_Basi1

Note 13 - Reconciliation of Basic and Diluted Per Share Data (Tables)	12 Months Ended
	Dec. 31, 2013
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'
	For the Years Ended December 31:	2013				2012				2011
	Allocation of earnings:
	Net income	$	30,515			$	4,063			$	34,157
	Income allocated to participating securities		(687	)			(49	)			(30	)
	Income allocated to common shares outstanding	$	29,828			$	4,014			$	34,127
	Weighted average common shares outstanding		19,913				19,420				19,238
	Basic earnings per share				1.5				0.21				1.77
	Stock options assumed exercised		721				454				685
	Weighted average diluted common shares and potential common share equivalents outstanding		20,634				19,874				19,923
	Diluted earnings per share				1.45				0.2				1.71
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	'
	2013	2012		2011
	130	811		135

Note_14_Income_Taxes_Tables

Note 14 - Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	'
			Years Ended December 31,
		2013			2012			2011
					(in thousands)
	Current:
	State	$	1,265		$	453		$	276
	U.S.		11,031			4,288			10,924
	Deferred:
	State		227			294			920
	U.S.		2,941			1,860			5,608
	Provision (benefit) for income taxes	$	15,464		$	6,895		$	17,728
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	'
			Years Ended December 31,
			2013			2012			2011
					(in thousands)
	Taxes at statutory rate	$	16,097		$	3,835		$	18,159
	Other non-deductible expenses		145			163			189
	Qualified production activities deduction		(1,334	)		(193	)		(1,305	)
	Charges related to U.S. Attorney investigation		—			2,625			—
	State taxes, net of federal benefit		969			485			778
	Excess executive compensation		—			—			128
	Impact of federal tax credits (1)		(85	)		—			490
	Change in deferred tax asset valuation allowance (2)		(77	)		(55	)		(1,120	)
	Impact of federal tax rate adjustment to 35%		—			—			491
	Other		(251	)		35			(82	)
	Provision (benefit) for income taxes	$	15,464		$	6,895		$	17,728
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	'
		2013			2012
		(in thousands)
	Deferred tax assets:
	Assets and accruals not yet deductible	$	4,369		$	3,639
	Equity based compensation		3,429			3,243
	Equity in loss of unconsolidated affiliates		125			125
	Tax credit carryforward		225			225
	Pension liability		3,716			5,636
	State income tax		492			404
	Valuation allowance		(584	)		(661	)
	Total deferred tax assets		11,772			12,611
	Deferred tax liabilities:
	Property and equipment		(21,844	)		(20,814	)
	Intangible assets		(590	)		(187	)
	Pension and other retirement benefits		(1,350	)		(1,272	)
	Assets currently deductible		(6,277	)		(4,967	)
	Total deferred tax liabilities		(30,061	)		(27,240	)
	Net deferred tax liability	$	(18,289	)	$	(14,629	)
	Deferred income tax asset (liability) current	$	1,062		$	1,165
	Deferred income tax asset (liability) non-current		(19,351	)		(15,794	)
	Net deferred tax liability	$	(18,289	)	$	(14,629	)
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]	'
		2013			2012			2011
		(in thousands)
	Balance at January 1,	$	1,514		$	1,513		$	896
	Additions for tax positions of prior years		58			37			451
	Reductions for tax positions of prior years		—			(36	)		—
	Additions based on tax positions related to the current year		—			—			166
	Balance at December 31,	$	1,572		$	1,514		$	1,513

Note_15_Accrued_Liabilities_Ta

Note 15 - Accrued Liabilities (Tables)	12 Months Ended
	Dec. 31, 2013
Disclosure Text Block Supplement [Abstract]	'
Schedule of Accrued Liabilities [Table Text Block]	'
		December 31,		December 31,
		2013		2012
		(in thousands)
	Insurance	$	7,222	$	12,307
	Reserve for plant closure costs		595		—
	Reserve for U.S. Attorney investigation		—		7,655
	Salary and benefits		9,423		4,989
	Trade creditors		5,100		3,914
	Taxes, other than income tax		64		42
	Income tax		4,132		—
	Deferred revenue		2,362		2,060
	Contractual obligations		—		470
	Accrued interest		200		225
	Other		47		79
	Total accrued liabilities	$	29,145	$	31,741

Note_16_Benefit_Plans_Tables

Note 16 - Benefit Plans (Tables)	12 Months Ended
	Dec. 31, 2013
Note 16 - Benefit Plans (Tables) [Line Items]	'
Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]	'
	Net Actuarial Loss (Gain)		$	915
	Prior Service Cost		$	0
Schedule of Changes in Projected Benefit Obligations [Table Text Block]	'
			Years Ended December 31,
			2013				2012
			(in thousands)
	Accumulated Benefit Obligations		$	25,945			$	29,202
	Change in Benefit Obligation
	Benefit Obligation at beginning of year		$	29,202			$	28,527
	Service Cost			—				—
	Interest Cost			991				1,095
	Plan Amendments			—				—
	Actuarial (Gain) Loss			(2,288	)			1,269
	Benefits Paid			(1,960	)			(1,689	)
	Benefit Obligation at end of year		$	25,945			$	29,202
	Change in Plan Assets
	Plan Assets at Fair Value at beginning of year		$	19,376			$	17,659
	Actual Return on Plan Assets			2,663				1,527
	Company Contributions			1,749				1,879
	Benefits Paid			(1,960	)			(1,689	)
	Plan Assets at Fair Value at end of year		$	21,828			$	19,376
	Funded Status of the Plan		$	(4,117	)		$	(9,826	)
	Additional Amounts Recognized in the Statement of Financial Position:
	Long-term Liabilities		$	(4,117	)		$	(9,826	)
	Amounts Recognized in Accumulated Other Comprehensive Loss:
	Net Actuarial (Loss) Gain, net of tax		$	(6,387	)		$	(9,952	)
	Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Loss:
	Net Actuarial (Loss) Gain, net of tax		$	2,560			$	(679	)
	Reversal of Amortization Item:
	Amortization of Net Loss, net of tax			1,005				986
	Total Recognized in Other Comprehensive Loss, net of tax		$	3,565			$	307
Schedule of Net Benefit Costs [Table Text Block]	'
				Years Ended December 31,
			2013				2012				2011
							(in thousands)
	Components of net periodic benefit cost:
	Service cost		$	—			$	—			$	—
	Interest cost			990				1,095				1,276
	Expected return on plan assets			(1,027	)			(1,303	)			(1,274	)
	Amortization of net loss			1,561				1,517				1,189
	Net periodic benefit cost		$	1,524			$	1,309			$	1,191
Schedule of Allocation of Plan Assets [Table Text Block]	'
			Plan Assets
			at
			December 31,
	Asset Category		2013								2012
			Actual				Target				Actual			Target
	Equity			64.5	%			60	%			59.9	%		60	%
	Debt securities			35.5				40				40.1			40
	Other			—				—				—			—
	Total			100	%			100	%			100	%		100	%
Fair Value of Plan Assets [Table Text Block]	'
			Fair Value of Plan Assets at
			December 31,
			(in thousands)
			Fair Value Measurements Using Level 2
			(except as noted)
	Asset Category		2013				2012
	Equity Securities
	Large-Cap Growth		$	4,833			$	3,946
	Large Company Value			2,031				1,772
	Mid-Cap Growth			897				753
	Mid-Cap Value			915				768
	Small Company Growth			873				774
	Small Company Value			912				785
	International			2,604	*			1,852	*
	REIT			1,016				955
	Fixed Income Securities
	U.S. Treasuries			2,525				2,409
	U.S. Govt. Agencies			2,003				2,333
	Corporate bonds			2,077				2,093
	International fixed income			220				332
	Asset-backed securities			608				255
	Mortgage-backed securities			314				349
	Total		$	21,828			$	19,376
Schedule of Expected Benefit Payments [Table Text Block]	'
					(in thousands)
	2014		2015		2016		2017		2018		2019-2023
	$1,769		$1,767		$1,789		$1,787		$1,797		$8,907
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
			2013								2012						2011
			Number of				Weighted				Number of			Weighted			Number of			Weighted
			Shares				Average				Shares			Average			Shares			Average
			Underlying				Exercise				Underlying			Exercise			Underlying			Exercise
			Options				Prices				Options			Prices			Options			Prices
	Outstanding at beginning of year			2,652			$	6.19				2,776		$	6.12			3,271		$	5.86
	Granted			—				—				98		$	6.8			60		$	13.41
	Exercised			(859	)		$	4.67				(92	)	$	4.46			(536	)	$	5.37
	Expired			—				—				—			—			—			—
	Forfeited			(7	)		$	12.81				(130	)	$	6.42			(19	)	$	5.33
	Outstanding at end of year			1,786			$	6.89				2,652		$	6.19			2,776		$	6.12
	Exercisable at end of year			1,786			$	6.89				2,206		$	6.31			1,228		$	6.51
	Weighted-average fair value of options granted							—						$	3.76					$	7.48
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value [Table Text Block]	'
			Aggregate Intrinsic Value
			2013				2012				2011
							(in thousands)
	Options outstanding as of December 31		$	9,814			$	2,045			$	3,770
	Options exercisable as of December 31		$	9,814			$	1,660			$	1,716
	Options exercised during the year		$	5,430			$	224			$	4,365
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	'
					Options Outstanding and Exercisable
	Range of				Number			Weighted Average		Weighted Average
	Exercise Prices				Outstanding			Remaining		Exercise Prices
					at 12/31/2013			Contractual Life (years)
	$2.22	to	$4.70			420,097		5.9		$	4.5
	$4.71	to	$6.00			34,000		4.6		$	5.13
	$6.01	to	$7.55			1,157,502		6.8		$	6.99
	$7.56	to	$10.58			44,200		3.6		$	8.65
	$10.59	to	$15.88			130,000		5.8		$	13.59
						1,785,799
Schedule of Nonvested Share Activity [Table Text Block]	'
			Year Ended				Weighted Average
			31-Dec-13				Grant-Date
							Fair Value
	Nonvested options as of January 1, 2013			446,671			$	3.21
	Granted			—				—
	Vested			(466,671	)		$	3.21
	Forfeited			—				—
	Nonvested options as of December 31, 2013			—				—
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]	'
	Date of Restricted		Grant Date				Restricted Stock Issued			Date of
	Stock Award		Fair Value				and Outstanding			Vesting
							as of December 31, 2013
	28-Feb-13		$	7.97				25,000		28-Feb-16
	1-Jul-13		$	9.08				33,036		1-Jan-14
								58,036
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]	'
			2013				Wgt. Avg.
			(in shares)				Grant Date
							Fair Value
	Outstanding at beginning of year			420,698			$	7.19
	Granted			58,036			$	8.6
	Vested			—				—
	Expired			—				—
	Forfeited			—				—
	Outstanding at end of year			478,734			$	7.36
Benefit Obligations [Member]	'
Note 16 - Benefit Plans (Tables) [Line Items]	'
Schedule of Assumptions Used [Table Text Block]	'
			Years Ended December 31,
			2013				2012
	Assumptions
	Weighted average assumptions used to determine benefit obligations at end of year
	Discount Rate			4.36	%			3.47	%
	Long-Term Rate of Return			7.25	%			7.25	%
	Salary Scale up to age 50		N/A				N/A
	Salary Scale over age 50		N/A				N/A
Net Periodic Benefit Cost [Member]	'
Note 16 - Benefit Plans (Tables) [Line Items]	'
Schedule of Assumptions Used [Table Text Block]	'
			Years Ended December 31,
			2013				2012				2011
	Weighted average assumptions used to determine net periodic benefit cost at beginning of year
	Discount Rate			3.47	%			4.01	%			5.08	%
	Long-Term Rate of Return			7.25	%			7.25	%			7.25	%
	Salary Scale up to age 50		N/A				N/A				N/A
	Salary Scale over age 50		N/A				N/A				N/A

Note_18_Commitments_And_Contin1

Note 18 - Commitments And Contingencies (Tables)	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	'
	2014	2015	2016	2017	2018	Thereafter
	$2,861	$2,502	$1,728	$1,613	$1,559	$1,472

Note_20_Industry_Segment_and_G1

Note 20 - Industry Segment and Geographic Information (Tables)	12 Months Ended
	Dec. 31, 2013
Segment Reporting [Abstract]	'
Schedule of Segment Reporting Information, by Segment [Table Text Block]	'
	2013	Animal Nutrition			Human Nutrition(1)			Unallocated			Total
	Revenue (2)	$	213,236		$	31,057		$	—		$	244,293
	Cost of sales		136,146			25,397			—			161,543
	Gross profit		77,090			5,660			—			82,750
	Selling, general and administrative expenses including research and development)		2,744			6,959			17,997			27,700
	Loss related to plant closure		6,597			—			—			6,597
	Other (gains) and losses		140			305			(5	)		440
	Operating income	$	67,609		$	(1,604	)	$	(17,992	)	$	48,013
	Depreciation and amortization	$	17,946		$	2,369		$	741		$	21,056
	Identifiable assets	$	277,063		$	53,093		$	1,238		$	331,394
	Capital expenditures	$	19,080		$	5,350		$	366		$	24,796
	2012	Animal Nutrition			Human Nutrition			Unallocated			Total
	Revenue (3)	$	213,624		$	22,015		$	—		$	235,639
	Cost of sales		176,588			16,995			—			193,583
	Gross profit		37,036			5,020			—			42,056
	Selling, general and administrative expenses (including research and development)		2,564			3,795			17,587			23,946
	Charges related to U.S. Attorney investigation		7,990			—			—			7,990
	Other (gains) and losses		(2,635	)		129			—			(2,506	)
	Operating income	$	29,117		$	1,096		$	(17,587	)	$	12,626
	Depreciation and amortization	$	15,859		$	1,315		$	825		$	17,999
	Identifiable assets	$	266,307		$	27,109		$	1,880		$	295,296
	Capital expenditures	$	22,810		$	1,759		$	495		$	25,064
	2011	Animal Nutrition			Human Nutrition			Unallocated			Total
	Revenue (4)	$	236,489		$	15,254		$	—		$	251,743
	Cost of sales		187,092			9,977			—			197,069
	Gross profit		49,397			5,277			—			54,674
	Selling, general and administrative expenses (including research and development)		2,804			3,286			18,548			24,638
	Charges related to U.S. Attorney investigation		545			—			—			545
	Other (gains) and losses		(24,869	)		1			—			(24,868	)
	Operating income	$	70,917		$	1,990		$	(18,548	)	$	54,359
	Depreciation and amortization	$	15,098		$	648		$	684		$	16,430
	Identifiable assets	$	248,672		$	27,048		$	2,110		$	277,830
	Capital expenditures	$	22,542		$	566		$	244		$	23,352
Reconciliation of Operating Income to Total Earnings Before Income Taxes [Table Text Block]	'
		Year ended December 31,
		2013			2012			2011
	Operating income for reportable segments	$	48,013		$	12,626		$	54,359
	Interest income		18			32			43
	Interest expense		(1,658	)		(1,335	)		(2,109	)
	Other expense, net		(394	)		(365	)		(408	)
	Income before income taxes	$	45,979		$	10,958		$	51,885
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]	'
		Years Ended December 31,
		2013						2012						2011
		Revenues			Percent			Revenues			Percent			Revenues		Percent
	U.S.	$	123.9			50.7	%	$	93.8			39.8	%	$	86.6		34.4	%
	Mexico		1.3			0.5			0.9			0.4			0.9		0.3
	Europe		31.5			12.9			18.6			7.9			30.3		12.1
	Canada		11.6			4.8			13.2			5.6			15.4		6.1
	Asia (1)		70.9			29			104.2			44.2			114.3		45.4
	South & Central America		4.8			2			4.7			2			4		1.6
	Other		0.3			0.1			0.2			0.1			0.2		0.1
	Total	$	244.3			100	%	$	235.6			100	%	$	251.7		100	%
Revenue from External Customers by Products and Services [Table Text Block]	'
		Years Ended December 31,
		2013						2012						2011
		Revenues			Percent			Revenues			Percent			Revenues		Percent
	Fish Meal	$	142.5			58.3	%	$	160.7			68.2	%	$	175.5		69.8	%
	Fish Oil		43.8			18			27.6			11.7			39.6		15.7
	Refined Fish Oil		22.7			9.3			17.8			7.6			15.6		6.2
	Fish Solubles and Other		4.2			1.7			7.5			3.2			5.8		2.3
	Dietary Supplement and Food Ingredients and Products		31.1			12.7			22			9.3			15.2		6
	Total	$	244.3			100	%	$	235.6			100	%	$	251.7		100	%

Note_21_Fair_Value_Disclosures1

Note 21 - Fair Value Disclosures (Tables)	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]	'
		Years Ended December 31,
		2013		2012
	Long-term Debt (Level 2):
	Carrying Value	$	24,242	$	27,300
	Estimated Fair Value	$	25,285	$	29,940
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	'
		31-Dec-13
		Fair Value Measurements Using								Assets
		Level 1		Level 2			Level 3			(Liabilities) at
										Fair Value
	Assets (Liabilities) (in thousands)
	Energy swap	$	—	$	275		$	—	$	275
	Total Assets (Liabilities)	$	—	$	275		$	—	$	275
		31-Dec-12
		Fair Value Measurements Using								Assets
		Level 1		Level 2			Level 3			(Liabilities) at
										Fair Value
	Assets (Liabilities) (in thousands)
	Energy swap	$	—	$	134		$	—	$	134
	Total Assets (Liabilities)	$	—	$	134		$	—	$	134
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	'
		Fair Value Measurements Using Significant
		Unobservable Inputs (Level 3 Inputs)
		Year Ended
		December 31,
		2013		2012
	Beginning Balance	$	—	$	(103	)
	Net Loss reclassified into interest expense related to interest rate swap transactions unrealized		—		—
	Net change associated with current period interest rate swap transactions realized		—		103
	Ending Balance	$	—	$	—

Note_23_Quarterly_Financial_Da1

Note 23 - Quarterly Financial Data (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2013
Quarterly Financial Information Disclosure [Abstract]	'
Schedule of Quarterly Financial Information [Table Text Block]	'
		Quarters Ended 2013
		March 31,			June 30,		September 30,		December 31,
		2013			2013		2013		2013
				(in thousands, except per share amounts)
	Revenues (1)	$	48,923		$	41,777	$	87,620	$	65,973
	Gross profit (1) (4)		12,097			13,283		29,420		27,950
	Operating income (1)(5)		4,723			6,690		21,921		14,679
	Net income (1)		2,845			3,990		13,962		9,718
	Earnings per share (2):
	Basic		0.14			0.2		0.68		0.47
	Diluted		0.14			0.19		0.66		0.45
		Quarters Ended 2012
		March 31,			June 30,		September 30,		December 31,
		2012			2012		2012		2012
				(in thousands, except per share amounts)
	Revenues (1)	$	41,088		$	47,448	$	83,970	$	63,133
	Gross profit (1)		8,892			6,847		13,398		12,919
	Operating income (1) (3)		3,170			4,201		2,904		2,351
	Net income (loss) (1) (3)		1,830			2,510		231		(508	)
	Earnings (loss) per share (2):
	Basic		0.09			0.13		0.01		(0.03	)
	Diluted		0.09			0.13		0.01		(0.03	)

Schedule_of_Valuation_and_Qual1

Schedule of Valuation and Qualifying Accounts (Tables)	12 Months Ended
	Dec. 31, 2013
Valuation and Qualifying Accounts [Abstract]	'
Allowance for Credit Losses on Financing Receivables [Table Text Block]	'
	Description	Balance at		Charged to			Deductions			Balance at
		Beginning		Costs and						End of
		of Period		Expenses						Period
	December 31, 2011:
	Allowance for doubtful accounts (A)	$	371,340	$	81,000	(B)	$	159,279	(C)	$	293,061
	December 31, 2012:
	Allowance for doubtful accounts (A)	$	293,061	$	48,000		$	—		$	341,061
	December 31, 2013:
	Allowance for doubtful accounts (A)	$	341,061	$	103,322	(D)	$	57,602		$	386,781

Note_1_Significant_Accounting_2

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) (USD $)

1 Months Ended

4 Months Ended

8 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

Jun. 30, 2013

Apr. 30, 2011

Oct. 30, 2010

Sep. 30, 2010

Dec. 31, 2010

Apr. 30, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Reclassification of Cash Flows From Investing Activities to Operating Activities Related to Accrued Capital Expenditures [Member]

Reclassification of Cash Flows From Investing Activities to Operating Activities Related to Accrued Capital Expenditures [Member]

Animal Nutrition [Member]

Human Nutrition [Member]

Unallocated Inventory and Net Change with Current Period Swap Transaction [Member]

Replacements and Major Improvements [Member]

Replacements and Major Improvements [Member]

Energy Swap [Member]

Energy Swap [Member]

Ineffective Portion of Diesel Energy Swaps [Member]

Ineffective Portion of Diesel Energy Swaps [Member]

Oil Spill [Member]

Oil Spill [Member]

Minimum [Member]

Maximum [Member]

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of Operating Segments

'

'

'

'

'

'

2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of Subsidiaries

'

'

'

'

'

'

'

'

'

'

'

2

3

'

'

'

'

'

'

'

'

'

Prior Period Reclassification Adjustment

'

'

'

'

'

'

'

'

'

$200,000

$500,000

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Legal Settlements

'

'

11,400,000

7,300,000

18,700,000

44,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Costs Of Goods And Services Sold, Percentage

'

'

'

'

'

'

'

'

4.40%

'

'

'

'

'

'

'

'

'

'

'

4.40%

8.90%

Reduction in Cost of Sales

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8,200,000

10,500,000

Loss from Catastrophes

'

-26,200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shipping, Handling and Transportation Costs

'

'

'

'

'

'

9,400,000

14,400,000

16,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Insurance Settlement, Operating Activities

3,100,000

'

'

'

'

'

'

300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Derivative Asset, Current

'

'

'

'

'

'

275,000

134,000

'

'

'

'

'

'

'

'

300,000

100,000

'

'

'

'

Deferred Tax Liabilities, Derivatives

'

'

'

'

'

'

96,100

15,100

'

'

'

'

'

'

'

'

100,000

15,100

'

'

'

'

Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax

'

'

'

'

'

'

179,000

28,000

-420,000

'

'

'

'

200,000

'

'

'

'

'

'

'

'

Accumulated Other Comprehensive Income Reclassified to Inventory Cost

'

'

'

'

'

'

200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Derivative Asset, Fair Value, Gross Asset

'

'

'

'

'

'

275,000

295,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Derivative Asset, Fair Value, Gross Liability

'

'

'

'

'

'

0

161,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cost of Goods and Services Sold

'

'

'

'

'

'

161,543,000

193,583,000

197,069,000

'

'

'

'

'

'

'

'

'

100,000

100,000

'

'

Property, Plant and Equipment, Useful Life

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'5 years

'15 years

'

'

'

'

'

'

Number of Reporting Units

'

'

'

'

'

'

2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Development Stage Entities, Stock Issued, Shares, Issued for Noncash Consideration (in Shares)

'

'

'

'

'

'

3,200

7,600

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of Stock and Warrants for Services or Claims

'

'

'

'

'

'

$25,200

$56,100

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Note_1_Significant_Accounting_3

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Energy Swap Balances (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2012
			NYMEX Heating Oil Swap [Member]	NYMEX Heating Oil Swap [Member]	NYMEX Natural Gas Swap [Member]	NYMEX Natural Gas Swap [Member]	Fuel Oil [Member]
			October to November, 2013 [Member]	May to November 2013 [Member]	April to October, 2014 [Member]	April to October 2013 [Member]	May to November 2013 [Member]
Derivative [Line Items]	'	'	'	'	'	'	'
Quantity	'	'	'998,700 Gallons	'1,359,782 Gallons	'307,374 MMBTUs	'381,150 MMBTUs	'676,200 Gallons
Price Per Unit (in Dollars per Item)	'	'	2.88	2.82	3.67	3.94	2.26
Energy Swap Asset/(Liability) (in Dollars)	$274,600	$134,200	$131,400	$244,800	$143,200	($149,600)	$39,000
Deferred Tax Asset/(Liability) (in Dollars)	-96,100	-15,100	-46,000	-53,800	-50,100	'	-13,600
Natural Gas - NYMEX Natural Gas Swap	'	'	'998,700 Gallons	'1,359,782 Gallons	'307,374 MMBTUs	'381,150 MMBTUs	'676,200 Gallons
Natural Gas - NYMEX Natural Gas Swap (in Dollars per Item)	'	'	2.88	2.82	3.67	3.94	2.26
Natural Gas - NYMEX Natural Gas Swap (in Dollars)	274,600	134,200	131,400	244,800	143,200	-149,600	39,000
Natural Gas - NYMEX Natural Gas Swap (in Dollars)	'	'	'	'	'	$52,300	'

Note_1_Significant_Accounting_4

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Changes Recorded, Net of Tax, in Accumulated Other Comprehensive Loss Resulting From the Energy Swap Agreements (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Changes Recorded, Net of Tax, in Accumulated Other Comprehensive Loss Resulting From the Energy Swap Agreements [Line Items]	'		'
Balance as of	$28		($420)
Amounts, net of tax, reclassified to unallocated inventory cost pool,	127	[1]	-328	[1]
Net change associated with current period swap transactions, net of tax,	278		120
Balance as of	179		28
Energy Related Derivative [Member] | Swap [Member]	'		'
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Changes Recorded, Net of Tax, in Accumulated Other Comprehensive Loss Resulting From the Energy Swap Agreements [Line Items]	'		'
Net change associated with current period swap transactions, net of tax,	278		120
Energy Related Derivative [Member]	'		'
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Changes Recorded, Net of Tax, in Accumulated Other Comprehensive Loss Resulting From the Energy Swap Agreements [Line Items]	'		'
Balance as of	28		-420
Amounts, net of tax, reclassified to unallocated inventory cost pool,	-127		328
Balance as of	$179		$28
[1]	This accumulated other comprehensive income component is reclassified to the unallocated inventory cost pool in the period when theenergy consumption takes place.

Note_1_Significant_Accounting_5

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Gross Amounts, Gross Amounts Offset and Net Amounts of Assets Presented in Balance Sheet (USD $)	Dec. 31, 2013	Dec. 31, 2012
Gross Amounts, Gross Amounts Offset and Net Amounts of Assets Presented in Balance Sheet [Abstract]	'	'
Gross Amount of Recognized Assets (Liabilities)	$275,000	$295,000
Gross Amounts of Assets (Liabilities) Offset	0	-161,000
Net Amounts of Assets (Liabilities) Presented in the Balance Sheet	$275,000	$134,000

Note_1_Significant_Accounting_6

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Energy Swap Aggreements	12 Months Ended
	Dec. 31, 2013
NYMEX Heating Oil Swap [Member] | May to November, 2014 [Member]	'
Derivative [Line Items]	'
Quantity	'333,366 Gallons
Price Per Unit (in Dollars per Item)	2.95
NGL-Mont Belvieu Propane [Member] | June to November, 2014 [Member]	'
Derivative [Line Items]	'
Quantity	'683,000 Gallons
Price Per Unit (in Dollars per Item)	1.09

Note_1_Significant_Accounting_7

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Estimated Useful Lives	12 Months Ended
	Dec. 31, 2013
Stainless Steel Equipment [Member]	'
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Estimated Useful Lives [Line Items]	'
Useful Life	'25 years
Fishing Vessels and Fish Processing Plants [Member] | Minimum [Member]	'
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Estimated Useful Lives [Line Items]	'
Useful Life	'15 years
Fishing Vessels and Fish Processing Plants [Member] | Maximum [Member]	'
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Estimated Useful Lives [Line Items]	'
Useful Life	'20 years
Machinery, Equipment, Furniture, Fixtures and Other [Member] | Minimum [Member]	'
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Estimated Useful Lives [Line Items]	'
Useful Life	'3 years
Machinery, Equipment, Furniture, Fixtures and Other [Member] | Maximum [Member]	'
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Estimated Useful Lives [Line Items]	'
Useful Life	'10 years

Note_1_Significant_Accounting_8

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Changes in Accumulated Other Comprehensive Loss (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Changes in Accumulated Other Comprehensive Loss [Abstract]	'		'		'
Balance as of	$28		($420)		'
Balance as of	-9,952		-10,259		'
Balance as of	-9,924		-10,679		'
Other comprehensive income	278		120		'
Other comprehensive income	2,560		-679		'
Other comprehensive income	2,838		-559		'
Amounts reclassified from accumulated other comprehensive loss	-127	[1]	328	[1]	'
Amounts reclassified from accumulated other comprehensive loss	1,005	[2]	986	[2]	'
Amounts reclassified from accumulated other comprehensive loss	878		1,314		'
Net current-period other comprehensive income	151		448		-925
Net current-period other comprehensive income	3,565		307		-2,071
Net current-period other comprehensive income	3,716		755		'
Balance as of	179		28		-420
Balance as of	-6,387		-9,952		-10,259
Balance as of	($6,208)		($9,924)		($10,679)
[1]	This accumulated other comprehensive income component is reclassified to the unallocated inventory cost pool in the period when theenergy consumption takes place.
[2]	This accumulated other comprehensive income component is included in the computation of net periodic pension costs as amortization ofactuarial loss which are explained in more detail in Note 16.

Note_2_Acquisition_of_Wisconsi2

Note 2 - Acquisition of Wisconsin Specialty Protein, L.L.C. (Details) (USD $)

1 Months Ended

4 Months Ended

12 Months Ended

Feb. 27, 2013

Sep. 30, 2011

Feb. 27, 2013

Sep. 30, 2011

Apr. 25, 2013

Apr. 25, 2013

Apr. 25, 2013

Apr. 25, 2013

Apr. 25, 2013

Feb. 27, 2013

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Equity Purchase Price [Member]

Equity Purchase Price [Member]

Estimated Working Capital [Member]

Estimated Working Capital [Member]

Reduced Earn Out Of Original Formula In 2013 [Member]

Annual Earn Out Payment of EBITDA, Low Percentage [Member]

Annual Earn Out Payment of EBITDA, Low Level [Member]

Annual Earn Out Payment of EBITDA, High Percentage [Member]

Annual Earn Out Payment of EBITDA, High Level [Member]

Wisconsin Specialty Protein [Member]

InCon [Member]

InCon [Member]

InCon [Member]

Wisconsin Specialty Protein [Member]

InCon [Member]

Wisconsin Specialty Protein [Member]

InCon [Member]

InCon [Member]

InCon [Member]

InCon [Member]

InCon [Member]

InCon [Member]

Note 2 - Acquisition of Wisconsin Specialty Protein, L.L.C. (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition, Percentage of Voting Interests Acquired

'

'

'

'

'

'

'

'

'

100.00%

'

'

'

Payments to Acquire Businesses, Gross

$26,500,000

$8,700,000

$600,000

$600,000

'

'

'

'

'

'

'

'

'

Business Acquisition, Transaction Costs

'

'

'

'

'

'

'

'

'

800,000

100,000

'

'

Proceeds from Previous Acquisition

'

'

'

'

'

'

'

'

'

'

'

'

200,000

Annual Earn Out Payments Percentage of EBITDA

'

'

'

'

35.00%

3.25%

'

19.50%

'

'

'

'

'

Earnings Before Deduction Of Interest Tax And Amortization Expense

'

'

'

'

'

'

3,000,000

'

12,000,000

'

'

'

'

Business Combination, Consideration Transferred

'

'

'

'

'

'

'

'

'

$27,079,000

$9,300,000

$9,270,000

'

Note_2_Acquisition_of_Wisconsi3

Note 2 - Acquisition of Wisconsin Specialty Protein, L.L.C. (Details) - Fair Value of the Wisconsin Specialty Protein Assets and Acquired Liabilities Assumed (USD $)	Dec. 31, 2013	Dec. 31, 2012	Feb. 27, 2013		Dec. 31, 2013
In Thousands, unless otherwise specified			Wisconsin Specialty Protein [Member]		Wisconsin Specialty Protein [Member]
Note 2 - Acquisition of Wisconsin Specialty Protein, L.L.C. (Details) - Fair Value of the Wisconsin Specialty Protein Assets and Acquired Liabilities Assumed [Line Items]	'	'	'		'
Cash	'	'	$403		'
Other current assets, net including receivables, prepaid and inventory	'	'	2,515		'
Property, plant, and equipment, net	'	'	14,095		'
Identifiable intangible assets (a)	'	'	4,448	[1]	'
Liabilities assumed	'	'	-5,996		'
Total identifiable net assets	'	'	15,465		'
Goodwill	19,600	7,986	11,614		11,614
Total consideration	'	'	$27,079		'
[1]	See Note 11 - Goodwill and Other Intangible Assets for weighted average lives.

Note_2_Acquisition_of_Wisconsi4

Note 2 - Acquisition of Wisconsin Specialty Protein, L.L.C. (Details) - Pro Forma Financial Information (Wisconsin Specialty Protein [Member], USD $)	10 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
Wisconsin Specialty Protein [Member]	'	'	'
Note 2 - Acquisition of Wisconsin Specialty Protein, L.L.C. (Details) - Pro Forma Financial Information [Line Items]	'	'	'
Revenue	$9,810	$246,361	$247,109
Net income (loss)	($195)	$30,518	$4,997

Note_3_Acquisition_of_Incon_Pr

Note 3 - Acquisition of Incon Processing, L.L.C. (Details) - Fair Values of the InCon Assets and Acquired Liabilities Assumed (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013
In Thousands, unless otherwise specified			InCon [Member]	InCon [Member]
Note 3 - Acquisition of Incon Processing, L.L.C. (Details) - Fair Values of the InCon Assets and Acquired Liabilities Assumed [Line Items]	'	'	'	'
Working capital (a)	'	'	'	$593	[1]
Property, plant, and equipment, net	'	'	'	6,400
Identifiable intangible assets (b)	'	'	'	1,341	[2]
Total identifiable net assets	'	'	'	8,334
Goodwill	19,600	7,986	'	936
Total consideration, net of final working capital adjustment	'	'	$9,300	$9,270
[1]	Includes cash and cash equivalents, accounts receivable, spare parts inventory and accounts payable.
[2]	See Note 11 - Goodwill and other intangible assets for weighted average lives.

Note_4_Gulf_Of_Mexico_Oil_Spil1

Note 4 - Gulf Of Mexico Oil Spill Disaster (Details) (USD $)	1 Months Ended			4 Months Ended	8 Months Ended	12 Months Ended
	Apr. 30, 2011	Oct. 30, 2010	Sep. 30, 2010	Dec. 31, 2010	Apr. 30, 2011	Dec. 31, 2011	Dec. 31, 2011	Dec. 31, 2010
							Oil Spill [Member]	Oil Spill [Member]
Note 4 - Gulf Of Mexico Oil Spill Disaster (Details) [Line Items]	'	'	'	'	'	'	'	'
Proceeds from Legal Settlements	'	$11,400,000	$7,300,000	$18,700,000	$44,800,000	'	'	'
Costs Of Goods And Services Sold, Percentage	'	'	'	'	'	4.40%	4.40%	8.90%
Reduction in Cost of Sales	'	'	'	'	'	'	8,200,000	10,500,000
Loss from Catastrophes	($26,200,000)	'	'	'	'	'	'	'

Note_5_Plant_Closure_Details_C

Note 5 - Plant Closure (Details) - Charges Incurred in Conjunction with Plant Closure (Cameron, Louisiana Menhaden Processing Plant [Member], USD $)	1 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013
Cameron, Louisiana Menhaden Processing Plant [Member]	'
Note 5 - Plant Closure (Details) - Charges Incurred in Conjunction with Plant Closure [Line Items]	'
Impairment of property, plant and equipment	$4,796
Write-off material and supplies inventory	97
Employee severance accruals	345
Estimated decommissioning costs	250
Other ongoing closure costs not attributable to future production	1,109
Total loss related to plant closure	$6,597

Note_6_Receivables_Net_Details

Note 6 - Receivables, Net (Details) (USD $)	1 Months Ended	12 Months Ended
	Jun. 30, 2013	Dec. 31, 2012	Dec. 31, 2013
Note 6 - Receivables, Net (Details) [Line Items]	'	'	'
Insurance Settlements Receivable, Current	'	$4,980,000	$1,806,000
Proceeds from Insurance Settlement, Operating Activities	3,100,000	300,000	'
Salvage Cost [Member]	'	'	'
Note 6 - Receivables, Net (Details) [Line Items]	'	'	'
Insurance Settlements Receivable, Current	'	3,400,000	'
Proceeds from Insurance Settlement, Operating Activities	$5,700,000	'	'

Note_6_Receivables_Net_Details1

Note 6 - Receivables, Net (Details) - Receivables (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Receivables [Abstract]	'	'
Trade	$18,689	$11,513
Insurance	1,806	4,980
Income tax	714	871
Other	310	236
Total accounts receivable	21,519	17,600
Less allowance for doubtful accounts	-379	-333
Receivables, net	$21,140	$17,267

Note_7_Inventory_Details_Class

Note 7 - Inventory (Details) - Classes of Inventory (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Inventory [Line Items]	'	'
Unallocated inventory cost pool (including off-season costs)	$6,655	$7,403
Other materials and supplies	8,880	9,821
Total inventory	94,339	66,659
Class, Fish Meal [Member]	'	'
Inventory [Line Items]	'	'
Inventory Goods	30,119	26,511
Class, Fish Oil [Member]	'	'
Inventory [Line Items]	'	'
Inventory Goods	41,081	17,352
Class, Fish Solubles [Member]	'	'
Inventory [Line Items]	'	'
Inventory Goods	2,599	1,391
Class, Nutraceutical Products [Member]	'	'
Inventory [Line Items]	'	'
Inventory Goods	3,650	4,181
Class, Dairy Protein Products [Member]	'	'
Inventory [Line Items]	'	'
Inventory Goods	$1,355	'

Note_8_Prepaid_Expenses_and_Ot2

Note 8 - Prepaid Expenses and Other Current Assets (Details) - Prepaid Expenses and Other Current Assets (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Note 8 - Prepaid Expenses and Other Current Assets (Details) - Prepaid Expenses and Other Current Assets [Line Items]	'	'
Prepaid insurance	$2,422	$2,554
Selling expenses	869	436
Fair market value of energy swaps, current portion	275	134
Total prepaid expenses and other current assets	3,915	3,430
Leases	53	118
Whey Process Filters [Member]	'	'
Note 8 - Prepaid Expenses and Other Current Assets (Details) - Prepaid Expenses and Other Current Assets [Line Items]	'	'
Other prepaids and expenses	38	'
Other Prepaids And Expenses [Member]	'	'
Note 8 - Prepaid Expenses and Other Current Assets (Details) - Prepaid Expenses and Other Current Assets [Line Items]	'	'
Other prepaids and expenses	$258	$188

Note_9_Other_Assets_Details

Note 9 - Other Assets (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Note 9 - Other Assets (Details) [Line Items]	'	'	'
Amortization	$1,400,000	$1,300,000	$1,200,000
Insurance Settlements Receivable	3,048,000	8,572,000	'
Jones Act [Member]	'	'	'
Note 9 - Other Assets (Details) [Line Items]	'	'	'
Insurance Settlements Receivable	$3,000,000	$8,600,000	'

Note_9_Other_Assets_Details_Ot

Note 9 - Other Assets (Details) - Other Assets (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Note 9 - Other Assets (Details) - Other Assets [Line Items]	'	'
Other Asset, Net	$5,234	$10,789
Insurance receivable, net of allowance for doubtful accounts	3,048	8,572
Property, Leased, Fishing Nets [Member]	'	'
Note 9 - Other Assets (Details) - Other Assets [Line Items]	'	'
Other Asset, Net	1,517	1,432
Title XI Debt Issuance Costs [Member]	'	'
Note 9 - Other Assets (Details) - Other Assets [Line Items]	'	'
Other Asset, Net	272	302
Other Debt Issuance Costs [Member]	'	'
Note 9 - Other Assets (Details) - Other Assets [Line Items]	'	'
Other Asset, Net	299	391
Deposits [Member]	'	'
Note 9 - Other Assets (Details) - Other Assets [Line Items]	'	'
Other Asset, Net	$98	$92

Note_9_Other_Assets_Details_Ot1

Note 9 - Other Assets (Details) - Other Assets (Parentheticals) (Property, Leased, Fishing Nets [Member], USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Property, Leased, Fishing Nets [Member]	'	'
Note 9 - Other Assets (Details) - Other Assets (Parentheticals) [Line Items]	'	'
Fish nets, accumulated amortization	$2,610	$1,243

Note_10_Property_Plant_and_Equ2

Note 10 - Property, Plant, and Equipment (Details) (USD $)	1 Months Ended	12 Months Ended			1 Months Ended
	Jun. 30, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013
					Cameron, Louisiana Menhaden Processing Plant [Member]
Note 10 - Property, Plant, and Equipment (Details) [Line Items]	'	'	'	'	'
Depreciation	'	$18,900,000	$16,300,000	$14,700,000	'
Interest Costs Capitalized	'	312,300	765,300	245,300	'
Impairment of Long-Lived Assets to be Disposed of	'	'	'	'	4,796,000
Proceeds from Sale of Property, Plant, and Equipment	5,200,000	'	'	'	'
Gain (Loss) on Disposition of Property Plant Equipment	'	'	$4,000,000	'	'

Note_10_Property_Plant_and_Equ3

Note 10 - Property, Plant, and Equipment (Details) - Property, Plant, and Equipment (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Property, Plant and Equipment [Line Items]	'	'
Property, Plant, and Equipment	$292,476	$277,873
Less accumulated depreciation and impairment	-148,363	-150,233
Property, plant and equipment, net	144,113	127,640
Land [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant, and Equipment	7,457	7,229
Equipment, Plant [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant, and Equipment	159,337	148,451
Property, Fishing Vessels [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant, and Equipment	101,745	103,754
Furniture and Fixtures [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant, and Equipment	7,091	7,225
Construction in Progress [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant, and Equipment	$16,846	$11,214

Note_11_Goodwill_and_Other_Int2

Note 11 - Goodwill and Other Intangible Assets (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Feb. 27, 2013
			Trade Names [Member]	Trade Names [Member]	Trade Secrets [Member]	Trade Secrets [Member]	Goodwill and Other Indefinite Lived Intangible Assets [Member]	InCon [Member]	Wisconsin Specialty Protein [Member]	Wisconsin Specialty Protein [Member]
					InCon [Member]	Maximum [Member]	Maximum [Member]
Note 11 - Goodwill and Other Intangible Assets (Details) [Line Items]	'	'	'	'	'	'	'	'	'	'
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)	$266,000	$129,000	$300,000	$100,000	'	'	'	'	'	'
Indefinite-Lived Intangible Assets (Excluding Goodwill)	2,615,000	1,753,000	'	'	1,000,000	'	'	'	'	'
Percentage Of Which Fair Value Exceeded Carrying Value Of Intangible Assets	'	'	'	'	'	5.00%	20.00%	'	'	'
Amount at which Carrying Value Exceeded Fair Value of Intangible Assets	'	'	'	100,000	'	'	'	'	'	'
Goodwill	19,600,000	7,986,000	'	'	'	'	'	936,000	11,614,000	11,614,000
Amortization of Intangible Assets	$600,000	$300,000	'	'	'	'	'	'	'	'

Note_11_Goodwill_and_Other_Int3

Note 11 - Goodwill and Other Intangible Assets (Details) - Changes in Carrying Amount of Goodwill Resulting from Company's Acquisitions (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2013	Feb. 27, 2013	Dec. 31, 2013	Dec. 31, 2012
		Wisconsin Specialty Protein [Member]	Wisconsin Specialty Protein [Member]	Cyvex and Incon [Member]	Cyvex and Incon [Member]
Goodwill [Line Items]	'	'	'	'	'
Balance as of	$7,986	'	$11,614	$7,986	$7,986
Acquisitions (1)	11,614	11,614	'	'	'
Balance as of	$19,600	$11,614	$11,614	$7,986	$7,986

Note_11_Goodwill_and_Other_Int4

Note 11 - Goodwill and Other Intangible Assets (Details) - Table of Intangible Assets Other than Goodwill (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Table of Intangible Assets Other than Goodwill [Abstract]	'	'
Customer relationships and non-competes	$5,930	$2,934
Less accumulated amortization	-613	-325
Less accumulated amortization	'10 years	'
Total intangible assets subject to amortization, net	5,317	2,609
Indefinite life intangible assets – trade names/secrets and other	2,615	1,753
Total intangible assets	$7,932	$4,362

Note_11_Goodwill_and_Other_Int5

Note 11 - Goodwill and Other Intangible Assets (Details) - Table of Future Amortization Expense (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Table of Future Amortization Expense [Abstract]	'	'
2014	$663	'
2015	655	'
2016	654	'
2017	654	'
Thereafter	2,691	'
Total estimated future amortization expense	$5,317	$2,609

Note_12_Notes_Payable_and_Long2

Note 12 - Notes Payable and Long-Term Debt (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Jun. 20, 2011	Dec. 31, 2013	Dec. 31, 2012	Mar. 21, 2012
			London Interbank Offered Rate (LIBOR) [Member]	Federal Funds Rate [Member]	Approval Letter [Member]	Approval Letter [Member]	Loan Agreement [Member]	Loan Agreement [Member]	Loan Agreement [Member]
			Loan Agreement [Member]	Loan Agreement [Member]
Note 12 - Notes Payable and Long-Term Debt (Details) [Line Items]	'	'	'	'	'	'	'	'	'
Line of Credit Facility, Maximum Borrowing Capacity	'	'	'	'	'	$10,000,000	'	'	$60,000,000
Line of Credit Facility, Amount Outstanding	'	'	'	'	24,200,000	'	0	0	'
Debt Instrument, Basis Spread on Variable Rate	'	'	1.50%	1.00%	'	'	'	'	'
Minimum Net Worth Required for Compliance	'	'	'	'	'	'	150,000,000	'	'
Line of Credit, Percent of Net Income, Covenant Terms	'	'	'	'	'	'	50.00%	'	'
Line of Credit Facility, Percent of Net Proceeds From Equity Interest, Covenant Terms	'	'	'	'	'	'	100.00%	'	'
Line of Credit Facility, Percent, Increase in Stockholders' Equity, Covenant Terms	'	'	'	'	'	'	100.00%	'	'
Asset Coverage Ratio	'	'	'	'	'	'	2.5	'	'
Letters of Credit Outstanding, Amount	$3,500,000	$3,100,000	'	'	'	'	'	'	'

Note_12_Notes_Payable_and_Long3

Note 12 - Notes Payable and Long-Term Debt (Details) - Table of Long-Term Debt (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Note 12 - Notes Payable and Long-Term Debt (Details) - Table of Long-Term Debt [Line Items]	'	'
Long-term debt gross	$24,242	$27,300
Less current maturities	-3,112	-3,058
Long-term debt	21,130	24,242
Installments Through 2025 [Member]	'	'
Note 12 - Notes Payable and Long-Term Debt (Details) - Table of Long-Term Debt [Line Items]	'	'
Long-term debt gross	24,211	27,228
Installments Through 2014 [Member]	'	'
Note 12 - Notes Payable and Long-Term Debt (Details) - Table of Long-Term Debt [Line Items]	'	'
Long-term debt gross	$31	$72

Note_12_Notes_Payable_and_Long4

Note 12 - Notes Payable and Long-Term Debt (Details) - Table of Long-Term Debt (Parentheticals)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Installments Through 2014 [Member]	'	'
Note 12 - Notes Payable and Long-Term Debt (Details) - Table of Long-Term Debt (Parentheticals) [Line Items]	'	'
Interest Rate	0.70%	0.80%
Eurodollar Rates Plus	'0.5%	'0.5%
Minimum [Member] | Installments Through 2025 [Member]	'	'
Note 12 - Notes Payable and Long-Term Debt (Details) - Table of Long-Term Debt (Parentheticals) [Line Items]	'	'
Interest Rate	5.70%	5.70%
Maximum [Member] | Installments Through 2025 [Member]	'	'
Note 12 - Notes Payable and Long-Term Debt (Details) - Table of Long-Term Debt (Parentheticals) [Line Items]	'	'
Interest Rate	7.60%	7.60%

Note_12_Notes_Payable_and_Long5

Note 12 - Notes Payable and Long-Term Debt (Details) - The Annual Maturities of Long-Term Debt (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
The Annual Maturities of Long-Term Debt [Abstract]	'
	$3,113
	2,643
	2,800
	2,788
	2,969
	$9,929

Note_13_Reconciliation_of_Basi2

Note 13 - Reconciliation of Basic and Diluted Per Share Data (Details) - Reconciliation of Basic and Diluted Per Share Data (USD $)

3 Months Ended

12 Months Ended

In Thousands, except Per Share data, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Reconciliation of Basic and Diluted Per Share Data [Abstract]

'

'

'

'

'

'

'

'

'

'

'

Net income (in Dollars)

$9,718

[1]

$13,962

[1]

$3,990

[1]

$2,845

[1]

($508)

[1],[2]

$231

[1],[2]

$2,510

[1],[2]

$1,830

[1],[2]

$30,515

$4,063

$34,157

Income allocated to participating securities (in Dollars)

'

'

'

'

'

'

'

'

-687

-49

-30

Income allocated to common shares outstanding (in Dollars)

'

'

'

'

'

'

'

'

$29,828

$4,014

$34,127

Weighted average common shares outstanding

'

'

'

'

'

'

'

'

19,913

19,420

19,238

Basic earnings per share (in Dollars per share)

$0.47

[3]

$0.68

[3]

$0.20

[3]

$0.14

[3]

($0.03)

[3]

$0.01

[3]

$0.13

[3]

$0.09

[3]

$1.50

$0.21

$1.77

Stock options assumed exercised

'

'

'

'

'

'

'

'

721

454

685

Weighted average diluted common shares and potential common share equivalents outstanding

'

'

'

'

'

'

'

'

20,634

19,874

19,923

Diluted earnings per share (in Dollars per share)

$0.45

[3]

$0.66

[3]

$0.19

[3]

$0.14

[3]

($0.03)

[3]

$0.01

[3]

$0.13

[3]

$0.09

[3]

$1.45

$0.20

$1.71

[1]

Revenues, gross profit, operating income, and net income (loss) are rounded to thousands each quarter. Therefore, the sum of the quarterly amounts may not equal the annual amounts reported.

[2]

Included in the quarter ended September 30, 2012 expense is a $4.1 million charge related to the U.S. Attorney investigation. A similar additional charge of $3.6 million was recognized for the quarter ended December 31, 2012. These charges were non-deductible for federal tax purposes.

[3]

Earnings per share are computed independently for each quarter and the full year based upon respective average shares outstanding. Therefore, the sum of the quarterly earnings per share amounts may not equal the annual amounts reported.

Note_13_Reconciliation_of_Basi3

Note 13 - Reconciliation of Basic and Diluted Per Share Data (Details) - Outstanding Shares Excluded from Computation of Diluted Earnings Per Share	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Outstanding Shares Excluded from Computation of Diluted Earnings Per Share [Abstract]	'	'	'
	130	811	135

Note_14_Income_Taxes_Details

Note 14 - Income Taxes (Details) (USD $)	12 Months Ended				3 Months Ended		12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011	Dec. 31, 2011	Dec. 31, 2011
					Wage Credits [Member]	State Net Operating Losses [Member]	Recognition of Certain Tax Credits [Member]
Note 14 - Income Taxes (Details) [Line Items]	'	'	'	'	'	'	'
Operating Loss Carryforwards	$10,300,000	'	'	'	'	'	'
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	35.00%	35.00%	35.00%	'	'	'	'
Income Tax Expense (Benefit)	15,464,000	6,895,000	17,728,000	'	'	'	490,000
Valuation Allowance, Deferred Tax Asset, Change in Amount	'	'	'	'	1,025,000	95,000	'
Unrecognized Tax Benefits	1,572,000	1,514,000	1,513,000	896,000	'	'	'
Unrecognized Tax Benefits, Interest on Income Taxes Accrued	81,000	53,000	33,000	'	'	'	'
Unrecognized Tax Benefits, Income Tax Penalties Accrued	$26,000	$2,000	$166,000	'	'	'	'

Note_14_Income_Taxes_Details_T

Note 14 - Income Taxes (Details) - The Company’s Provision (Benefit) for Income Taxes Consisted of the Following: (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
The Company’s Provision (Benefit) for Income Taxes Consisted of the Following: [Abstract]	'	'	'
State	$1,265	$453	$276
U.S.	11,031	4,288	10,924
State	227	294	920
U.S.	2,941	1,860	5,608
Provision (benefit) for income taxes	$15,464	$6,895	$17,728

Note_14_Income_Taxes_Details_R

Note 14 - Income Taxes (Details) - Reconciliation of the Income Tax Provisions (Benefits) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Reconciliation of the Income Tax Provisions (Benefits) [Abstract]	'		'		'
Taxes at statutory rate	$16,097		$3,835		$18,159
Other non-deductible expenses	145		163		189
Qualified production activities deduction	-1,334		-193		-1,305
Charges related to U.S. Attorney investigation	'		2,625		'
State taxes, net of federal benefit	969		485		778
Excess executive compensation	'		'		128
Impact of federal tax credits (1)	-85	[1]	'	[1]	490	[1]
Change in deferred tax asset valuation allowance (2)	-77	[2]	-55	[2]	-1,120	[2]
Impact of federal tax rate adjustment to 35%	'		'		491
Other	-251		35		-82
Provision (benefit) for income taxes	$15,464		$6,895		$17,728
[1]	As a result of recognizing certain tax credits in 2011, the Company realized a $490,000 income tax expense.
[2]	During the fourth quarter of 2011, the Company reversed a deferred tax valuation allowance of $1,025,000 related to wage credits and $95,000 related to state net operating losses.

Note_14_Income_Taxes_Details_D

Note 14 - Income Taxes (Details) - Deferred Tax Assets and Deferred Tax Liabilities (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Deferred Tax Assets and Deferred Tax Liabilities [Abstract]	'	'
Assets and accruals not yet deductible	$4,369	$3,639
Equity based compensation	3,429	3,243
Equity in loss of unconsolidated affiliates	125	125
Tax credit carryforward	225	225
Pension liability	3,716	5,636
State income tax	492	404
Valuation allowance	-584	-661
Total deferred tax assets	11,772	12,611
Property and equipment	-21,844	-20,814
Intangible assets	-590	-187
Pension and other retirement benefits	-1,350	-1,272
Assets currently deductible	-6,277	-4,967
Total deferred tax liabilities	-30,061	-27,240
Net deferred tax liability	-18,289	-14,629
Deferred income tax asset (liability) current	1,062	1,165
Deferred income tax asset (liability) non-current	($19,351)	($15,794)

Note_14_Income_Taxes_Details_A

Note 14 - Income Taxes (Details) - A Reconciliation of the Beginning and Ending Amount of Unrecognized Tax Benefits (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
A Reconciliation of the Beginning and Ending Amount of Unrecognized Tax Benefits [Abstract]	'	'	'
Balance at January 1,	$1,514	$1,513	$896
Additions for tax positions of prior years	58	37	451
Reductions for tax positions of prior years	'	-36	'
Additions based on tax positions related to the current year	'	'	166
Balance at December 31,	$1,572	$1,514	$1,513

Note_15_Accrued_Liabilities_De

Note 15 - Accrued Liabilities (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Disclosure Text Block Supplement [Abstract]	'	'
Deferred Revenue, Current	$2,362	$2,060

Note_15_Accrued_Liabilities_De1

Note 15 - Accrued Liabilities (Details) - Table of Accrued Liabilities (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Note 15 - Accrued Liabilities (Details) - Table of Accrued Liabilities [Line Items]	'	'
Insurance	$7,222	$12,307
Reserve for plant closure costs	595	'
Reserve for U.S. Attorney investigation	'	7,655
Salary and benefits	9,423	4,989
Total accrued liabilities	29,145	31,741
Taxes, other than income tax	64	42
Income tax	4,132	'
Deferred revenue	2,362	2,060
Contractual obligations	'	470
Accrued interest	200	225
Trade Creditors [Member]	'	'
Note 15 - Accrued Liabilities (Details) - Table of Accrued Liabilities [Line Items]	'	'
Other Accrued liabilities	5,100	3,914
Other Liabilities [Member]	'	'
Note 15 - Accrued Liabilities (Details) - Table of Accrued Liabilities [Line Items]	'	'
Other Accrued liabilities	$47	$79

Note_16_Benefit_Plans_Details

Note 16 - Benefit Plans (Details) (USD $)

1 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

Jan. 27, 2000

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Jan. 27, 2000

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2014

Jan. 26, 1998

Jan. 27, 2000

Jan. 26, 1998

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2012

Maximum Available for Awards [Member]

Employee Stock Option [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Board of Directors Chairman [Member]

Director [Member]

Director [Member]

Prior Discount Rate [Member]

Revised Discount Rate [Member]

Minimum [Member]

Maximum [Member]

Note 16 - Benefit Plans (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Defined Contribution Plan, Employer Discretionary Contribution Amount

'

'

$1,200,000

$1,100,000

$1,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax

'

'

3,565,000

307,000

-2,071,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Defined Benefit Plan, Net Periodic Benefit Cost

'

800,000

1,524,000

1,309,000

1,191,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Return on Assets

'

7.25%

7.25%

7.25%

7.25%

'

'

'

'

'

'

'

'

'

'

'

'

'

Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate

'

'

4.36%

3.47%

'

'

'

'

'

'

'

'

'

'

3.47%

4.36%

'

'

Defined Benefit Plans, Estimated Future Employer Contributions in Next Fiscal Year

'

2,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

'

'

'3 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award Expiration Term

'

'

'10 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in Shares)

'

'

'

'

'

15,000,000

'

'

'

'

'

568,200

10,000

14,200

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum

25.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Allocated Share-based Compensation Expense

'

'

600,000

3,100,000

3,200,000

'

'

1,400,000

600,000

100,000

'

'

'

'

'

'

'

'

Allocated Share-based Compensation Expense, Net of Tax

'

'

400,000

2,000,000

2,100,000

'

'

900,000

400,000

100,000

'

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized

'

'

'

'

'

'

0

1,500,000

'

'

1,000,000

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares)

'

'

859,000

92,000

536,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

'

'

'

0.00%

0.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate

'

'

'

65.70%

64.10%

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

'

'

'

0.86%

1.64%

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'5 years

'6 years

Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Net

'

'

'

'

'

'

'

900,000

'

'

700,000

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition

'

'

'

'

'

'

'

'1 year 109 days

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value

'

'

$9,814,000

$2,045,000

$3,770,000

'

'

$6,000,000

$2,600,000

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number (in Shares)

'

'

'

'

'

'

'

238,734

'

'

'

'

'

'

'

'

'

'

Note_16_Benefit_Plans_Details_

Note 16 - Benefit Plans (Details) - The Amounts in Accumulated Other Comprehensive Loss that are Expected to be Recognized as a Component of Net Periodic Benefit Cost (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013
The Amounts in Accumulated Other Comprehensive Loss that are Expected to be Recognized as a Component of Net Periodic Benefit Cost [Abstract]	'
Net Actuarial Loss (Gain)	$915
Prior Service Cost	$0

Note_16_Benefit_Plans_Details_1

Note 16 - Benefit Plans (Details) - Benefit Obligations, Fair Value of Plan Assets, and the Funded Status of Pension Plan (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Benefit Obligations, Fair Value of Plan Assets, and the Funded Status of Pension Plan [Abstract]	'		'		'
Accumulated Benefit Obligations	$25,945		$29,202		'
Change in Benefit Obligation	'		'		'
Benefit Obligation	29,202		28,527		'
Interest Cost	991		1,095		'
Actuarial (Gain) Loss	-2,288		1,269		'
Benefits Paid	-1,960		-1,689		'
Benefit Obligation	25,945		29,202		28,527
Change in Plan Assets	'		'		'
Plan Assets at Fair Value	19,376		17,659		'
Funded Status of the Plan	-4,117		-9,826		'
Actual Return on Plan Assets	2,663		1,527		'
Company Contributions	1,749		1,879		'
Plan Assets at Fair Value	21,828		19,376		17,659
Additional Amounts Recognized in the Statement of Financial Position:	'		'		'
Long-term Liabilities	-4,117		-9,826		'
Amounts Recognized in Accumulated Other Comprehensive Loss:	'		'		'
Net Actuarial (Loss) Gain, net of tax	-6,387		-9,952		-10,259
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Loss:	'		'		'
Net Actuarial (Loss) Gain, net of tax	2,560		-679		'
Reversal of Amortization Item:	'		'		'
Amortization of Net Loss, net of tax	1,005	[1]	986	[1]	'
Total Recognized in Other Comprehensive Loss, net of tax	$3,565		$307		($2,071)
[1]	This accumulated other comprehensive income component is included in the computation of net periodic pension costs as amortization ofactuarial loss which are explained in more detail in Note 16.

Note_16_Benefit_Plans_Details_2

Note 16 - Benefit Plans (Details) - Weighted Average Assumptions Used to Determine Benefit Obligations	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Weighted average assumptions used to determine benefit obligations at end of year	'	'	'	'
Discount Rate	'	4.36%	3.47%	'
Long-Term Rate of Return	7.25%	7.25%	7.25%	7.25%

Note_16_Benefit_Plans_Details_3

Note 16 - Benefit Plans (Details) - Weighted Average Assumptions Used to Determine Net Periodic Benefit Cost	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Weighted average assumptions used to determine net periodic benefit cost at beginning of year	'	'	'	'
Discount Rate	'	3.47%	4.01%	5.08%
Long-Term Rate of Return	7.25%	7.25%	7.25%	7.25%

Note_16_Benefit_Plans_Details_4

Note 16 - Benefit Plans (Details) - Summary of Components of Net Periodic Benefit Cost (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Components of net periodic benefit cost:	'	'	'	'
Service cost	'	$0	$0	$0
Interest cost	'	991	1,095	'
Expected return on plan assets	'	-1,027	-1,303	-1,274
Amortization of net loss	'	1,561	1,517	1,189
Net periodic benefit cost	800	1,524	1,309	1,191
Component of Net Periodic Benefit Cost [Member]	'	'	'	'
Components of net periodic benefit cost:	'	'	'	'
Interest cost	'	$990	$1,095	$1,276

Note_16_Benefit_Plans_Details_5

Note 16 - Benefit Plans (Details) - The Company’s Pension Plan Weighted-Average Asset Allocations	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Note 16 - Benefit Plans (Details) - The Company’s Pension Plan Weighted-Average Asset Allocations [Line Items]	'	'
Actual	100.00%	100.00%
Target	100.00%	100.00%
Equity Securities [Member]	'	'
Note 16 - Benefit Plans (Details) - The Company’s Pension Plan Weighted-Average Asset Allocations [Line Items]	'	'
Actual	64.50%	59.90%
Target	60.00%	60.00%
Debt Securities [Member]	'	'
Note 16 - Benefit Plans (Details) - The Company’s Pension Plan Weighted-Average Asset Allocations [Line Items]	'	'
Actual	35.50%	40.10%
Target	40.00%	40.00%

Note_16_Benefit_Plans_Details_6

Note 16 - Benefit Plans (Details) - The Fair Values of the Company’s Pension Plan Assets by Major Category (USD $)	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
In Thousands, unless otherwise specified
Note 16 - Benefit Plans (Details) - The Fair Values of the Company’s Pension Plan Assets by Major Category [Line Items]	'		'		'
Fair value of plan assets	$21,828		$19,376		$17,659
Large-Cap Growth [Member]	'		'		'
Note 16 - Benefit Plans (Details) - The Fair Values of the Company’s Pension Plan Assets by Major Category [Line Items]	'		'		'
Fair value of plan assets	4,833		3,946		'
Large Company Value [Member]	'		'		'
Note 16 - Benefit Plans (Details) - The Fair Values of the Company’s Pension Plan Assets by Major Category [Line Items]	'		'		'
Fair value of plan assets	2,031		1,772		'
Mid-Cap Growth [Member]	'		'		'
Note 16 - Benefit Plans (Details) - The Fair Values of the Company’s Pension Plan Assets by Major Category [Line Items]	'		'		'
Fair value of plan assets	897		753		'
Mid-Cap Value [Member]	'		'		'
Note 16 - Benefit Plans (Details) - The Fair Values of the Company’s Pension Plan Assets by Major Category [Line Items]	'		'		'
Fair value of plan assets	915		768		'
Small Company Growth [Member]	'		'		'
Note 16 - Benefit Plans (Details) - The Fair Values of the Company’s Pension Plan Assets by Major Category [Line Items]	'		'		'
Fair value of plan assets	873		774		'
Small Company Value [Member]	'		'		'
Note 16 - Benefit Plans (Details) - The Fair Values of the Company’s Pension Plan Assets by Major Category [Line Items]	'		'		'
Fair value of plan assets	912		785		'
International [Member]	'		'		'
Note 16 - Benefit Plans (Details) - The Fair Values of the Company’s Pension Plan Assets by Major Category [Line Items]	'		'		'
Fair value of plan assets	2,604	[1]	1,852	[1]	'
REIT [Member]	'		'		'
Note 16 - Benefit Plans (Details) - The Fair Values of the Company’s Pension Plan Assets by Major Category [Line Items]	'		'		'
Fair value of plan assets	1,016		955		'
US Treasury Securities [Member]	'		'		'
Note 16 - Benefit Plans (Details) - The Fair Values of the Company’s Pension Plan Assets by Major Category [Line Items]	'		'		'
Fair value of plan assets	2,525		2,409		'
US Government Agencies Debt Securities [Member]	'		'		'
Note 16 - Benefit Plans (Details) - The Fair Values of the Company’s Pension Plan Assets by Major Category [Line Items]	'		'		'
Fair value of plan assets	2,003		2,333		'
Corporate Debt Securities [Member]	'		'		'
Note 16 - Benefit Plans (Details) - The Fair Values of the Company’s Pension Plan Assets by Major Category [Line Items]	'		'		'
Fair value of plan assets	2,077		2,093		'
International Fixed Income [Member]	'		'		'
Note 16 - Benefit Plans (Details) - The Fair Values of the Company’s Pension Plan Assets by Major Category [Line Items]	'		'		'
Fair value of plan assets	220		332		'
Asset-backed Securities [Member]	'		'		'
Note 16 - Benefit Plans (Details) - The Fair Values of the Company’s Pension Plan Assets by Major Category [Line Items]	'		'		'
Fair value of plan assets	608		255		'
Mortgage-backed Securities, Issued by US Government Sponsored Enterprises [Member]	'		'		'
Note 16 - Benefit Plans (Details) - The Fair Values of the Company’s Pension Plan Assets by Major Category [Line Items]	'		'		'
Fair value of plan assets	$314		$349		'
[1]	Categorized as Level 1 of the fair value hierarchy.

Note_16_Benefit_Plans_Details_7

Note 16 - Benefit Plans (Details) - Projected Benefit Payments (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Projected Benefit Payments [Abstract]	'
	$1,769
	1,767
	1,789
	1,787
	1,797
	$8,907

Note_16_Benefit_Plans_Details_8

Note 16 - Benefit Plans (Details) - A Summary of Option Activity (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
A Summary of Option Activity [Abstract]	'	'	'
Outstanding at beginning of year (in Shares)	2,652,000	2,776,000	3,271,000
Outstanding at beginning of year	$6.19	$6.12	$5.86
Granted (in Shares)	'	98,000	60,000
Granted	'	$6.80	$13.41
Exercised (in Shares)	-859,000	-92,000	-536,000
Exercised	$4.67	$4.46	$5.37
Forfeited (in Shares)	-7,000	-130,000	-19,000
Forfeited	$12.81	$6.42	$5.33
Outstanding at end of year (in Shares)	1,786,000	2,652,000	2,776,000
Outstanding at end of year	$6.89	$6.19	$6.12
Exercisable at end of year (in Shares)	1,786,000	2,206,000	1,228,000
Exercisable at end of year	$6.89	$6.31	$6.51
Weighted-average fair value of options granted	'	$3.76	$7.48

Note_16_Benefit_Plans_Details_9

Note 16 - Benefit Plans (Details) - Aggregate Intrinsic Value (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Aggregate Intrinsic Value [Abstract]	'	'	'
Options outstanding as of December 31	$9,814	$2,045	$3,770
Options exercisable as of December 31	9,814	1,660	1,716
Options exercised during the year	$5,430	$224	$4,365

Recovered_Sheet1

Note 16 - Benefit Plans (Details) - Stock Options Outstanding (USD $)	12 Months Ended
	Dec. 31, 2013
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding (in Shares)	1,785,799
Range of $2.22 - 4.70 [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Exercise Price Range, Lower Limit	$2.22
Exercise Price Range, Upper Limit	$4.70
Number Outstanding (in Shares)	420,097
Weighted Average Remaining Contractual Life	'5 years 328 days
Weighted Average Exercise Prices	$4.50
Range of $4.71 - 6.00 [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Exercise Price Range, Lower Limit	$4.71
Exercise Price Range, Upper Limit	$6
Number Outstanding (in Shares)	34,000
Weighted Average Remaining Contractual Life	'4 years 219 days
Weighted Average Exercise Prices	$5.13
Range of $6.01 - 7.55 [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Exercise Price Range, Lower Limit	$6.01
Exercise Price Range, Upper Limit	$7.55
Number Outstanding (in Shares)	1,157,502
Weighted Average Remaining Contractual Life	'6 years 292 days
Weighted Average Exercise Prices	$6.99
Range of $7.56 - 10.58 [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Exercise Price Range, Lower Limit	$7.56
Exercise Price Range, Upper Limit	$10.58
Number Outstanding (in Shares)	44,200
Weighted Average Remaining Contractual Life	'3 years 219 days
Weighted Average Exercise Prices	$8.65
Range of $10.59 - 15.88 [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Exercise Price Range, Lower Limit	$10.59
Exercise Price Range, Upper Limit	$15.88
Number Outstanding (in Shares)	130,000
Weighted Average Remaining Contractual Life	'5 years 292 days
Weighted Average Exercise Prices	$13.59

Recovered_Sheet2

Note 16 - Benefit Plans (Details) - Nonvested Options (Nonvested [Member], USD $)	12 Months Ended
	Dec. 31, 2013
Nonvested [Member]	'
Note 16 - Benefit Plans (Details) - Nonvested Options [Line Items]	'
Nonvested options as of January 1, 2013	446,671
Nonvested options as of January 1, 2013 (in Dollars per share)	$3.21
Vested	-466,671
Vested (in Dollars per share)	$3.21
Nonvested options as of December 31, 2013	0
Nonvested options as of December 31, 2013 (in Dollars per share)	$0

Recovered_Sheet3

Note 16 - Benefit Plans (Details) - Restricted Stock Issued and Outstanding Under The 2006 Long-Term Incentive Plan (USD $)	12 Months Ended
	Dec. 31, 2013
Note 16 - Benefit Plans (Details) - Restricted Stock Issued and Outstanding Under The 2006 Long-Term Incentive Plan [Line Items]	'
Grant Date Fair Value (in Dollars per share)	$8.60
Restricted Stock Issued and Outstanding	58,036
Februay 28, 2013 [Member] | The 2006 Long-Term Incentive Plan [Member]	'
Note 16 - Benefit Plans (Details) - Restricted Stock Issued and Outstanding Under The 2006 Long-Term Incentive Plan [Line Items]	'
Grant Date Fair Value (in Dollars per share)	$7.97
Restricted Stock Issued and Outstanding	25,000
July 1, 2013 [Member] | The 2006 Long-Term Incentive Plan [Member]	'
Note 16 - Benefit Plans (Details) - Restricted Stock Issued and Outstanding Under The 2006 Long-Term Incentive Plan [Line Items]	'
Grant Date Fair Value (in Dollars per share)	$9.08
Restricted Stock Issued and Outstanding	33,036
The 2006 Long-Term Incentive Plan [Member]	'
Note 16 - Benefit Plans (Details) - Restricted Stock Issued and Outstanding Under The 2006 Long-Term Incentive Plan [Line Items]	'
Restricted Stock Issued and Outstanding	58,036

Recovered_Sheet4

Note 16 - Benefit Plans (Details) - A Summary of the Company’s Non-Vested Restricted Stock Activity (USD $)	12 Months Ended
	Dec. 31, 2013
A Summary of the Company’s Non-Vested Restricted Stock Activity [Abstract]	'
Outstanding at beginning of year	420,698
Outstanding at beginning of year (in Dollars per share)	$7.19
Granted	58,036
Granted (in Dollars per share)	$8.60
Outstanding at end of year	478,734
Outstanding at end of year (in Dollars per share)	$7.36

Note_17_Hurricane_Losses_Insur1

Note 17 - Hurricane Losses, Insurance Recoveries and Other Proceeds (Details) (USD $)	1 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2011	Dec. 31, 2011
		Storm 2005 [Member]
Note 17 - Hurricane Losses, Insurance Recoveries and Other Proceeds (Details) [Line Items]	'	'
Loss from Catastrophes	($26,200)	($787)

Note_18_Commitments_And_Contin2

Note 18 - Commitments And Contingencies (Details) (USD $)

1 Months Ended

3 Months Ended

12 Months Ended

1 Months Ended

7 Months Ended

1 Months Ended

12 Months Ended

Jun. 30, 2013

Dec. 31, 2012

Sep. 30, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Apr. 25, 2013

Apr. 25, 2013

Apr. 25, 2013

Apr. 25, 2013

Apr. 25, 2013

Jul. 31, 2013

Jun. 30, 2013

Jun. 30, 2013

Jul. 31, 2013

18-May-11

Dec. 31, 2011

18-May-11

Jun. 30, 2013

Dec. 31, 2013

Dec. 31, 2013

Reduced Earn Out Of Original Formula In 2013 [Member]

Annual Earn Out Payment of EBITDA, Low Percentage [Member]

Annual Earn Out Payment of EBITDA, Low Level [Member]

Annual Earn Out Payment of EBITDA, High Percentage [Member]

Annual Earn Out Payment of EBITDA, High Level [Member]

Fine [Member]

Fine [Member]

Required Contribution [Member]

Contribution [Member]

Mssissippi Ship Channel [Member]

Insurance Value Of Vessel [Member]

Insurance Value Of Vessel [Member]

Salvage Cost [Member]

Minimum [Member]

Maximum [Member]

Note 18 - Commitments And Contingencies (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Operating Lease Term

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'1 year

'7 years

Operating Leases, Rent Expense

'

'

'

$2,700,000

$2,400,000

$2,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Annual Earn Out Payments Percentage of EBITDA

'

'

'

'

'

'

35.00%

3.25%

'

19.50%

'

'

'

'

'

'

'

'

'

'

'

Earnings Before Deduction Of Interest Tax And Amortization Expense

'

'

'

'

'

'

'

'

3,000,000

'

12,000,000

'

'

'

'

'

'

'

'

'

'

Insurance Settlements Receivable

'

8,572,000

'

3,048,000

8,572,000

'

'

'

'

'

'

'

'

'

'

5,900,000

'

1,800,000

'

'

'

Proceeds from Insurance Settlement, Operating Activities

3,100,000

'

'

'

300,000

'

'

'

'

'

'

'

'

'

'

'

1,800,000

'

5,700,000

'

'

Litigation Settlement, Amount

'

'

'

'

'

'

'

'

'

'

'

'

5,500,000

2,000,000

'

'

'

'

'

'

'

Payments for Legal Settlements

'

'

'

'

'

'

'

'

'

'

'

5,500,000

'

'

2,000,000

'

'

'

'

'

'

Charges Related to US Attorney Investigation

'

$3,600,000

$4,100,000

'

$7,990,000

$545,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of 2011 Fish Catch

'

'

'

'

'

1.60%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Note_18_Commitments_And_Contin3

Note 18 - Commitments And Contingencies (Details) - Future Minimum Payments Under Non-Cancelable Operating Lease Obligations (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Future Minimum Payments Under Non-Cancelable Operating Lease Obligations [Abstract]	'
	$2,861
	2,502
	1,728
	1,613
	1,559
	$1,472

Note_19_Related_Party_Transact1

Note 19 - Related Party Transactions (Details) (USD $)	4 Months Ended	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2013	Dec. 31, 2012
Note 19 - Related Party Transactions (Details) [Line Items]	'	'	'
Related Party Transaction, Other Revenues from Transactions with Related Party	$200,000	$500,000	$300,000
Related Party Transaction, Purchases from Related Party	'	82,500	2,500
InCon [Member]	'	'	'
Note 19 - Related Party Transactions (Details) [Line Items]	'	'	'
Proceeds from Previous Acquisition	'	'	$200,000

Note_20_Industry_Segment_and_G2

Note 20 - Industry Segment and Geographic Information (Details) (USD $)

3 Months Ended

12 Months Ended

In Thousands, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Note 20 - Industry Segment and Geographic Information (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Number of Reportable Segments

'

'

'

'

'

'

'

'

2

'

'

Revenues

$65,973

[1]

$87,620

[1]

$41,777

[1]

$48,923

[1]

$63,133

[1]

$83,970

[1]

$47,448

[1]

$41,088

[1]

$244,293

[2]

$235,639

[3]

$251,743

[4]

Export Sales [Member]

'

'

'

'

'

'

'

'

'

'

'

Note 20 - Industry Segment and Geographic Information (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

'

'

'

'

120,000

142,000

165,000

Transferred From Animal Nutrition To Human Nutrition Segment [Member]

'

'

'

'

'

'

'

'

'

'

'

Note 20 - Industry Segment and Geographic Information (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

'

'

'

'

1,300

1,600

400

Customer A [Member]

'

'

'

'

'

'

'

'

'

'

'

Note 20 - Industry Segment and Geographic Information (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

'

'

'

'

22,700

43,500

38,600

Customer B [Member]

'

'

'

'

'

'

'

'

'

'

'

Note 20 - Industry Segment and Geographic Information (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

'

'

'

'

'

'

36,800

CHINA

'

'

'

'

'

'

'

'

'

'

'

Note 20 - Industry Segment and Geographic Information (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

'

'

'

'

$47,400

$89,500

$102,600

[1]

Revenues, gross profit, operating income, and net income (loss) are rounded to thousands each quarter. Therefore, the sum of the quarterly amounts may not equal the annual amounts reported.

[2]

Excludes revenue from internal customers of $1.3 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.

[3]

Excludes revenue from internal customers of $1.6 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.

[4]

Excludes revenue from internal customers of $0.4 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.

Note_20_Industry_Segment_and_G3

Note 20 - Industry Segment and Geographic Information (Details) - Reported Segments (USD $)

3 Months Ended

12 Months Ended

In Thousands, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenue

$65,973

[1]

$87,620

[1]

$41,777

[1]

$48,923

[1]

$63,133

[1]

$83,970

[1]

$47,448

[1]

$41,088

[1]

$244,293

[2]

$235,639

[3]

$251,743

[4]

Cost of sales

'

'

'

'

'

'

'

'

161,543

193,583

197,069

Gross profit

27,950

[1],[5]

29,420

[1],[5]

13,283

[1],[5]

12,097

[1],[5]

12,919

[1]

13,398

[1]

6,847

[1]

8,892

[1]

82,750

42,056

54,674

Selling, general and administrative expenses (including research and development)

'

'

'

'

'

'

'

'

27,700

23,946

24,638

Charges related to U.S. Attorney investigation

'

'

'

'

3,600

4,100

'

'

'

7,990

545

Other (gains) and losses

'

'

'

'

'

'

'

'

440

-2,506

-24,868

Operating income

14,679

[1],[6]

21,921

[1],[6]

6,690

[1],[6]

4,723

[1],[6]

2,351

[1],[7]

2,904

[1],[7]

4,201

[1],[7]

3,170

[1],[7]

48,013

12,626

54,359

Depreciation and amortization

'

'

'

'

'

'

'

'

21,056

17,999

16,430

Identifiable assets

331,394

'

'

'

295,296

'

'

'

331,394

295,296

277,830

Capital expenditures

'

'

'

'

'

'

'

'

24,796

25,064

23,352

Animal Nutrition [Member] | Plant Closure [Member]

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Loss related to plant closure

'

'

'

'

'

'

'

'

6,597

'

'

Animal Nutrition [Member]

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenue

'

'

'

'

'

'

'

'

213,236

[2]

213,624

[3]

236,489

[4]

Cost of sales

'

'

'

'

'

'

'

'

136,146

176,588

187,092

Gross profit

'

'

'

'

'

'

'

'

77,090

37,036

49,397

Selling, general and administrative expenses (including research and development)

'

'

'

'

'

'

'

'

2,744

2,564

2,804

Charges related to U.S. Attorney investigation

'

'

'

'

'

'

'

'

'

7,990

545

Other (gains) and losses

'

'

'

'

'

'

'

'

140

-2,635

-24,869

Operating income

'

'

'

'

'

'

'

'

67,609

29,117

70,917

Depreciation and amortization

'

'

'

'

'

'

'

'

17,946

15,859

15,098

Identifiable assets

277,063

'

'

'

266,307

'

'

'

277,063

266,307

248,672

Capital expenditures

'

'

'

'

'

'

'

'

19,080

22,810

22,542

Human Nutrition [Member] | Plant Closure [Member]

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Loss related to plant closure

'

'

'

'

'

'

'

'

'

[8]

'

'

Human Nutrition [Member]

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenue

'

'

'

'

'

'

'

'

31,057

[2],[8]

22,015

[3]

15,254

[4]

Cost of sales

'

'

'

'

'

'

'

'

25,397

[8]

16,995

9,977

Gross profit

'

'

'

'

'

'

'

'

5,660

[8]

5,020

5,277

Selling, general and administrative expenses (including research and development)

'

'

'

'

'

'

'

'

6,959

[8]

3,795

3,286

Other (gains) and losses

'

'

'

'

'

'

'

'

305

[8]

129

1

Operating income

'

'

'

'

'

'

'

'

-1,604

[8]

1,096

1,990

Depreciation and amortization

'

'

'

'

'

'

'

'

2,369

[8]

1,315

648

Identifiable assets

53,093

[8]

'

'

'

27,109

'

'

'

53,093

[8]

27,109

27,048

Capital expenditures

'

'

'

'

'

'

'

'

5,350

[8]

1,759

566

Unallocated [Member]

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenue

'

'

'

'

'

'

'

'

'

[2]

'

[3]

'

[4]

Selling, general and administrative expenses (including research and development)

'

'

'

'

'

'

'

'

17,997

17,587

18,548

Other (gains) and losses

'

'

'

'

'

'

'

'

-5

'

'

Operating income

'

'

'

'

'

'

'

'

-17,992

-17,587

-18,548

Depreciation and amortization

'

'

'

'

'

'

'

'

741

825

684

Identifiable assets

1,238

'

'

'

1,880

'

'

'

1,238

1,880

2,110

Capital expenditures

'

'

'

'

'

'

'

'

366

495

244

Plant Closure [Member]

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Loss related to plant closure

$6,600

'

'

'

'

'

'

'

$6,597

'

'

[1]

Revenues, gross profit, operating income, and net income (loss) are rounded to thousands each quarter. Therefore, the sum of the quarterly amounts may not equal the annual amounts reported.

[2]

Excludes revenue from internal customers of $1.3 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.

[3]

Excludes revenue from internal customers of $1.6 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.

[4]

Excludes revenue from internal customers of $0.4 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.

[5]

Gross profit as a percentage of revenues for the quarter ended December 31, 2013 increased substantially as compared to the previous three quarters of 2013. This increase was due to greater than anticipated inventory production after September 30, 2013. As a result, standard cost for 2013 inventory, for which sales commenced largely in the third quarter of 2013, was decreased and cumulatively adjusted all previous sales of 2013 inventory production during the quarter ended December 31, 2013. The impact of the change in standard cost to the quarter ended December 31, 2013 is estimated to be approximately $4 million.

[6]

Included in the quarter ended December 31, 2013 expense is a $6.6 million charge related to the loss on the plant closure.

[7]

Included in the quarter ended September 30, 2012 expense is a $4.1 million charge related to the U.S. Attorney investigation. A similar additional charge of $3.6 million was recognized for the quarter ended December 31, 2012. These charges were non-deductible for federal tax purposes.

[8]

Includes revenues and related expenses for WSP from February 27, 2013 through December 31, 2013.

Note_20_Industry_Segment_and_G4

Note 20 - Industry Segment and Geographic Information (Details) - A Reconciliation of Total Segment Operating Income to Total Earnings from Operations Before Income Taxes (USD $)

3 Months Ended

12 Months Ended

In Thousands, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

A Reconciliation of Total Segment Operating Income to Total Earnings from Operations Before Income Taxes [Abstract]

'

'

'

'

'

'

'

'

'

'

'

Operating income for reportable segments

$14,679

[1],[2]

$21,921

[1],[2]

$6,690

[1],[2]

$4,723

[1],[2]

$2,351

[1],[3]

$2,904

[1],[3]

$4,201

[1],[3]

$3,170

[1],[3]

$48,013

$12,626

$54,359

Interest income

'

'

'

'

'

'

'

'

18

32

43

Interest expense

'

'

'

'

'

'

'

'

-1,658

-1,335

-2,109

Other expense, net

'

'

'

'

'

'

'

'

-394

-365

-408

Income before income taxes

'

'

'

'

'

'

'

'

$45,979

$10,958

$51,885

[1]

Revenues, gross profit, operating income, and net income (loss) are rounded to thousands each quarter. Therefore, the sum of the quarterly amounts may not equal the annual amounts reported.

[2]

Included in the quarter ended December 31, 2013 expense is a $6.6 million charge related to the loss on the plant closure.

[3]

Included in the quarter ended September 30, 2012 expense is a $4.1 million charge related to the U.S. Attorney investigation. A similar additional charge of $3.6 million was recognized for the quarter ended December 31, 2012. These charges were non-deductible for federal tax purposes.

Note_20_Industry_Segment_and_G5

Note 20 - Industry Segment and Geographic Information (Details) - Geographical Distribution of Revenues (USD $)

3 Months Ended

12 Months Ended

In Thousands, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Note 20 - Industry Segment and Geographic Information (Details) - Geographical Distribution of Revenues [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues (in Dollars)

$65,973

[1]

$87,620

[1]

$41,777

[1]

$48,923

[1]

$63,133

[1]

$83,970

[1]

$47,448

[1]

$41,088

[1]

$244,293

[2]

$235,639

[3]

$251,743

[4]

Percent

'

'

'

'

'

'

'

'

100.00%

100.00%

100.00%

UNITED STATES

'

'

'

'

'

'

'

'

'

'

'

Note 20 - Industry Segment and Geographic Information (Details) - Geographical Distribution of Revenues [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues (in Dollars)

'

'

'

'

'

'

'

'

123,900

93,800

86,600

Percent

'

'

'

'

'

'

'

'

50.70%

39.80%

34.40%

MEXICO

'

'

'

'

'

'

'

'

'

'

'

Note 20 - Industry Segment and Geographic Information (Details) - Geographical Distribution of Revenues [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues (in Dollars)

'

'

'

'

'

'

'

'

1,300

900

900

Percent

'

'

'

'

'

'

'

'

0.50%

0.40%

0.30%

Europe [Member]

'

'

'

'

'

'

'

'

'

'

'

Note 20 - Industry Segment and Geographic Information (Details) - Geographical Distribution of Revenues [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues (in Dollars)

'

'

'

'

'

'

'

'

31,500

18,600

30,300

Percent

'

'

'

'

'

'

'

'

12.90%

7.90%

12.10%

CANADA

'

'

'

'

'

'

'

'

'

'

'

Note 20 - Industry Segment and Geographic Information (Details) - Geographical Distribution of Revenues [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues (in Dollars)

'

'

'

'

'

'

'

'

11,600

13,200

15,400

Percent

'

'

'

'

'

'

'

'

4.80%

5.60%

6.10%

Asia [Member]

'

'

'

'

'

'

'

'

'

'

'

Note 20 - Industry Segment and Geographic Information (Details) - Geographical Distribution of Revenues [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues (in Dollars)

'

'

'

'

'

'

'

'

70,900

[5]

104,200

[5]

114,300

[5]

Percent

'

'

'

'

'

'

'

'

29.00%

[5]

44.20%

[5]

45.40%

[5]

South and Central America [Member]

'

'

'

'

'

'

'

'

'

'

'

Note 20 - Industry Segment and Geographic Information (Details) - Geographical Distribution of Revenues [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues (in Dollars)

'

'

'

'

'

'

'

'

4,800

4,700

4,000

Percent

'

'

'

'

'

'

'

'

2.00%

2.00%

1.60%

Other Region [Member]

'

'

'

'

'

'

'

'

'

'

'

Note 20 - Industry Segment and Geographic Information (Details) - Geographical Distribution of Revenues [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues (in Dollars)

'

'

'

'

'

'

'

'

$300

$200

$200

Percent

'

'

'

'

'

'

'

'

0.10%

0.10%

0.10%

[1]

Revenues, gross profit, operating income, and net income (loss) are rounded to thousands each quarter. Therefore, the sum of the quarterly amounts may not equal the annual amounts reported.

[2]

Excludes revenue from internal customers of $1.3 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.

[3]

Excludes revenue from internal customers of $1.6 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.

[4]

Excludes revenue from internal customers of $0.4 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.

[5]

Of this balance, China comprised approximately $47.4 million, $89.5 million and $102.6 million for the years ended December 31, 2013, 2012 and 2011, respectively.

Note_20_Industry_Segment_and_G6

Note 20 - Industry Segment and Geographic Information (Details) - Revenues by Product (USD $)

3 Months Ended

12 Months Ended

In Thousands, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Revenue from External Customer [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues (in Dollars)

$65,973

[1]

$87,620

[1]

$41,777

[1]

$48,923

[1]

$63,133

[1]

$83,970

[1]

$47,448

[1]

$41,088

[1]

$244,293

[2]

$235,639

[3]

$251,743

[4]

Percent

'

'

'

'

'

'

'

'

100.00%

100.00%

100.00%

Fish Meal [Member]

'

'

'

'

'

'

'

'

'

'

'

Revenue from External Customer [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues (in Dollars)

'

'

'

'

'

'

'

'

142,500

160,700

175,500

Percent

'

'

'

'

'

'

'

'

58.30%

68.20%

69.80%

Fish Oil [Member]

'

'

'

'

'

'

'

'

'

'

'

Revenue from External Customer [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues (in Dollars)

'

'

'

'

'

'

'

'

43,800

27,600

39,600

Percent

'

'

'

'

'

'

'

'

18.00%

11.70%

15.70%

Refined Fish Oil [Member]

'

'

'

'

'

'

'

'

'

'

'

Revenue from External Customer [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues (in Dollars)

'

'

'

'

'

'

'

'

22,700

17,800

15,600

Percent

'

'

'

'

'

'

'

'

9.30%

7.60%

6.20%

Fish Solubles and Other [Member]

'

'

'

'

'

'

'

'

'

'

'

Revenue from External Customer [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues (in Dollars)

'

'

'

'

'

'

'

'

4,200

7,500

5,800

Percent

'

'

'

'

'

'

'

'

1.70%

3.20%

2.30%

Dietary Supplement and Food Ingredients and Products [Member]

'

'

'

'

'

'

'

'

'

'

'

Revenue from External Customer [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues (in Dollars)

'

'

'

'

'

'

'

'

$31,100

$22,000

$15,200

Percent

'

'

'

'

'

'

'

'

12.70%

9.30%

6.00%

[1]

Revenues, gross profit, operating income, and net income (loss) are rounded to thousands each quarter. Therefore, the sum of the quarterly amounts may not equal the annual amounts reported.

[2]

Excludes revenue from internal customers of $1.3 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.

[3]

Excludes revenue from internal customers of $1.6 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.

[4]

Excludes revenue from internal customers of $0.4 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.

Note_21_Fair_Value_Disclosures2

Note 21 - Fair Value Disclosures (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Fair Value Disclosures [Abstract]	'	'
Letters of Credit Outstanding, Amount	$3.50	$3.10

Note_21_Fair_Value_Disclosures3

Note 21 - Fair Value Disclosures (Details) - Table of Long-Term Debt, Carrying Value and Fair Value (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Table of Long-Term Debt, Carrying Value and Fair Value [Abstract]	'	'
Carrying Value	$24,242	$27,300
Estimated Fair Value	$25,285	$29,940

Note_21_Fair_Value_Disclosures4

Note 21 - Fair Value Disclosures (Details) - Table of Fair Value, Assets and Liabilities Accounted for an a Recurring Basis (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Note 21 - Fair Value Disclosures (Details) - Table of Fair Value, Assets and Liabilities Accounted for an a Recurring Basis [Line Items]	'	'
Fair Value of derivative asset	$275	$134
Energy Swap [Member] | Fair Value, Inputs, Level 1 [Member]	'	'
Note 21 - Fair Value Disclosures (Details) - Table of Fair Value, Assets and Liabilities Accounted for an a Recurring Basis [Line Items]	'	'
Fair Value of derivative asset	0	0
Energy Swap [Member] | Fair Value, Inputs, Level 2 [Member]	'	'
Note 21 - Fair Value Disclosures (Details) - Table of Fair Value, Assets and Liabilities Accounted for an a Recurring Basis [Line Items]	'	'
Fair Value of derivative asset	275	134
Energy Swap [Member] | Fair Value, Inputs, Level 3 [Member]	'	'
Note 21 - Fair Value Disclosures (Details) - Table of Fair Value, Assets and Liabilities Accounted for an a Recurring Basis [Line Items]	'	'
Fair Value of derivative asset	0	0
Energy Swap [Member]	'	'
Note 21 - Fair Value Disclosures (Details) - Table of Fair Value, Assets and Liabilities Accounted for an a Recurring Basis [Line Items]	'	'
Fair Value of derivative asset	275	134
Fair Value, Inputs, Level 1 [Member]	'	'
Note 21 - Fair Value Disclosures (Details) - Table of Fair Value, Assets and Liabilities Accounted for an a Recurring Basis [Line Items]	'	'
Fair Value of derivative asset	0	0
Fair Value, Inputs, Level 2 [Member]	'	'
Note 21 - Fair Value Disclosures (Details) - Table of Fair Value, Assets and Liabilities Accounted for an a Recurring Basis [Line Items]	'	'
Fair Value of derivative asset	275	134
Fair Value, Inputs, Level 3 [Member]	'	'
Note 21 - Fair Value Disclosures (Details) - Table of Fair Value, Assets and Liabilities Accounted for an a Recurring Basis [Line Items]	'	'
Fair Value of derivative asset	$0	'

Note_21_Fair_Value_Disclosures5

Note 21 - Fair Value Disclosures (Details) - Table of Fair Value, Assets Accounted for on a Recurring Basis, Level 3 Inputs (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2012
Table of Fair Value, Assets Accounted for on a Recurring Basis, Level 3 Inputs [Abstract]	'
Beginning Balance	($103)
Net Loss reclassified into interest expense related to interest rate swap transactions unrealized	0
Net change associated with current period interest rate swap transactions realized	103
Ending Balance	$0

Note_22_Shareholder_Rights_Pla1

Note 22 - Shareholder Rights Plan (Details)	12 Months Ended
	Dec. 31, 2013
Stockholders' Equity Note [Abstract]	'
Number of Rights Dividend Declared for Each Outstanding Common Stock	1
Discount on Common Stock Each Right Holder is Entitled to Pursuant to Shareholder Rights Plan	50.00%
Percent of Common Stock Acquired	15.00%
Percent of Assets or Earnings Power Sold or Transferred	50.00%
Redemption Price Per Right (in Dollars per Item)	0.01
Rights Extension Period	'10 years

Note_23_Quarterly_Financial_Da2

Note 23 - Quarterly Financial Data (Unaudited) (Details) (USD $)	3 Months Ended			12 Months Ended		3 Months Ended	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013	Dec. 31, 2013
						Plant Closure [Member]	Plant Closure [Member]
Note 23 - Quarterly Financial Data (Unaudited) (Details) [Line Items]	'	'	'	'	'	'	'
Charges Related to US Attorney Investigation	'	$3,600,000	$4,100,000	$7,990,000	$545,000	'	'
Change in Standard Cost, Estimated Impact on Gross Profit	4,000,000	'	'	'	'	'	'
Gain (Loss) on Disposition of Assets	'	'	'	'	'	($6,600,000)	($6,597,000)

Note_23_Quarterly_Financial_Da3

Note 23 - Quarterly Financial Data (Unaudited) (Details) - Unaudited Operating Results (USD $)

3 Months Ended

12 Months Ended

In Thousands, except Per Share data, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Unaudited Operating Results [Abstract]

'

'

'

'

'

'

'

'

'

'

'

Revenues (1)

$65,973

[1]

$87,620

[1]

$41,777

[1]

$48,923

[1]

$63,133

[1]

$83,970

[1]

$47,448

[1]

$41,088

[1]

$244,293

[2]

$235,639

[3]

$251,743

[4]

Gross profit (1) (4)

27,950

[1],[5]

29,420

[1],[5]

13,283

[1],[5]

12,097

[1],[5]

12,919

[1]

13,398

[1]

6,847

[1]

8,892

[1]

82,750

42,056

54,674

Operating income (1)(5)

14,679

[1],[6]

21,921

[1],[6]

6,690

[1],[6]

4,723

[1],[6]

2,351

[1],[7]

2,904

[1],[7]

4,201

[1],[7]

3,170

[1],[7]

48,013

12,626

54,359

Net income (1)

$9,718

[1]

$13,962

[1]

$3,990

[1]

$2,845

[1]

($508)

[1],[7]

$231

[1],[7]

$2,510

[1],[7]

$1,830

[1],[7]

$30,515

$4,063

$34,157

Earnings per share (2):

'

'

'

'

'

'

'

'

'

'

'

Basic (in Dollars per share)

$0.47

[8]

$0.68

[8]

$0.20

[8]

$0.14

[8]

($0.03)

[8]

$0.01

[8]

$0.13

[8]

$0.09

[8]

$1.50

$0.21

$1.77

Diluted (in Dollars per share)

$0.45

[8]

$0.66

[8]

$0.19

[8]

$0.14

[8]

($0.03)

[8]

$0.01

[8]

$0.13

[8]

$0.09

[8]

$1.45

$0.20

$1.71

[1]

Revenues, gross profit, operating income, and net income (loss) are rounded to thousands each quarter. Therefore, the sum of the quarterly amounts may not equal the annual amounts reported.

[2]

Excludes revenue from internal customers of $1.3 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.

[3]

Excludes revenue from internal customers of $1.6 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.

[4]

Excludes revenue from internal customers of $0.4 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.

[5]

Gross profit as a percentage of revenues for the quarter ended December 31, 2013 increased substantially as compared to the previous three quarters of 2013. This increase was due to greater than anticipated inventory production after September 30, 2013. As a result, standard cost for 2013 inventory, for which sales commenced largely in the third quarter of 2013, was decreased and cumulatively adjusted all previous sales of 2013 inventory production during the quarter ended December 31, 2013. The impact of the change in standard cost to the quarter ended December 31, 2013 is estimated to be approximately $4 million.

[6]

Included in the quarter ended December 31, 2013 expense is a $6.6 million charge related to the loss on the plant closure.

[7]

Included in the quarter ended September 30, 2012 expense is a $4.1 million charge related to the U.S. Attorney investigation. A similar additional charge of $3.6 million was recognized for the quarter ended December 31, 2012. These charges were non-deductible for federal tax purposes.

[8]

Earnings per share are computed independently for each quarter and the full year based upon respective average shares outstanding. Therefore, the sum of the quarterly earnings per share amounts may not equal the annual amounts reported.

Schedule_of_Valuation_and_Qual2

Schedule of Valuation and Qualifying Accounts (Details) (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2011	Dec. 31, 2013
		InCon [Member]	Wisconsin Specialty Protein [Member]
Schedule of Valuation and Qualifying Accounts (Details) [Line Items]	'	'	'
Valuation Allowances and Reserves, Reserves of Businesses Acquired	'	$33,000	$47,822
Allowance for Doubtful Accounts Receivable, Write-offs	$200,000	'	'

Schedule_of_Valuation_and_Qual3

Schedule of Valuation and Qualifying Accounts (Details) - Summary of Valuation Allowance (Allowance for Doubtful Accounts [Member], USD $)	12 Months Ended
	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Allowance for Doubtful Accounts [Member]	'		'		'
Financing Receivable, Allowance for Credit Losses [Line Items]	'		'		'
Allowance for doubtful accounts	$341,061	[1]	$293,061	[1]	$371,340	[1]
Allowance for doubtful accounts	103,322	[1],[2]	48,000	[1]	81,000	[1],[3]
Allowance for doubtful accounts	57,602	[1]	'	[1]	159,279	[1],[4]
Allowance for doubtful accounts	$386,781	[1]	$341,061	[1]	$293,061	[1]
[1]	Includes allowance for doubtful accounts receivable and insurance receivable.
[2]	During 2013, the acquisition of WSP added an additional $47,822 to the allowance for doubtful accounts.
[3]	During 2011, the acquisition of InCon added an additional $33,000 to the allowance for doubtful accounts.
[4]	During 2011, a fully reserved insurance receivable of $0.2 million was written off.